Document:

NONE OF THE SECURITIES TO WHICH THIS
PRIVATE PLACEMENT SUBSCRIPTION AGREEMENT (THE “SUBSCRIPTION AGREEMENT”) RELATES HAVE BEEN REGISTERED UNDER THE 1933
ACT, OR ANY U.S. STATE SECURITIES LAWS, AND, UNLESS SO REGISTERED, NONE MAY BE OFFERED OR SOLD, DIRECTLY OR INDIRECTLY, IN THE
UNITED STATES OR TO U.S. PERSONS (AS DEFINED HEREIN) EXCEPT IN ACCORDANCE WITH THE PROVISIONS OF REGULATION S UNDER THE 1933 ACT,
PURSUANT TO AN EFFECTIVE REGISTRATION STATEMENT UNDER THE 1933 ACT, OR PURSUANT TO AN AVAILABLE EXEMPTION FROM, OR IN A TRANSACTION
NOT SUBJECT TO, THE REGISTRATION REQUIREMENTS OF THE 1933 ACT AND IN EACH CASE ONLY IN ACCORDANCE WITH APPLICABLE STATE SECURITIES
LAWS.  IN ADDITION, HEDGING TRANSACTIONS INVOLVING THE SECURITIES MAY NOT BE CONDUCTED UNLESS IN ACCORDANCE WITH THE 1933
ACT.

 

SUBSCRIPTION AGREEMENT

 

1.            PURCHASE
AND SALE.

 

1.1          The undersigned
(the “Subscriber”) hereby irrevocably subscribes for and agrees to purchase from the Company the amount set forth on
the signature page hereto (the “Subscription Proceeds”), on the basis of the representations and warranties and subject
to the terms and conditions set forth herein, up to 1,000,000 units at a price of $.15 per Unit (the “Offering”), with
each “Unit” consisting of one share of Common Stock of the Company and a warrant (in the form annexed hereto) to purchase
two shares of Common Stock of the Company at a price of $.64 per share for a period of three years (such subscription and agreement
to purchase being the “Subscription”). Subject to the terms hereof, the Subscription will be effective upon its acceptance
by the Company. The Offering is not subject to any minimum aggregate subscription level.

 

2.            THE
TRANSACTION.

 

2.1          The Subscription Proceeds must
accompany this Subscription and shall be paid to the Company by wire transfer or by check of immediately available funds. The wiring
instructions are provided on the Acceptance page of this Subscription Agreement.

 

2.2           The
Subscriber acknowledges and agrees that this Subscription Agreement, the Subscription Proceeds and any other documents delivered
in connection herewith will be held on behalf of the Company.  In the event that this Subscription Agreement is not accepted
by the Company for whatever reason, which the Company expressly reserves the right to do, within 30 days of the delivery of an
executed Subscription Agreement by the Subscriber, this Subscription Agreement, the Subscription Proceeds (without interest thereon)
and any other documents delivered in connection herewith will be returned to the Subscriber at the address of the Subscriber as
set forth in this Subscription Agreement.

 

2.3           Where
the Subscription Proceeds are paid to the Company, the Company is entitled to treat such Subscription Proceeds as an interest free
loan to the Company until such time as the Subscription is accepted and the certificates representing the Units have been issued
to the Subscriber.

 

2.4           Closing
of the Offering (the “Closing”) shall occur on or before such date as may be determined by the Company (the “Closing
Date”).

 

2.5           The
Company may, at its discretion, elect to close the Offering in one or more closings, in which event the Company may agree with
one or more subscribers (including the Subscriber hereunder) to complete delivery of the securities underlying the Units to such
subscriber(s) against payment therefor at any time on or prior to the Closing Date.

 

    	 

    	 

    

 

3.          REPRESENTATIONS
AND WARRANTIES OF THE COMPANY.

 

As a material inducement
to the Subscriber to enter into this Agreement and to acquire the Units, the Company represents and warrants that the following
statements are true and correct in all material respects, except as expressly qualified or modified herein.

 

3.1           Validity
of Transactions. This Agreement, and each document executed and delivered by the Company in connection with the transactions
contemplated by this Agreement, have been duly authorized, executed and delivered by the Company and is each the valid and legally
binding obligation of the Company, enforceable in accordance with its terms, except as limited by applicable bankruptcy, insolvency
reorganization and moratorium laws and other laws affecting enforcement of creditor’s rights generally and by general principles
of equity.

 

3.2           Valid
Issuance. The securities underlying the Units that are being sold to the Subscriber hereunder are duly and validly issued,
fully paid and nonassessable and free of restrictions on transfer, other than restrictions on transfer under this Agreement and
under applicable federal and state securities laws, and will be free of all other liens and adverse claims.

 

3.3           Securities
Law Compliance. Assuming the accuracy of the representations and warranties of the Subscriber set forth in Section 4 of this
Agreement, the offer, sale and delivery of the securities underlying the Units will constitute an exempted transaction under the
Securities Act of 1933, as amended and now in effect (“Securities Act”), and registration of the securities underlying
the Units under the Securities Act is not required.

 

4.          REPRESENTATIONS
AND WARRANTIES OF THE SUBSCRIBER.

 

Each Subscriber hereby
represents, warrants, and covenants with the Company as follows:

 

4.1           Legal
Power. The Subscriber has the requisite power to enter into this Agreement, to purchase the Units hereunder, and to carry out
and perform its obligations under the terms of this Agreement.

 

4.2           Due
Execution. This Agreement has been duly executed and delivered by Subscriber, and, upon due execution and delivery by the Company,
this Agreement will be a valid and binding agreement of the Subscriber.

 

4.3           Receipt
of Restricted Securities. The Subscriber has been advised that the Units and securities underlying the Units have not been
registered under the Securities Act or any other applicable securities laws and that the Units are being offered and sold pursuant
to Section 4(2) of the Securities Act, and that the Company’s reliance upon Section 4(2) of the Securities Act is predicated
in part on the Subscriber’s representations as contained herein.

 

4.3.1           The
Subscriber acknowledges that the Units and the securities underlying the Units have not been registered under the Securities Act
or the securities laws of any state and are being offered, and will be sold, pursuant to applicable exemptions from such registration
for nonpublic offerings and will be sold as “restricted securities” as defined by Rule 144 promulgated pursuant to
the Securities Act. The Units and securities underlying the Units may not be resold in the absence of an effective registration
thereof under the Securities Act and applicable state securities laws unless, in the opinion of the Company’s counsel, an
applicable exemption from registration is available.

 

4.3.2           The
Subscriber is acquiring the Units for its own account, for investment purposes only and not with a view to, or for sale in connection
with, a distribution, as that term is used in Section 2(11) of the Securities Act, in a manner which would require registration
under the Securities Act or any state securities laws.

 

    	2

    	 

    

 

4.3.3           The
Subscriber understands and acknowledges that the securities underlying the Units will bear the following legend (or something similar):

 

THE SECURITIES EVIDENCED BY THIS
CERTIFICATE HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED, OR THE SECURITIES LAWS OF ANY STATE. THE SECURITIES
HAVE BEEN ACQUIRED FOR INVESTMENT AND MAY NOT BE SOLD OR TRANSFERRED FOR VALUE IN THE ABSENCE OF AN EFFECTIVE REGISTRATION THEREOF
UNDER THE SECURITIES ACT OF 1933 AND/OR THE SECURITIES ACT OF ANY STATE HAVING JURISDICTION OR AN OPINION OF COUNSEL ACCEPTABLE
TO THE CORPORATION THAT SUCH REGISTRATION IS NOT REQUIRED UNDER SUCH ACT OR ACTS.

 

4.3.4           The
Subscriber acknowledges that an investment in the Units is not liquid and is transferable only under limited conditions. The Subscriber
acknowledges that such securities must be held indefinitely unless they are subsequently registered under the Securities Act or
an exemption from such registration is available. The Subscriber is aware of the provisions of Rule 144 promulgated under the Securities
Act, which permits limited resale of securities purchased in a private placement subject to the satisfaction of certain conditions
and that such Rule is not now available and, in the future, may not become available for resale of the securities underlying the
Units.

 

4.4           Subscriber
Status.  At the time the Subscriber was offered the Units, it was, and at the date hereof it is an “accredited investor”
as defined in Rule 501(a)(1), (a)(2), (a)(3), (a)(7) or (a)(8) under the Securities Act.  The Subscriber, either alone or
together with its representatives, has such knowledge, sophistication and experience in business and financial matters so as to
be capable of evaluating the merits and risks of the prospective investment in the Units, and has so evaluated the merits and risks
of such investment.  The Subscriber is able to bear the economic risk of an investment in the Units and, at the present time,
is able to afford a complete loss of such investment.

 

4.5           Access
to Information; Independent Investigation. The Subscriber, in making the decision to purchase the Units, has relied upon independent
investigations made by his/her/its representative, and the Subscriber or his/her/its representative have, prior to any sale to
the Subscriber, been given access and the opportunity to ask questions of and to receive answers from, the Company or any person
acting on its behalf concerning the books and records of the Company, all material contracts and documents of the Company, and
the terms and conditions of the transactions contemplated by this Agreement. The Subscriber or his/her/its representative has been
furnished with all materials relating to the business, finances, and operation of the Company and the Subscriber or his/her/its
representative has received complete and satisfactory answers to any and all inquiries relating thereto. Other than as contained
herein, and the business plan of the Company as supplied by the Company to the Subscriber, no other representations or warranties
have been made by the Company, either orally or in writing.

 

4.6           Miscellaneous.

 

(a)          The Subscriber is aware that an investment in the Company is speculative and involves certain risks, including the possible
loss of the investment;

 

    	3

    	 

    

 

(b)          The entering
into of this Subscription Agreement and the transactions contemplated hereby do not result in the violation of any of the terms
and provisions of any law applicable to, or, if applicable, the documents of, the Subscriber, or of any agreement, written or oral,
to which the Subscriber may be a party or by which the Subscriber is or may be bound;

 

(c)          The
Subscriber has duly executed and delivered this Subscription Agreement and it constitutes a valid and binding agreement of the
Subscriber enforceable against the Subscriber in accordance with its terms;

 

(d)          The Subscriber
understands and agrees that the Company and others will rely upon the truth and accuracy of the acknowledgements, representations
and agreements contained in this Subscription Agreement, and agrees that if any of such acknowledgements, representations and agreements
are no longer accurate or have been breached, the Subscriber shall promptly notify the Company;

 

(e)          The
Subscriber is acquiring the Units pursuant to an exemption from the registration and prospectus requirements of applicable securities
legislation in all jurisdictions relevant to this Subscription, and, as a consequence, the Subscriber will not be entitled to use
most of the civil remedies available under applicable securities legislation and the Subscriber will not receive information that
would otherwise be required to be provided to the Subscriber pursuant to applicable securities legislation;

 

(f)          The
Subscriber is not an underwriter of, or dealer in, the common shares of the Company, nor is the Subscriber participating, pursuant
to a contractual agreement or otherwise, in the distribution of the securities of the Company;

 

(g)          the Subscriber
has made an independent examination and investigation of an investment in the Units and the Company and has depended on the advice
of its legal and financial advisors and agrees that the Company will not be responsible in anyway whatsoever for the Subscriber's
decision to invest in the Units and the Company;

 

(h)          The
Subscriber

 

(i)          is
able to fend for him/her/itself in the Subscription;

 

(ii)         has
such knowledge and experience in business matters as to be capable of evaluating the merits and risks of its prospective investment
in the Units; and

 

(iii)        has
the ability to bear the economic risks of its prospective investment and can afford the complete loss of such investment;

 

(i)          The
Subscriber understands and agrees not to engage in any hedging transactions involving any of the Units unless such transactions
are in compliance with the provisions of the 1933 Act and in each case only in accordance with applicable state and federal securities
laws;

 

(j)          No
person has made to the Subscriber any written or oral representations:

 

(i)          that
any person will resell or repurchase any of the securities underlying the Units;

 

(ii)         that
any person will refund the purchase price of any of the Units;

 

    	4

    	 

    

 

(iii)        as
to the future price or value of any of the securities underlying the Units; or

 

(iv)        That
any of the securities underlying the Units will be listed and posted for trading on any stock exchange or automated dealer quotation
system or that application has been made to list and post any of the securities underlying the Units of the Company on any stock
exchange or automated dealer quotation system.

 

(k) The Subscriber has
acknowledged that the decision to purchase the Units was solely made on the basis of publicly available information. The Subscriber
hereby waives, to the fullest extent permitted by law, any rights of withdrawal, rescission or compensation for damages to which
the Subscriber might be entitled in connection with the distribution of any of the securities underlying the Units.

 

5.            MISCELLANEOUS.

 

   5.1           Governing
Law; Venue; Waiver of Jury Trial.  All questions concerning the construction, validity, enforcement and interpretation
of this Agreement shall be governed by and construed and enforced in accordance with the internal laws of the State of Connecticut,
without regard to the principles of conflicts of law thereof.  Each party hereby irrevocably submits to the exclusive jurisdiction
of the state and federal courts sitting in the County of Fairfield for the adjudication of any dispute hereunder or in connection
herewith or with any transaction contemplated hereby or discussed herein (including with respect to the enforcement of this Agreement),
and hereby irrevocably waives, and agrees not to assert in any suit, action or proceeding, any claim that it is not personally
subject to the jurisdiction of any such court, that such suit, action or proceeding is improper or inconvenient venue for such
proceeding.  Each party hereby irrevocably waives personal service of process and consents to process being served in any
such suit, action or proceeding by mailing a copy thereof via registered or certified mail or overnight delivery (with evidence
of delivery) to such party at the address in effect for notices to it under this Agreement and agrees that such service shall constitute
good and sufficient service of process and notice thereof.  Nothing contained herein shall be deemed to limit in any way any
right to serve process in any manner permitted by law.  The parties hereby waive all rights to a trial by jury.  If either
party shall commence an action or proceeding to enforce any provisions of this Agreement, then the prevailing party in such action
or proceeding shall be reimbursed by the other party for its attorney’s fees and other costs and expenses incurred with the
investigation, preparation and prosecution of such action or proceeding.

 

5.2           Successors
and Assigns. Except as otherwise expressly provided herein, the provisions hereof shall inure to the benefit of, and be binding
upon, the successors, assigns, heirs, executors, and administrators of the parties hereto.

 

5.3           Entire
Agreement. This Agreement and the Exhibits hereto and thereto, and the other documents delivered pursuant hereto and thereto,
constitute the full and entire understanding and agreement among the parties with regard to the subjects hereof and no party shall
be liable or bound to any other party in any manner by any representations, warranties, covenants, or agreements except as specifically
set forth herein or therein. Nothing in this Agreement, express or implied, is intended to confer upon any party, other than the
parties hereto and their respective successors and assigns, any rights, remedies, obligations, or liabilities under or by reason
of this Agreement, except as expressly provided herein.

 

5.4           Severability.
In case any provision of this Agreement shall be invalid, illegal, or unenforceable, it shall to the extent practicable, be modified
so as to make it valid, legal and enforceable and to retain as nearly as practicable the intent of the parties, and the validity,
legality, and enforceability of the remaining provisions shall not in any way be affected or impaired thereby.

 

    	5

    	 

    

 

5.5           Amendment
and Waiver. Except as otherwise provided herein, any term of this Agreement may be amended, and the observance of any term
of this Agreement may be waived (either generally or in a particular instance, either retroactively or prospectively, and either
for a specified period of time or indefinitely), with the written consent of the Company and the Subscriber. Any amendment or waiver
effected in accordance with this Section shall be binding upon each future holder of any security purchased under this Agreement
(including securities into which such securities have been converted) and the Company.

 

5.6           Notices.
All notices and other communications required or permitted hereunder shall be in writing and shall be effective when delivered
personally, or sent by telex or telecopier (with receipt confirmed), provided that a copy is mailed by registered mail, return
receipt requested, or when received by the addressee, if sent by Express Mail, Federal Express or other express delivery service
(receipt requested).

 

5.7           Faxes
and Counterparts. This Agreement may be executed in one or more counterparts. Delivery of an executed counterpart of the Agreement
or any exhibit attached hereto by facsimile transmission shall be equally as effective as delivery of an executed hard copy of
the same. Any party delivering an executed counterpart of this Agreement or any exhibit attached hereto by facsimile transmission
shall also deliver an executed hard copy of the same, but the failure by such party to deliver such executed hard copy shall not
affect the validity, enforceability or binding nature effect of this Agreement or such exhibit.

 

5.8           Titles
and Subtitles. The titles of the paragraphs and subparagraphs of this Agreement are for convenience of reference only and are
not to be considered in construing this Agreement.

 

    	6

    	 

    

 

IN WITNESS WHEREOF
the Subscriber has duly executed this Subscription Agreement as of the date of acceptance by the Company.

 

	DELIVERY AND REGISTRATION INSTRUCTIONS	 
	 	 
	Delivery - please deliver the Share certificates to:	 
	 	 
	 	 
	 	 
	 	 

 

The undersigned hereby acknowledges that
he or she will deliver to the Company all such additional completed forms in respect of the Subscriber's purchase of the Units
as may be required for filing with the appropriate securities commissions and regulatory authorities.

 

	 	 
	(Name of Subscriber – Please type or print)	 
	 	 
	 	 
	(Signature and, if applicable, Office)	 
	 	 
	 	 
	(Address of Subscriber)	 
	 	 
	 	 
	(City, State, and Zip Code of Subscriber)	 
	 	 
	 	 
	(SS # or Tax ID # of Subscriber)	 
	 	 
	 	 
	(Fax Number and email address)	 

 

	Subscription Amount:	 	Dollar Amount: USD$_______________	 	# Units:____________________

 

ACCEPTANCE

 

The above-mentioned
Agreement in respect of the Units is hereby accepted by 3D Total Solutions, Inc.

 

DATED at ____________________________________, the ________day
of __________________, 2014.

 

	3D Total Solutions, Inc.	 
	 	 	 
	Per:	 	 
	 	 	 
	 	 	 
	 	James Endee – President	 
	 	Authorized Signatory	 

 

    	7EX-10.1

 Exhibit 10.1 

EXECUTION COPY 
 CREDIT
AND SECURITY AGREEMENT 
 THIS CREDIT AND SECURITY AGREEMENT (this “Agreement”), dated as of July 14, 2014
(the “Closing Date”) by and among MIDCAP FINANCIAL SBIC, LP, a Delaware limited partnership (“MidCap”), as administrative agent (“Agent”), the Lenders listed on the Credit Facility
Schedule attached hereto and otherwise party hereto from time to time (each a “Lender”, and collectively the “Lenders”), and ZS PHARMA, INC., a Delaware corporation (“Borrower”), provides
the terms on which Lenders agree to lend to Borrower and Borrower shall repay Lenders. The parties agree as follows: 
 1
ACCOUNTING AND OTHER TERMS 
 Accounting terms not defined in this Agreement shall be construed in accordance with
GAAP. Calculations and determinations must be made in accordance with GAAP. Capitalized terms not otherwise defined in this Agreement shall have the meanings set forth in Section 15. All other terms contained in this Agreement, unless
otherwise indicated, shall have the meaning provided by the Code to the extent such terms are defined therein. All headings numbered without a decimal point are herein referred to as “Articles,” and all paragraphs numbered with a decimal
point (and all subparagraphs or subsections thereof) are herein referred to as “Sections.” 
 2 CREDIT FACILITIES AND
TERMS 
 2.1 Promise to Pay. Borrower hereby unconditionally promises to pay to each Lender in accordance with each
Lender’s respective Pro Rata Share of each Credit Facility, the outstanding principal amount of all Credit Extensions made by the Lenders under such Credit Facility and accrued and unpaid interest thereon and any other amounts due hereunder as
and when due in accordance with this Agreement. 
 2.2 Credit Facilities. Subject to the terms and conditions hereof, each Lender,
severally, but not jointly, agrees to make available to Borrower Credit Extensions in respect of each Credit Facility set forth opposite such Lender’s name on the Credit Facility Schedule, in each case not to exceed such Lender’s
commitment as identified on the Credit Facility Schedule (such commitment of each Lender, as it may be amended to reflect assignments made in accordance with this Agreement or terminated or reduced in accordance with this Agreement, its
“Applicable Commitment”, and the aggregate of all such commitments, the “Applicable Commitments”). 
 2.3
Term Credit Facilities. 
 (a) Nature of Credit Facility; Credit Extension Requests. For any Credit Facility
identified on the Credit Facility Schedule as a term facility (a “Term Credit Facility”), Credit Extensions in respect of a Term Credit Facility may be requested by Borrower during the Draw Period for such Term Credit
Facility. For any Credit Extension requested under a Term Credit Facility other than on the Closing Date, Agent must receive the completed Credit Extension Form by 12:00 noon (New York time) fifteen (15) Business Days prior to the date of the
Credit Extension is to be funded. To the extent any Term Credit Facility proceeds are repaid for any reason, whether voluntarily or involuntarily (including repayments from insurance or condemnation proceeds), Agent and Lenders shall have no
obligation to re-advance such sums to Borrower. 
 (b) Principal Payments. Principal payable on account of a Term
Credit Facility shall be payable by Borrower to each Lender immediately upon the earliest of (i) the date(s) set forth in the Amortization Schedule for such Term Credit Facility (or if no such Amortization Schedule is attached,
then upon Agent’s demand for payment), or (ii) the Maturity Date. Except as this Agreement may specifically provide otherwise, all prepayments of Credit Extensions under Term Credit Facilities shall be applied by Agent to the applicable
Term Credit Facility in inverse order of maturity. The monthly payments required under the Amortization Schedule shall continue in the same amount (for so long as the applicable Term Credit Facility shall remain outstanding) notwithstanding
any partial prepayment, whether mandatory or optional, of the applicable Term Credit Facility. 

 (c) Mandatory Prepayment. If a Term Credit Facility is accelerated
following the occurrence of an Event of Default, Borrower shall immediately pay to Agent, for payment to each Lender in accordance with its respective Pro Rata Share, an amount equal to the sum of: (i) all outstanding principal of the Term
Credit Facility and all other Obligations, plus accrued and unpaid interest thereon, (ii) any fees payable under the Fee Letter by reason of such prepayment, (iii) the Applicable Prepayment Fee as specified in the Credit Facility
Schedule for the Credit Facility being prepaid, and (iv) all other sums that shall have become due and payable, including Protective Advances. Additionally, at the election of Agent, Borrower shall prepay the Term Credit Facilities (to be
allocated pro rata among the outstanding Credit Extensions under all Term Credit Facilities) in the following amounts: (A) on the date on which any Credit Party (or Agent as loss payee or assignee) receives any casualty proceeds in excess of
Five Hundred Thousand Dollars ($500,000) in the aggregate for personal property and real property, in respect of assets upon which Agent maintained a Lien, an amount equal to one hundred percent (100%) of such proceeds (net of out-of-pocket
expenses and, in the case of personal property, repayment of any permitted purchase money debt encumbering the personal property that suffered such casualty), or such lesser portion of such proceeds as Agent shall elect to apply to the Obligations;
and (B) upon receipt by any Credit Party of the proceeds of any asset disposition of personal property not made in the Ordinary Course of Business (other than transfers permitted by Section 7.1) an amount equal to one hundred
percent (100%) of the net cash proceeds of such asset disposition (net of out-of-pocket expenses and repayment of any permitted purchase money debt encumbering such asset), or such lesser portion as Agent shall elect to apply to the
Obligations. Notwithstanding the foregoing, (a) so long as no Default or Event of Default has occurred and is continuing, Borrower shall have the option of applying the proceeds of any casualty policy up to $500,000 in the aggregate with
respect to any property loss in any one year, toward the replacement or repair of destroyed or damaged property; provided that any such replaced or repaired property (x) shall be of equal or like value as the replaced or repaired Collateral and
(y) shall be deemed Collateral in which Agent and Lenders have been granted a first priority security interest, and (b) after the occurrence and during the continuance of a Default or Event of Default, all proceeds payable under such
casualty policy shall, at the option of Agent, be payable to Agent, for the ratable benefit of the Lenders, on account of the Obligations. 

(d) Permitted Prepayment. After the Closed Period, if any, for the applicable Term Credit Facility as specified in the
Credit Facility Schedule, Borrower shall have the option to prepay the Prepayable Amount (as defined below) of a Term Credit Facility advanced by the Lenders under this Agreement, provided Borrower (i) provides written notice to
Agent of its election to prepay the Prepayable Amount at least thirty (30) days prior to such prepayment, and (ii) pays to Agent, for payment to each Lender in accordance with its respective Pro Rata Share, on the date of such prepayment,
an amount equal to the sum of (A) the Prepayable Amount plus accrued and unpaid interest thereon, (B) any fees payable under the Fee Letter by reason of such prepayment, (C) the Applicable Prepayment Fee as specified in the Credit
Facility Schedule for the Credit Facility being prepaid, and (D) all Protective Advances. The term “Prepayable Amount” means all or any portion of the Credit Extensions and all other Obligations under all Term Credit
Facilities. 
 2.4 Reserved. 

2.5 Reserved. 
 2.6
Interest and Payments; Administration. 
 (a) Interest; Computation of Interest. Each Credit Extension shall
bear interest on the outstanding principal amount thereof from the date when made until paid in full at a rate per annum equal to the Interest Rate. Each Lender may, upon the failure of Borrower to pay any fees or interest as required herein,
capitalize such interest and fees and begin to accrue interest thereon until paid in full, which such interest shall be at a rate per annum equal to the Interest Rate unless and until the Default Rate shall otherwise apply. All other Obligations
shall bear interest on the outstanding amount thereof from the date they first become payable by Borrower under the Financing Documents until paid in full at a rate per annum equal to the Interest Rate unless and until the Default Rate shall
otherwise apply. Interest on the Credit Extensions and all fees payable under the Financing Documents shall be computed on the basis of a 360-day year and the actual number of days elapsed in the period during which such interest accrues. In
computing interest on any Credit Extension or other advance, the date of the making of such Credit Extension or advance shall be included and the date of payment shall be excluded; provided, however, that if any Credit Extension or
advance is repaid on the same day on which it is made, such day shall be included in computing interest on such Credit Extension or advance. 

  
 2 

 (b) Default Rate. Upon the election of Agent following the occurrence and
during the continuance of an Event of Default, Obligations shall bear interest at a rate per annum which is four hundred basis points (4.00%) above the rate that is otherwise applicable thereto (the “Default Rate”). Payment or
acceptance of the increased interest rate provided in this subsection is not a permitted alternative to timely payment and shall not constitute a waiver of any Event of Default or otherwise prejudice or limit any rights or remedies of Agent or
Lenders. 
 (c) Payments Generally. Except as otherwise provided in this Section 2.6(c), all payments in
respect of the Obligations shall be made to each Lender in accordance with their Pro Rata Share. Payments of principal and interest in respect of any Credit Facility identified on the Credit Facility Schedule as “Term” shall be made
to each applicable Lender. All Obligations are payable upon demand of Agent in the absence of any other due date specified herein. All fees payable under the Financing Documents shall be deemed non-refundable as of the date paid. Any payment
required to be made to Agent or a Lender under this Agreement may be made by debit or automated clearing house payment initiated by Agent or such Lender from any of Borrower’s deposit accounts, including the Designated Funding Account, and
Borrower hereby authorizes Agent and each Lender to debit any such accounts for any amounts Borrower owes hereunder when due. Without limiting the foregoing, Borrower shall tender to Agent and Lenders any authorization forms as Agent or any Lender
may require to implement such debit or automated clearing house payment. These debits or automated clearing house payments shall not constitute a set-off. Payments of principal and/or interest received after 2:00 p.m. New York time are considered
received at the opening of business on the next Business Day. When a payment is due on a day that is not a Business Day, the payment is due the next Business Day and additional fees or interest, as applicable, shall continue to accrue until paid.
All payments to be made by Borrower under any Financing Document shall be made without set-off, recoupment or counterclaim, in lawful money of the United States and in immediately available funds. The balance of the Obligations, as recorded in
Agent’s books and records at any time (absent manifest error), shall be conclusive and binding evidence of the amounts due and owing to Agent and Lenders by each Borrower absent manifest error; provided, however, that any failure
to so record or any error in so recording shall not limit or otherwise affect any Borrower’s duty to pay all amounts owing hereunder or under any Financing Document. Agent shall endeavor to provide Borrower with a monthly statement regarding
the Credit Extensions (but neither Agent nor any Lender shall have any liability if Agent shall fail to provide any such statement). Unless Borrower notifies Agent of any objection to any such statement (specifically describing the basis for such
objection) within ninety (90) days after the date of receipt thereof, it shall be deemed final, binding and conclusive upon Borrower in all respects as to all matters reflected therein. 

(d) Interest Payments; Maturity Date. Commencing on the first
(1st) Payment Date following the funding of a Credit Extension, and continuing on the Payment Date of each successive month thereafter through and including the Maturity Date, Borrower shall
make monthly payments of interest, in arrears, calculated as set forth in this Section 2.6. All unpaid principal and accrued interest is due and payable in full on the Maturity Date or any earlier date specified herein. If the
Obligations are not paid in full on or before the Maturity Date, all interest thereafter accruing shall be payable immediately upon accrual. 

(e) Fees. Borrower shall pay, as and when due and payable under the terms of the Fee Letter, to Agent and each Lender,
for their own accounts and not for the benefit of any other Lenders, the fees set forth in the Fee Letter. 
 (f)
Protective Advances. Borrower shall pay to Agent for the account of Lenders all Protective Advances (including reasonable attorneys’ fees and expenses for documentation and negotiation of this Agreement and the other Financing Documents)
when due under any Financing Document (and in the absence of any other due date specified herein, such Protective Advances shall be due upon demand). 

(g) Maximum Lawful Rate. In no event shall the interest charged hereunder with respect to the Obligations exceed the
maximum amount permitted under the Laws of the State of Maryland. Notwithstanding anything to the contrary in any Financing Document, if at any time the rate of interest payable hereunder (the “Stated Rate”) would exceed the highest
rate of interest permitted under any applicable Law to be charged (the “Maximum Lawful Rate”), then for so long as the Maximum Lawful Rate would be so exceeded, the rate of interest payable shall be equal to the Maximum Lawful Rate;
provided, however, that if at any time thereafter the Stated Rate is less than the Maximum Lawful Rate, Borrower shall, to the extent permitted by Law, continue to pay 

  
 3 

 
interest at the Maximum Lawful Rate until such time as the total interest received is equal to the total interest which would have been received had the Stated Rate been (but for the operation of
this provision) the interest rate payable. Thereafter, the interest rate payable shall be the Stated Rate unless and until the Stated Rate again would exceed the Maximum Lawful Rate, in which event this provision shall again apply. In no event shall
the total interest received by any Lender exceed the amount which it could lawfully have received, had the interest been calculated for the full term hereof at the Maximum Lawful Rate. If, notwithstanding the prior sentence, any Lender has received
interest hereunder in excess of the Maximum Lawful Rate, such excess amount shall be applied to the reduction of the principal balance of such Lender’s Credit Extensions or to other amounts (other than interest) payable hereunder, and if no
such Credit Extensions or other amounts are then outstanding, such excess or part thereof remaining shall be paid to Borrower. In computing interest payable with reference to the Maximum Lawful Rate applicable to any Lender, such interest shall be
calculated at a daily rate equal to the Maximum Lawful Rate divided by the number of days in the year in which such calculation is made. 

(h) Taxes; Additional Costs. 

(i) All payments of principal and interest on the Obligations and all other amounts payable by Borrower hereunder shall be made without
withholding or deduction for any Taxes, except as required by applicable Law. If any withholding or deduction from any payment to be made by any Borrower hereunder is required in respect of any Taxes pursuant to any applicable Law, then:
(i) Borrower shall make such withholding or deduction and shall pay directly to the relevant taxing authority the full amount required to be so withheld or deducted; (ii) Borrower will promptly forward to Agent an official receipt, if any,
or other documentation satisfactory to Agent evidencing any payment of Indemnified Taxes to such taxing authority; and (iii) if any such withheld or deducted Tax is an Indemnified Tax, the sum payable by Borrower shall be increased as necessary
so that after making all required withholdings and deductions for such Indemnified Tax (including withholdings and deductions applicable to additional sums payable under this Section 2.6(h)(i)) the applicable Recipient shall
receive an amount equal to the sum it would have received had no such withholdings or deductions been made. If any Indemnified Taxes are directly asserted against Agent or any Lender with respect to any payment made by Borrower hereunder, Agent or
such Lender may pay such Indemnified Taxes and Borrower will promptly pay the full amount of such Indemnified Taxes paid by Agent or such Lender (including any penalty, interest or reasonable expense paid thereby with respect to such Indemnified
Taxes and including any Indemnified Taxes paid on additional sums payable under this Section 2.6(h)(i)) so long as such amounts were paid on or after the day which is two hundred seventy (270) days prior to the date on which
Borrower received written demand therefor. A certificate as to the amount of such payment by Agent or Lender delivered to Borrower by the Agent or such Lender shall be conclusive, absent manifest error. 

(ii) [Intentionally omitted]. 

(iii) Each Lender that (A) is a “United States person” as defined in Section 7701(a)(30) of the Internal Revenue Code of
1986, as amended, and (B) (1) is a party hereto on the Closing Date or (2) purports to become an assignee of an interest as a Lender under this Agreement after the Closing Date (unless such Lender was already a Lender hereunder
immediately prior to such assignment) shall deliver to each of Borrower and Agent on or prior to the date on which such Lender becomes a Lender hereunder (and from time to time thereafter upon the reasonable request of Agent or Borrower or as
required by applicable Law) one or more (as Borrower or Agent may reasonably request) duly completed, valid, and executed originals of United States Internal Revenue Service Form W-9 (or any successor thereto) certifying that such Lender is exempt
from U.S. federal backup withholding tax. Each Lender that (A) is not a “United States person” as defined in Section 7701(a)(30) of the Internal Revenue Code of 1986, as amended, and (B) (1) is a party hereto on the
Closing Date or (2) purports to become an assignee of an interest as a Lender under this Agreement after the Closing Date (unless such Lender was already a Lender hereunder immediately prior to such assignment) shall deliver to each of Borrower
and Agent on or prior to the date on which such Lender becomes a Lender hereunder (and from time to time thereafter upon the reasonable request of Agent or Borrower or as required by applicable Law) one or more (as Borrower or Agent may reasonably
request) duly completed, valid, and executed originals of United States Internal Revenue Service Forms W-8ECI, W-8BEN, W-8BEN-E, W-8IMY (as applicable) or any successor thereto and all other applicable forms, certificates or documents prescribed by
the United States Internal Revenue Service or reasonably requested by Borrower or Agent certifying as to such Lender’s entitlement to a complete exemption from withholding or deduction of Taxes. If a payment made to a Lender hereunder would be
subject to U.S. federal withholding Tax imposed by FATCA if such Lender were to fail to comply with the applicable reporting requirements of FATCA (including those contained in Section 1471(b) or 1472(b) of the Code, as applicable), such Lender
shall deliver to the Borrower and Agent at the time or times prescribed by law and at such time or times reasonably requested by the Borrower or Agent such documentation prescribed by applicable 

  
 4 

 
Law (including as prescribed by Section 1471(b)(3)(C)(i) of the Code) and such additional documentation reasonably requested by the Borrower or Agent as may be necessary for the Borrower and
Agent to comply with their obligations under FATCA and to determine that such Lender has complied with such Lender’s obligations under FATCA or to determine the amount to deduct and withhold from such payment. Solely for purposes of this
Section 2.6(h)(iii), “FATCA” shall include any amendments made to FATCA after the date of this Agreement. Each Lender agrees that if any form or certification it previously delivered pursuant to this Section 2.6(h)(iii)
expires or becomes obsolete or inaccurate in any respect, it shall update such form or certification or promptly notify the Borrower and the Administrative Agent in writing of its legal inability to do so. 

(iv) Except with respect to Indemnified Taxes or the imposition of, or any change in the rate of, any Excluded Tax, if any Lender shall
determine in its commercially reasonable judgment that the adoption or taking effect of, or any change in, any applicable Law regarding capital adequacy, in each instance, after the Closing Date, or any change after the Closing Date in the
interpretation, administration or application thereof by any Governmental Authority, central bank or comparable agency charged with the interpretation, administration or application thereof, or the compliance by any Lender or any Person controlling
such Lender with any request, guideline or directive regarding capital adequacy (whether or not having the force of law) of any such Governmental Authority, central bank or comparable agency adopted or otherwise taking effect after the Closing Date,
has or would have the effect of reducing the rate of return on such Lender’s or such controlling Person’s capital as a consequence of such Lender’s obligations hereunder to a level below that which such Lender or such controlling
Person could have achieved but for such adoption, taking effect, change, interpretation, administration, application or compliance (taking into consideration such Lender’s or such controlling Person’s policies with respect to capital
adequacy) then from time to time, upon written demand by such Lender (which demand shall be accompanied by a statement setting forth the basis for such demand and a calculation of the amount thereof in reasonable detail, a copy of which shall be
furnished to Agent), Borrower shall promptly pay to such Lender such additional amount as will compensate such Lender or such controlling Person for such reduction, so long as such amounts have accrued on or after the day which is two hundred
seventy (270) days prior to the date on which such Lender first made demand therefor; provided, however, that notwithstanding anything in this Agreement to the contrary, (A) the Dodd-Frank Wall Street Reform and Consumer
Protection Act and all requests, rules, guidelines or directives thereunder or issued in connection therewith and (B) all requests, rules, guidelines or directives promulgated by the Bank for International Settlements, the Basel Committee on
Banking Supervision (or any successor or similar authority) or the United States or foreign regulatory authorities, in each case pursuant to Basel III, shall in each case be deemed to be a “change in applicable Law”, regardless of the date
enacted, adopted or issued. 
 (v) If any Lender requires compensation under Section 2.6 (h)(iv), or requires any Borrower to
pay Indemnified Taxes or any additional amount to any Lender or any Governmental Authority for the account of any Lender pursuant to this subsection (h), then, upon the written request of Borrower, such Lender shall use reasonable efforts to
designate a different lending office for funding or booking its Credit Extensions hereunder or to assign its rights and obligations hereunder (subject to the terms of this Agreement) to another of its offices, branches or affiliates, if, in the
judgment of such Lender, such designation or assignment (A) would eliminate or reduce amounts payable pursuant to any such subsection, as the case may be, in the future, and (B) would not subject such Lender to any unreimbursed cost or
expense and would not otherwise be disadvantageous to such Lender. Borrower hereby agrees to pay all reasonable costs and expenses incurred by any Lender in connection with any such designation or assignment. 

(vi) If any Recipient reasonably determines that it has received a refund of, or utilized any offset to Taxes arising with respect to, any
Indemnified Taxes (including any penalty, interest or reasonable expense paid with respect to Indemnified Taxes) paid by any Borrower or with respect to which any Borrower has paid additional amounts hereunder, it shall pay over to the relevant
Borrower an amount equal to such refund or offset (but only to the extent of payments made, or additional amounts paid, hereunder), net of all out-of-pocket expenses (including any Taxes) of the Recipient directly relating to obtaining such refund
or utilizing such offset and without interest (other than any interest paid by the relevant taxing authority with respect to such refund or offset), provided that Borrower, upon the request of the Recipient, agrees to promptly repay the
amount paid over to Borrower (plus any interest, penalties or other charges imposed by the relevant taxing authority) if the Recipient is required to repay such refund to such taxing authority but only to the extent not arising as a result of the
Recipient’s negligence, wrongful act, or wrongful omission. Notwithstanding anything to the contrary in this Section 2.6(h)(vi), in no event will the indemnified party be required to pay any amount to an indemnifying party pursuant
to this Section 2.6(h)(vi) the payment of which would place the indemnified party in a less favorable net after-Tax position than the indemnified party would have been in if the Tax subject to indemnification and giving rise to such
refund had not been deducted, withheld or otherwise imposed and the indemnification payments or additional amounts with respect to such Tax had never been paid. This Section 2.6(h)(vi) shall not be construed to require Recipient to make
available its tax returns (or any other information relating to its Taxes which it deems confidential) to any Borrower. 

  
 5 

 (vii) Each party’s obligations under this Section 2.6(h) shall survive the resignation
or replacement of the Agent or any assignment of rights by, or the replacement of, a Lender, the termination of the commitments and the repayment, satisfaction or discharge of all obligations hereunder. 

(i) Administrative Fees and Charges. 

(i) Borrower shall pay to Agent, for its own account and not for the benefit of any other Lenders, all reasonable out-of-pocket fees and
expenses in connection with audits and inspections of the books and records of the Credit Parties, audits, valuations or appraisals of the Collateral, audits of Borrower’s compliance with applicable Laws and such other matters as Agent shall
deem appropriate, which shall be due and payable on the first Business Day of the month following the date of issuance by Agent of a written request for payment thereof to any Borrower; provided, that, as long as no Default has
occurred within the preceding twelve (12) months, Agent shall be entitled to such reimbursement for no more than one audit and inspection per calendar quarter. 

(ii) If payments of principal or interest due on the Obligations, or any other amounts due hereunder or under the other Financing Documents,
are not timely made and remain overdue for a period of five (5) days, Borrower, without notice or demand by Agent, promptly shall pay to Agent, for its own account and not for the benefit of any other Lenders, as additional compensation to
Agent in administering the Obligations, an amount equal to five percent (5.0%) of each delinquent payment. 
 (j) Good Faith
Deposit. Borrower has paid to Agent, for payment to each Lender, a deposit of Fifty Thousand Dollars ($50,000) (the “Good Faith Deposit”) to initiate Agent’s due diligence review process. On the Closing Date, such Good
Faith Deposit not utilized to pay the Agent’s costs and expenses (including without limitation out-of-pocket attorneys’ fees) associated with the transactions contemplated by this Agreement will be applied to the fees set forth in
Section 2.6(e) or the Protective Advances. 
 2.7 Secured Promissory Notes. At the election of any Lender made as to each
Credit Facility for which it has made Credit Extensions, each Credit Facility shall be evidenced by one or more secured promissory notes in form and substance satisfactory to Agent and Lenders (each a “Secured Promissory Note”).
Upon receipt of an affidavit of an officer of a Lender as to the loss, theft, destruction, or mutilation of its Secured Promissory Note, Borrower shall issue, in lieu thereof, a replacement Secured Promissory Note in the same principal amount
thereof and of like tenor. 
 3 CONDITIONS OF CREDIT EXTENSIONS 

3.1 Conditions Precedent to Initial Credit Extension. Each Lender’s obligation to make an advance in respect of a Credit Facility
is subject to the condition precedent that Agent shall consent to or shall have received, in form and substance satisfactory to Agent, all items listed on the Closing Deliveries Schedule attached hereto. 

3.2 Conditions Precedent to all Credit Extensions. The obligation of each Lender to make each Credit Extension, including the initial
Credit Extension, is subject to the following conditions precedent: 
 (a) satisfaction of all Applicable Funding Conditions
for the applicable Credit Extension as set forth in the Credit Facility Schedule, each in form and substance satisfactory to Agent and each Lender; 

(b) timely receipt by the Agent and each Lender of an executed Credit Extension Form in the form attached hereto; 

(c) (i) for Credit Extensions made on the Closing Date, the representations and warranties in Article 5 and elsewhere in
the Financing Documents shall be true, correct and complete in all respects on the Closing Date; provided, however, that those representations and warranties expressly referring to a specific date shall be true, correct and complete in
all respects as of such date; and 

  
 6 

 (ii) for Credit Extensions made after the Closing Date, if any, the representations and
warranties in Article 5 and elsewhere in the Financing Documents shall be true, correct and complete in all material respects on the date of the Credit Extension Form and on the Funding Date of each Credit Extension; provided, however,
that such materiality qualifier shall not be applicable to any representations and warranties that already are qualified or modified by materiality in the text thereof; and provided, further that those representations and warranties
expressly referring to a specific date shall be true, accurate and complete in all material respects as of such date. Each Credit Extension shall constitute Borrower’s representation and warranty on that date that the representations and
warranties in Article 5 and elsewhere in the Financing Documents remain true, correct and complete in all material respects on the date of such Credit Extension; provided, however, that such materiality qualifier shall not be
applicable to any representations and warranties that already are qualified or modified by materiality in the text thereof; and provided, further that those representations and warranties expressly referring to a specific date shall be
true, correct and complete in all material respects as of such specific date; 
 (d) no Default or Event of Default shall have occurred and
be continuing or result from the Credit Extension; 
 (e) Agent shall be satisfied with the results of any searches conducted under
Section 3.5; 
 (f) receipt by Agent of such evidence as Agent shall request to confirm that the deliveries made in
Section 3.1 remain current, accurate and in full force and effect, or if not, updates thereto, each in form and substance satisfactory to Agent; and 

(g) as determined in such Lender’s sole discretion, there has not been any Material Adverse Change. 

3.3 Method of Borrowing. Each Credit Extension in respect of each Credit Facility shall be in an amount at least equal to the applicable
Minimum Credit Extension Amount for such Credit Facility as set forth in the Credit Facility Schedule or such lesser amount as shall remain undisbursed under the Applicable Commitments for such Credit Facility. The date of funding for any
requested Credit Extension shall be a Business Day. To obtain a Credit Extension, Borrower shall deliver to Agent a completed Credit Extension Form executed by a Responsible Officer. Agent may rely on any notice given by a person whom Agent
reasonably believes is a Responsible Officer or designee thereof. Agent and Lenders shall have no duty to verify the authenticity of any such notice. 

3.4 Funding of Credit Facilities. Upon the terms and subject to the conditions set forth herein, each Lender, severally and not jointly,
shall make available to Agent its Pro Rata Share of the requested Credit Extension, in lawful money of the United States of America in immediately available funds, prior to 11:00 a.m. (New York time) on the specified date for the Credit Extension.
Agent shall, unless it shall have determined that one of the conditions set forth in Section 3.1 or 3.2, as applicable, has not been satisfied, by 2:00 p.m. (New York time) on such day, credit the amounts received by it in like
funds to Borrower by wire transfer to the Designated Funding Account (or to the account of Borrower in respect of the Obligations, if the Credit Extension is being made to pay an Obligation of Borrower). A Credit Extension made prior to the
satisfaction of any conditions set forth in Section 3.1 or 3.2 shall not constitute a waiver by Agent or Lenders of Borrower’s obligation to satisfy such conditions, and any such Credit Extension made in the absence of such
satisfaction shall be made in Agent’s discretion. 
 3.5 Searches. Before the Closing Date, and thereafter (as and when
determined by Agent in its discretion), Agent shall have the right to perform, all at Borrower’s expense, the searches described in clauses (a), (b), and (c) below against Borrower and any other Credit Party, the results of which are to be
consistent with Borrower’s representations and warranties under this Agreement and the reasonably satisfactory results of which shall be a condition precedent to all Credit Extensions requested by Borrower: (a) title investigations, UCC
searches and fixture filings searches; (b) judgment, pending litigation, federal tax lien, personal property tax lien, and corporate and partnership tax lien searches, in each jurisdiction searched under clause (a) above; and
(c) searches of applicable corporate, limited liability company, partnership and related records to confirm the continued existence, organization and good standing of the applicable Person and the exact legal name under which such Person is
organized. 

  
 7 

 4 CREATION OF SECURITY INTEREST 

4.1 Grant of Security Interest. To secure the payment and performance in full of all of the Obligations, the Borrower hereby grants to
Agent, for the ratable benefit of the Lenders, a continuing security interest in, and pledges to Agent, for the ratable benefit of the Lenders, the Collateral, wherever located, whether now owned or hereafter acquired or arising, and all proceeds
and products thereof. Borrower represents, warrants, and covenants that the security interest granted herein is and shall at all times continue to be a first priority perfected security interest in the Collateral, subject only to Permitted Liens
that may have priority by operation of applicable Law or by the terms of a written intercreditor or subordination agreement entered into by Agent. Notwithstanding the foregoing, in the event that Borrower or any Credit Party acquires any Equipment
after the Closing Date pursuant to a Permitted Purchase Money Financing where the cost of such acquisition is not 100% financed by the Permitted Purchase Money Financing, Agent and Lenders agree that Agent may, in its reasonable discretion, release
Agent’s lien in the Equipment being so financed (or Agent’s lien in Borrower’s leasehold interest in any such Equipment, if applicable) to the extent that such Permitted Purchase Money Financing does not permit Agent to have a lien in
such Equipment (or in Borrower’s leasehold interest in any such Equipment) ; provided, that, if Agent has released its lien on such Equipment (or on Borrower’s leasehold interest in any such Equipment) in accordance herewith,
upon payment in full of the Permitted Purchase Money Financing, such Equipment owned in fee simple by Borrower or any Credit Party shall again become part of the Collateral automatically and without further action by Borrower, any Credit Party,
Agent or any Lender and, if upon expiration of the relevant equipment lease, Borrower or any Credit Party acquires any such Equipment, such Equipment shall become part of the Collateral automatically and without further action by Borrower, any
Credit Party, Agent or any Lender. 
 4.2 Representations and Covenants. 

(a) As of the Closing Date, Borrower has no ownership interest in any Chattel Paper, letter of credit rights, commercial tort
claims, Instruments, documents or investment property (other than equity interests in any Subsidiaries of Borrower disclosed on the Disclosure Schedule attached hereto). 

(b) Borrower shall deliver to Agent all tangible Chattel Paper and all Instruments and documents owned by any Borrower and
constituting part of the Collateral duly endorsed and accompanied by duly executed instruments of transfer or assignment, all in form and substance satisfactory to Agent. Borrower shall provide Agent with “control” (as in the Code) of all
electronic Chattel Paper owned by any Borrower and constituting part of the Collateral by having Agent identified as the assignee on the records pertaining to the single authoritative copy thereof and otherwise complying with the applicable elements
of control set forth in the UCC. Borrower also shall deliver to Agent all security agreements securing any such Chattel Paper and securing any such Instruments. Borrower will mark conspicuously all such Chattel Paper and all such Instruments and
Documents with a legend, in form and substance satisfactory to Agent, indicating that such Chattel Paper and such Instruments and Documents are subject to the security interests and Liens in favor of Agent created pursuant to this Agreement and the
Financing Documents. 
 (c) Borrower shall deliver to Agent all letters of credit on which any Borrower is the beneficiary
and which give rise to letter of credit rights owned by such Borrower which constitute part of the Collateral in each case duly endorsed and accompanied by duly executed instruments of transfer or assignment, all in form and substance satisfactory
to Agent. Borrower shall take any and all actions as may be necessary or desirable, or that Agent may request, from time to time, to cause Agent to obtain exclusive “control” (as defined in the Code) of any such letter of credit rights in
a manner acceptable to Agent. 
 (d) Borrower shall promptly advise Agent upon any Borrower becoming aware that it has any
interests in any commercial tort claim that constitutes part of the Collateral, which such notice shall include descriptions of the events and circumstances giving rise to such commercial tort claim and the dates such events and circumstances
occurred, the potential defendants with respect such commercial tort claim and any court proceedings that have been instituted with respect to such commercial tort claims, and Borrower shall, with respect to any such commercial tort claim, execute
and deliver to Agent such documents as Agent shall request to perfect, preserve or protect the Liens, rights and remedies of Agent with respect to any such commercial tort claim. 

(e) Except for Accounts and Inventory in an aggregate amount of Five Hundred Thousand Dollars ($500,000), no Accounts or
Inventory or other Collateral shall at any time be in the possession or control of any warehouse, consignee, bailee or any of Borrower’s agents or processors without written notice to Agent within thirty (30) days of such Person coming
into possession or control thereof and the receipt by Agent, if Agent has so 

  
 8 

 
requested, of warehouse receipts, consignment agreements or bailee lien waivers (as applicable) satisfactory to Agent. Borrower shall, upon the request of Agent, notify any such warehouse,
consignee, bailee, agent or processor of the security interests and Liens in favor of Agent created pursuant to this Agreement and the Financing Documents, instruct such Person to hold all such Collateral for Agent’s account subject to
Agent’s instructions and shall obtain an acknowledgement from such Person that such Person holds the Collateral for Agent’s benefit. 

(f) Upon request of Agent, Borrower shall promptly deliver to Agent any and all certificates of title, applications for title
or similar evidence of ownership of all such tangible personal property and shall cause Agent to be named as lienholder on any such certificate of title or other evidence of ownership. Borrower shall not permit any such tangible personal property to
become fixtures to real estate unless such real estate is subject to a Lien in favor of Agent. 
 (g) Borrower hereby
authorizes Agent to file without the signature of such Borrower one or more UCC financing statements relating to its Liens on all or any part of the Collateral, which financing statements may list Agent as the “secured party” and such
Borrower as the “debtor” and which describe and indicate the collateral covered thereby as all or any part of the Collateral under the Financing Documents in such jurisdictions as Agent from time to time determines are appropriate, and to
file without the signature of such Borrower any continuations of or corrective amendments to any such financing statements, in any such case in order for Agent to perfect, preserve or protect the Liens, rights and remedies of Agent with respect to
the Collateral. Borrower also ratifies its authorization for Agent to have filed in any jurisdiction any initial financing statements or amendments thereto if filed prior to the date hereof. Any financing statement may include a notice that any
disposition of the Collateral, except as expressly permitted pursuant to this Agreement, by either Borrower or any other Person, shall be deemed to violate the rights of Agent and the Lenders under the UCC. 

(h) As of the Closing Date, no Borrower holds, and after the Closing Date Borrower shall promptly notify Agent in writing upon
creation or acquisition by any Borrower of, any Collateral which constitutes a claim against any Governmental Authority, including, without limitation, the federal government of the United States or any instrumentality or agency thereof, the
assignment of which claim is restricted by any applicable Law, including, without limitation, the federal Assignment of Claims Act and any other comparable Law. Upon the request of Agent, Borrower shall take such steps as may be necessary or
desirable, or that Agent may request, to comply with any such applicable Law. 
 (i) Borrower shall furnish to Agent from
time to time any statements and schedules further identifying or describing the Collateral and any other information, reports or evidence concerning the Collateral as Agent may reasonably request from time to time. 

5 REPRESENTATIONS AND WARRANTIES 

Borrower represents and warrants as follows on the Closing Date, the date of each Credit Extension, and the date of delivery of each Compliance
Certificate delivered pursuant to Section 6.2(b):  
 5.1 Due Organization, Authorization: Power and Authority.

 (a) Each Credit Party is duly existing and in good standing, as a Registered Organization in its respective jurisdiction
of formation. Each Credit Party is qualified and licensed to do business and is in good standing in any jurisdiction in which the conduct of its business or its ownership of property requires that it be qualified except where the failure to do so
could not reasonably be expected to have a Material Adverse Change. The Financing Documents have been duly authorized, executed and delivered by each Credit Party and constitute legal, valid and binding agreements enforceable in accordance with
their terms. The execution, delivery and performance by each Credit Party of each Financing Document executed or to be executed by it is in each case within such Credit Party’s powers. 

(b) The execution, delivery and performance by each Credit Party of the Financing Documents to which it is a party do not
(i) conflict with any of such Credit Party’s Organizational Documents; (ii) contravene, conflict with, constitute a default under or violate any Law, except to the extent that such contravention, conflict,

  
 9 

 
default or violation could not reasonably be expected to have a Material Adverse Change; (iii) contravene, conflict or violate any applicable order, writ, judgment, injunction, decree,
determination or award of any Governmental Authority by which such Credit Party or any of its property or assets may be bound or affected; (iv) require any action by, filing, registration, or qualification with, or Required Permit from, any
Governmental Authority (except such Required Permits which have already been obtained and are in full force and effect); or (v) constitute a default under or conflict with any Material Agreement (it being understood that the Existing Licenses
and the Existing Sublicense may require the consent of the applicable licensor (in the case of the Existing Licenses) and the licensee (in the case of the Existing Sublicense) in order for Borrower to assign any such Existing License or Existing
Sublicense.). No Credit Party is in default under any agreement to which it is a party or by which it is bound in which the default could reasonably be expected to have a Material Adverse Change, or which questions the validity of the Financing
Documents. 
 5.2 Litigation. Except as disclosed on the Disclosure Schedule or, after the Closing Date, pursuant to
Section 6.7, there are no actions, suits, proceedings or formal investigations pending or, to the knowledge of the Responsible Officers, threatened in writing by or against any Credit Party which involves the reasonable likelihood of any
judgment or liability of more than Five Hundred Thousand Dollars ($500,000.00) or that could reasonably be expected to result in a Material Adverse Change, or which questions the validity of the Financing Documents, or the other documents required
thereby or any action to be taken pursuant to any of the foregoing, nor does any Credit Party have reason to believe that any such actions, suits, proceedings or investigations are threatened. 

5.3 No Material Deterioration in Financial Condition; Financial Statements. All financial statements for the Credit Parties delivered to
Agent or any Lender fairly present, in conformity with GAAP, in all material respects the consolidated financial condition and consolidated results of operations of such Credit Party. There has been no material deterioration in the consolidated
financial condition of any Credit Party from the most recent financial statements submitted to Agent or any Lender. 
 5.4 Solvency.
The fair salable value of each Credit Party’s assets (including goodwill minus disposition costs) exceeds the fair value of its liabilities. After giving effect to the transactions described in this Agreement, (a) no Credit Party is
left with unreasonably small capital in relation to its business as presently conducted, and (b) each Credit Party is able to pay its debts (including trade debts) as they mature. 

5.5 Subsidiaries; Investments. Borrower and its Subsidiaries do not own any stock, partnership interest or other equity securities,
except for Permitted Investments. 
 5.6 Tax Returns and Payments; Pension Contributions. Each Credit Party has timely filed all tax
returns and reports required to be filed thereby with a taxing authority (except where the failure to file any such tax return or report does not result in penalties or other liabilities to the Credit Parties in excess of, individually or in the
aggregate at any time for all of the Credit Parties, Twenty Thousand Dollars ($20,000), and there are no Liens on the Collateral in favor of a Governmental Authority resulting from the failure to file any such tax return or report except for
Permitted Liens). Each Credit Party has timely paid all foreign, federal, state and local Taxes owed by such Credit Party, except for (1) such Taxes that do not at any time exceed an amount of, individually or in the aggregate for all of the
Credit Parties, Twenty Thousand Dollars ($20,000) and (2) such Taxes being contested in good faith by appropriate proceedings promptly and diligently instituted and conducted for which adequate reserves have been set aside on the Books thereof
in accordance with the immediately succeeding sentence, and there are no Liens on any Collateral in favor of a Governmental Authority resulting from such unpaid Taxes, except for Permitted Liens. No Credit Party has deferred payment of any contested
Taxes other than contested Taxes with respect to which such Credit Party (a) in good faith contests its obligation to pay the Taxes by appropriate proceedings promptly and diligently instituted and conducted, (b) notifies Agent in writing
of the commencement of, and any material development in, the proceedings, and (c) posts bonds or takes any other steps required to prevent the Governmental Authority levying such contested Taxes from obtaining a Lien upon any of the Collateral
that is other than a Permitted Lien. No Credit Party is aware of any claims or adjustments in excess of Twenty Thousand Dollars ($20,000) proposed for any of the Credit Party’s prior tax years which could result in additional Taxes becoming due
and payable by any Credit Party. No Credit Party nor any trade or business (whether or not incorporated) that is under common control with any Credit Party within the meaning of Section 414(b) or (c) of the Internal Revenue Code of 1986,
as amended (the “Internal Revenue Code”) (and Sections 414(m) and (o) of the Internal Revenue Code for purposes of the provisions relating to Section 412 of the Internal Revenue Code) or Section 4001 of ERISA (an
“ERISA Affiliate”) has failed to satisfy the “minimum funding standards” (as defined in Section 412 of or Section 302 of ERISA), whether or not waived, no Credit 

  
 10 

 
Party or ERISA Affiliate has incurred liability with respect to the withdrawal or partial withdrawal of any Credit Party or ERISA Affiliate from any multiemployer plan as defined in
Section 4001(a)(3) of ERISA, and no Credit Party or ERISA Affiliate has incurred any liability under Title IV of ERISA with respect to the termination of any employee pension benefit plan subject to the provisions of Title IV of ERISA (other
than with respect to any “standard termination” under Section 4041(b) of ERISA). No “reportable event” as defined in Section 4043(c) of ERISA (or the regulations issued thereunder) (other than an event for which the
30-day notice requirement is waived) has occurred with respect to any employee pension benefit plan subject to the provisions of Title IV of ERISA. 

5.7 Disclosure Schedule. All information set forth in the Disclosure Schedule is true, accurate and complete as of the date
hereof. All information set forth in the Perfection Certificate is true, accurate and complete as of the date hereof. 
 6 AFFIRMATIVE
COVENANTS 
 Borrower covenants and agrees as follows: 

6.1 Organization and Existence; Government Compliance. 

(a) Each Credit Party shall maintain its legal existence and good standing in its respective jurisdiction of formation and
maintain qualification in each jurisdiction in which the failure to so qualify could reasonably be expected to have a Material Adverse Change; provided, however, that the foregoing shall not prohibit any merger or consolidation, otherwise
expressly permitted pursuant to this Agreement. If a Credit Party is not now a Registered Organization but later becomes one, Borrower shall promptly notify Agent of such occurrence and provide Agent with such Credit Party’s organizational
identification number. 
 (b) Each Credit Party shall comply with all Laws, ordinances and regulations to which it or its
business locations is subject, the noncompliance with which could reasonably be expected to result in a Material Adverse Change. Each Credit Party shall obtain and keep in full force and effect and comply with all of the Required Permits, except
where failure to have or maintain compliance with or effectiveness of such Required Permit could not reasonably be expected to result in a Material Adverse Change. Upon request of Agent, each Credit Party shall promptly provide copies of any such
obtained Required Permits to Agent. Borrower shall notify Agent within three (3) Business Days (but in any event prior to Borrower submitting any requests for Credit Extensions or release of any reserves) of the occurrence of any facts, events
or circumstances known to a Borrower, whether threatened, existing or pending, that could reasonably be expected to cause any Required Permit to become limited, suspended or revoked, except where such limitation, revocation or suspension is not
reasonably expected to result in a Material Adverse Change. 
 6.2 Financial Statements, Reports, Certificates. 

(a) Each Credit Party shall deliver to Agent and each Lender: (i) as soon as available, but no later than forty-five
(45) days after the last day of each month, a company prepared consolidated and consolidating balance sheet, income statement and cash flow statement covering such Credit Party’s consolidated operations for such month certified by a
Responsible Officer and in a form acceptable to Agent and each Lender; (ii) as soon as available, but no later than one hundred twenty (120) days after the last day of a Credit Party’s fiscal year, audited consolidated and
consolidating financial statements prepared under GAAP, consistently applied, together with an unqualified opinion on the financial statements from an independent certified public accounting firm acceptable to Agent and each Lender in its reasonable
discretion (it being understood that Ernst & Young or any other national recognized accounting firm is acceptable to Agent and Lender); (iii) as soon as available after approval thereof by such Credit Party’s governing board, but
no later than sixty (60) days after the last day of such Credit Party’s fiscal year, and as amended and/or updated, such Credit Party’s financial operating budget for current fiscal year; (iv) within ten (10) days of
delivery, copies of all readily available statements, reports and notices made available to all of such Credit Party’s security holders or to any holders of Subordinated Debt; (v) in the event that such Credit Party is or becomes subject
to the reporting requirements under the Securities Exchange Act of 1934, as amended, within five (5) days of filing, all reports on Form 10-K, 10-Q and 8-K filed with the Securities and Exchange
Commission (“SEC”) or a link thereto on such Credit Party’s or another website on the Internet; (vi) budgets, sales projections, operating plans and other financial information reasonably requested by Agent or any Lender;
(vii) as 

  
 11 

 
soon as available, but no later than forty-five (45) days after the last day of each month, copies of the month-end account statements for each Collateral Account maintained by a Credit
Party, which statements may be provided to Agent and each Lender by Borrower or directly from the applicable institution(s); and (viii) promptly and in any event within five (5) Business Days of such request, such additional readily
available information, reports or statements regarding the Credit Parties or their respective businesses, contractors and subcontractors as Agent or any Lender may from time to time reasonably request. 

(b) Within forty-five (45) days after the last day of each month, Borrower shall deliver to Agent and each Lender with the
monthly financial statements described above, a duly completed Compliance Certificate signed by a Responsible Officer. 
 (c)
Borrower shall cause each Credit Party to keep proper books of record and account in accordance with GAAP in all material respects which full, true and correct entries shall be made of all dealings and transactions in relation to its business and
activities. Upon reasonable prior written notice and during business hours (which such limitations shall not apply if a Default or Event of Default has occurred), Borrower shall allow, and cause each Credit Party to allow, Agent and Lenders to visit
and inspect any properties of a Credit Party, to examine and make abstracts or copies from any Credit Party’s books, to conduct a collateral audit and analysis of its operations and the Collateral to verify the amount and age of the accounts,
the identity and credit of the respective account debtors, to review the billing practices of the Credit Party and to discuss its affairs, finances and accounts with their officers, employees and independent public accountants as often as may
reasonably be desired. Borrower shall reimburse Agent and each Lender for all reasonable costs and expenses associated with such visits and inspections; provided, however, that Borrower shall only be required to reimburse Agent and
each Lender for such costs and expenses for no more than one (1) such visit and inspection per twelve (12) month period unless a Default or Event of Default has occurred and is continuing at the time Agent incurs any costs or expenses
associated with such visit or inspection. 
 (d) Borrower shall, and shall cause each Credit Party to, notify Agent and each
Lender within five (5) days after sending or receiving any material correspondence, reports, documents and other filings from or to any Governmental Authority that could reasonably be expected to have a material adverse effect on any of the
Required Permits material to Borrower’s business or otherwise on the operations of Borrower or any of its Subsidiaries, and at the request of Agent, within three (3) days of any request by Agent, provide copies of the foregoing to Agent.

 6.3 Maintenance of Property. Borrower shall use commercially reasonable efforts to keep all equipment and other tangible personal
property other than Inventory to be maintained and preserved in the same condition, repair and in working order as of the date hereof, ordinary wear and tear excepted, and shall promptly make or cause to be made all repairs, replacements and other
improvements in connection therewith that are necessary or desirable to such end. Borrower shall cause each Credit Party to use commercially reasonable efforts to keep all Inventory in good and marketable condition, free from material defects.
Returns and allowances between a Credit Party and its Account Debtors shall follow the Credit Party’s customary practices as they exist at the Closing Date and any changes in customary practices not materially adverse to Lender’s interest
in any Account. Borrower shall promptly notify Agent of all returns, recoveries, disputes and claims that involve more than Five Hundred Thousand Dollars ($500,000) of Inventory collectively among all Credit Parties. 

6.4 Taxes; Pensions. Borrower shall timely file and cause each Credit Party to timely file, all tax returns and reports required to be
filed thereby with a taxing authority (except where the failure to file any such tax return or report does not result in penalties or other liabilities to the Credit Parties in excess of, individually or in the aggregate at any time for all of the
Credit Parties, Twenty Thousand Dollars ($20,000) and there are no Liens on any of the Collateral in favor of a Governmental Authority resulting from the failure to file any such tax return or report, except for Permitted Liens) and timely pay, and
cause each Credit Party to timely pay, all foreign, federal, state, and local Taxes, owed, except for (i) Taxes that do not at any time exceed an amount of, individually or in the aggregate for all of the Credit Parties, Twenty Thousand Dollars
($20,000) and with respect to which there are no Liens on any Collateral in favor of a Governmental Authority resulting from such unpaid Taxes, except for Permitted Liens and (ii) deferred payment of any Taxes contested pursuant to the terms of
Section 5.6, and shall deliver to Agent, on demand, appropriate certificates attesting to such payments. Borrower shall pay, and cause each Credit Party to pay, all amounts necessary to fund all present pension, profit sharing and
deferred compensation plans in accordance with their terms. Each Credit Party and their ERISA Affiliates shall timely make all required contributions to each employee pension benefit plan sponsored, maintained, contributed to, or to which any Credit
Party of any ERISA Affiliate has any liability and that is subject to the provisions of Title IV of ERISA. Borrower shall give written notice to Agent and each Lender promptly (and in any event within three (3) Business Days) upon Borrower

  
 12 

 
becoming aware of any (i) Borrower’s or any ERISA Affiliate’s failure to make any contribution required to be made with respect to any employee pension benefit plan sponsored,
maintained, contributed to, by Borrower or any ERISA Affiliate as to which Borrower’s or any ERISA Affiliate has any liability subject to the provisions of Title IV of ERISA not having been timely made, (ii) notice of the Pension Benefit
Guaranty Corporation’s intention to terminate or to have a trustee appointed to administer any such employee pension benefit plan, or (iii) complete or partial withdrawal by Borrower or any ERISA Affiliate from any employee pension benefit
plan subject to the provisions of Title IV of ERISA. 
 6.5 Insurance. Borrower shall, and shall cause each Credit Party to,
keep its business and the Collateral insured for risks and in amounts standard for companies of similar size in Borrower’s industry and location and as Agent may reasonably request as a result of any change in respect of such standard.
Insurance policies shall be in a form, with companies, and in amounts that are reasonably satisfactory to Agent and standard for companies in the Borrower’s industry and location. All property policies shall have a lender’s loss payable
endorsement showing Agent as sole lender’s loss payee and waive subrogation against Agent, and all liability policies shall show, or have endorsements showing, Agent as an additional insured. Except for purchase money lienholders and Equipment
lessors as to Equipment purchased or leased by Borrower after the Closing Date, no other loss payees may be shown on the policies unless Agent shall otherwise consent in writing. If required by Agent, all policies (or the loss payable and additional
insured endorsements) shall provide that the insurer shall endeavor to give Agent at least thirty (30) days’ notice before canceling, amending, or declining to renew its policy. At Agent’s request, Borrower shall deliver certified
copies of all such Credit Party insurance policies and evidence of all premium payments. If any Credit Party fails to obtain insurance as required under this Section 6.5 or to pay any amount or furnish any required proof of payment to
third persons and Agent, Agent may make all or part of such payment or obtain such insurance policies required in this Section 6.5, and take any action under the policies Agent deems prudent. Notwithstanding the foregoing, Borrower may
reasonably use proceeds received under any policy to replace or repair the property to the extent permitted pursuant to Section 2.3(c). 

6.6 Collateral Accounts. Borrower shall, and shall cause each Credit Party to, provide Agent five (5) days prior written notice
before establishing any Collateral Account at or with any bank or financial institution. In addition, for each Collateral Account that any Credit Party at any time maintains, Borrower shall, and shall cause each Credit Party to, cause the applicable
bank or financial institution at or with which any Collateral Account is maintained to execute and deliver a Control Agreement or other appropriate instrument with respect to such Collateral Account to perfect Agent’s Lien in such Collateral
Account in accordance with the terms hereunder, which Control Agreement may not be terminated without prior written consent of Agent. The provisions of the previous sentence shall not apply to, and for purposes of provisions relating to perfection
and control, the term Collateral Account shall not include (i) the Chase Credit Card Security Account and (ii) deposit accounts exclusively used for payroll, payroll taxes and other employee wage and benefit payments to or for the benefit
of a Credit Party’s employees and identified to Agent by Borrower as such; provided, however, that at all times Borrower shall maintain one or more separate Deposit Accounts to hold any and all amounts to be used for payroll,
payroll taxes and other employee wage and benefit payments, and shall not commingle any monies allocated for such purposes with funds in any other Deposit Account. 

6.7 Notices of Material Agreements, Litigation and Defaults; Cooperation in Litigation. Promptly (and in any event within three
(3) Business Days), (a) upon Borrower becoming aware of the existence of any Default or Event of Default or (b) upon the execution and delivery of any Material Agreement and each material amendment, consent, waiver or other
modification, and each notice of termination or default or similar notice delivered to or by a Credit Party in connection with any Material Agreement, or (c) upon Borrower becoming aware of any action, suit, proceeding or investigation (pending
or threatened in writing) by or against Borrower or any Credit Party which involves the reasonable likelihood of any judgment or liability of more than Five Hundred Thousand Dollars ($500,000) or that could result in a Material Adverse Change, or
which questions the validity of any of the Financing Documents or any action taken pursuant thereto, or the other documents required thereby or any action to be taken pursuant to any of the foregoing, Borrower shall give written notice to Agent and
each Lender of such occurrence, and which shall include a reasonably detailed description of such event and, upon request of Agent, such further information or documentation as Agent shall reasonably require. From the date hereof and continuing
through the termination of this Agreement, Borrower shall, and shall cause each Credit Party to, make available to Agent and each Lender, without expense to Agent or any Lender, each Credit Party’s officers, employees and agents and books
(which absent the occurrence of a Default or Event of Default, shall be at reasonable times and upon reasonable notice), to the extent that Agent or any Lender may reasonably deem them necessary to prosecute or defend any third-party suit or
proceeding instituted by or against Agent or any Lender with respect to any Collateral or relating to a Credit Party. 

  
 13 

 6.8 Creation/Acquisition of Subsidiaries. In the event Borrower or any Subsidiary
creates or, to the extent permitted hereunder, acquires any Subsidiary, Borrower and such Subsidiary shall promptly (and in any event within five (5) Business Days of such creation or acquisition) notify Agent of the creation or acquisition of
such new Subsidiary and take all such action as may be reasonably required by Agent or the Required Lenders to (i) cause each such Domestic Subsidiary other than an Excluded Domestic Subsidiary to become a co-Borrower hereunder or to guarantee
the Obligations of Borrower under the Financing Documents, within an additional fifteen (15) Business Days of such notice, and (ii) in each case, grant a continuing pledge and security interest in and to the assets of such Subsidiary to
the extent such assets are of the type that would constitute Collateral (substantially as described on Exhibit A hereto); provided that, notwithstanding anything to the contrary herein or in any Financing Document, only 65% of the issued
and outstanding voting stock or other voting interests, and 100% of any other equity interests, of any First-Tier Foreign Subsidiary or of any Excluded Domestic Subsidiary shall be required to be pledged (whether owned directly or indirectly by
Borrower or by any such Subsidiary) or shall be Collateral hereunder or under any Financing Document; and Borrower shall grant and pledge to Agent, for the ratable benefit of the Lenders, a perfected security interest in the stock, units or other
evidence of ownership of each Subsidiary to the extent required to be pledged pursuant to the terms hereof (the foregoing collectively, the “Joinder Requirements”); provided that Borrower shall not be permitted to make any
Investment (other than Permitted Investments) in such Subsidiary until such time as Borrower has satisfied the Joinder Requirements. 
 6.9
Use of Proceeds. Borrower shall use the proceeds of the Credit Extensions solely for (a) transaction fees incurred in connection with the Financing Documents, (b) for working capital needs of Borrower and its Subsidiaries,
(c) other general corporate purposes, or (d) if applicable, any other Permitted Purpose specified in the Credit Facility Schedule for such Credit Facility. No portion of the proceeds of the Credit Extensions will be used for family,
personal, agricultural or household use. 
 6.10 Hazardous Materials; Remediation. 

(a) If any release or disposal of Hazardous Materials shall occur or shall have occurred on any real property or any other assets of any
Borrower or any other Credit Party, such Borrower will cause, or direct the applicable Credit Party to cause, the prompt containment and removal of such Hazardous Materials and the remediation of such real property or other assets as is necessary to
comply with all Laws and to reasonably preserve the value of such real property or other assets. Without limiting the generality of the foregoing, each Borrower shall, and shall cause each other Credit Party to, comply with each Law requiring the
performance at any real property by any Borrower or any other Credit Party of activities in response to the release or threatened release of a Hazardous Material. 

(b) Borrower will provide Agent within thirty (30) days after written demand therefor with a bond, letter of credit or similar financial
assurance evidencing to the reasonable satisfaction of Agent that sufficient funds are available to pay the cost of removing, treating and disposing of any Hazardous Materials or Hazardous Materials Contamination and discharging any assessment which
may be established on any property as a result thereof, such demand to be made, if at all, upon Agent’s determination that the failure to remove, treat or dispose of any Hazardous Materials or Hazardous Materials Contamination, or the failure
to discharge any such assessment could reasonably be expected to have a Material Adverse Change. 
 (c) If there is any conflict between this
Section 6.10 and any environmental indemnity agreement which is a Financing Document, the environmental indemnity agreement shall govern and control. 

6.11 Power of Attorney. Each of the officers of Agent is hereby irrevocably made, constituted and appointed the true and lawful attorney
for each Borrower (without requiring any of them to act as such) with full power of substitution to do the following: (a) upon Borrower’s failure to take the action, pay, contest or settle any Lien, charge, encumbrance, security interest,
and adverse claim in or to the Collateral (in each case, so long as no Default or Event of Default has occurred, other than Permitted Liens), or any judgment based thereon, or otherwise take any action to terminate or discharge the same; (b) so
long as Agent has provided not less than three (3) Business Days’ prior written notice to Borrower to perform the same and Borrower has failed to take such action, (i) execute in the name of or on behalf of the Borrower any schedules,
assignments, instruments, documents, and statements that Agent or any Lender reasonably deems necessary to perfect or better perfect Agent’s security interest or Lien in any Collateral, (ii) do such other and further acts and deeds in the
name of Borrower that Agent may deem necessary or desirable to enforce, protect or preserve any Collateral or its rights therein, including, but not limited to, to sign Borrower’s name on any invoice or bill of lading for any Account or drafts
against Account Debtors; and (iii) after the occurrence and during the continuance of an Event of Default, (A) endorse the name of any Borrower upon any 

  
 14 

 
and all checks, drafts, money orders, and other instruments for the payment of money that are payable to Borrower; (B) make, settle, and adjust all claims under Borrower’s insurance
policies; (C) take any action any Credit Party is required to take under this Agreement or any other Financing Document; (D) transfer the Collateral into the name of Agent or a third party as the Code permits; (E) exercise any rights
and remedies described in this Agreement or the other Financing Documents; and (F) do such other and further acts and deeds in the name of Borrower that Agent may deem necessary or desirable to enforce its rights with regard to any Collateral.

 6.12 Further Assurances. Borrower shall, and shall cause each Credit Party to, promptly execute any further instruments and take
further action as Agent reasonably requests to perfect or better perfect or continue Agent’s Lien in the Collateral or to effect the purposes of this Agreement or any other Financing Document. 

6.13 Post-Closing Obligations. Borrower shall, and shall cause each Credit Party to, complete each of the post-closing
obligations and/or deliver to Agent each of the documents, instruments, agreements and information listed on the Post-Closing Obligations Schedule attached hereto, on or before the date set forth for each such item thereon (as may be extended
by the Agent in writing in its sole discretion), each of which shall be completed or provided in form and substance satisfactory to Agent and Lenders. 

6.14 Disclosure Schedule. Borrower shall deliver to Agent a proposed update to the Disclosure Schedule correcting all outdated,
inaccurate, incomplete or misleading information prior to the funding of the second Term Credit Facility identified on the Credit Facility Schedule is funded. With respect to any proposed updates to the Disclosure Schedule involving
Permitted Liens, Permitted Indebtedness or Permitted Investments, Agent will replace the Disclosure Schedule attached hereto with such proposed update only if such updated information is consistent with the definitions of and limitations
herein pertaining to Permitted Liens, Permitted Indebtedness or Permitted Investments. With respect to any proposed updates to the Disclosure Schedule involving other matters, Agent will replace the applicable portion of the Disclosure
Schedule attached hereto with such proposed update upon Agent’s approval thereof. 
 6.15 Landlord Agreements. Subject to the
Post-Closing Obligations Schedule, Borrower shall use commercially reasonable efforts to promptly obtain a landlord agreement from the lessor of each leased property with respect to each location where any Collateral is stored or located, in
each case in respect of locations at which Collateral is stored or located on the Closing Date, solely to the extent that the Collateral stored or located at each such location or the value thereof materially increases from that which is stored or
located at such location as of the Closing Date. 
 7 NEGATIVE COVENANTS 

Borrower shall not do, nor shall it permit any Credit Party to do any of the following without the prior written consent of Agent: 

7.1 Dispositions. Convey, sell, abandon, lease, license, transfer, assign or otherwise dispose of (collectively,
“Transfer”) all or any part of its business or property, except for (a) sales, transfers or dispositions of Inventory in the Ordinary Course of Business; (b) sales or abandonment of
worn-out or obsolete Equipment; (c) sales or abandonment of Equipment that is no longer used or useful in its business having a book value not exceeding $250,000 in the aggregate during the term of this
Agreement; (d) between Borrowers; and (e) licenses and leases constituting Permitted Licenses or Permitted Liens. For clarification, the transfer or payment of money to vendors for the acquisition of Equipment or for the payment of
ordinary business expenses shall not be deemed a transfer or disposition under this Section 7.1. 
 7.2 Changes in Business,
Management, Ownership or Business Locations. (a) Engage in any business other than the businesses currently engaged in by Borrower or such Subsidiary, as applicable, or reasonably related thereto; (b) liquidate or dissolve;
(c) enter into any transaction or series of related transactions which would result in a Change in Control unless the agreement governing such transactions provides, as a condition precedent to the consummation of such transactions, for either
(x) the indefeasible payment in full in cash of all Obligations or (y) the consent of Agent and Lenders; (d) add any new offices or business locations, or enter into any new leases with respect to existing offices or business
locations (unless such new or existing offices or business locations contain less than Twenty-Five Thousand Dollars ($25,000) in Borrower’s assets or property and do not contain any of Borrower’s Books) without first delivering a
fully-executed Access Agreement to Agent; (e) change its jurisdiction of organization; (f) change its organizational structure or type; (g) change its legal name; or (h) change any organizational number (if any) assigned by its
jurisdiction of organization; (I) in the case of clauses (e), (f), (g) and (h), without at least fifteen (15) Business Days’ prior written notice to Agent and the acknowledgement of Agent that all actions reasonably required by
Agent, including those to continue the perfection of its Liens, have been completed and (II) in the case of clause (e), to any jurisdiction outside of the United States of America. 

  
 15 

 7.3 Mergers or Acquisitions. Merge or consolidate with any other Person, or acquire all or
substantially all of the capital stock or property of another Person; provided, however, that a Subsidiary of Borrower may merge or consolidate into Borrower or into another Subsidiary that is a Borrower, so long as (a) Borrower has
provided Agent with prior written notice of such transaction, (b) the Borrower (or other Borrower) shall be the surviving legal entity (provided, that, ZS Pharma, Inc. shall always remain a Borrower and a surviving entity of any such merger),
(c) Borrower’s tangible net worth is not thereby reduced, (d) no Event of Default has occurred and is continuing prior thereto or arises as a result therefrom, and (e) Borrower shall be in compliance with the covenants set forth
in this Agreement both before and after giving effect to such transaction. 
 7.4 Indebtedness. Create, incur, assume, or be liable
for any Indebtedness other than Permitted Indebtedness. 
 7.5 Encumbrance. (a) Create, incur, allow, or suffer to exist any Lien
on any of its property, except for Permitted Liens, (b) permit any Collateral to fail to be subject to the first priority security interest granted herein except for Permitted Liens that may have priority by operation of applicable Law or by
the terms of a written intercreditor or subordination agreement entered into by Agent, or (c) enter into any agreement, document, instrument or other arrangement (except with or in favor of Agent) with any Person which directly or indirectly
prohibits or has the effect of prohibiting Borrower or any Subsidiary from assigning, mortgaging, pledging, granting a security interest in or upon, or encumbering any of Borrower’s or any Subsidiary’s Collateral or Intellectual Property,
except as is otherwise permitted in the definition of “Permitted Liens” herein. 
 7.6 Maintenance of Collateral Accounts.
Maintain any Collateral Account, except pursuant to the terms of Section 6.6 hereof. 
 7.7 Distributions; Investments; Margin
Stock. (a) Pay any dividends (other than dividends payable solely in common stock or other equity interests and payments of any dividends by any Credit Party to Borrower) or make any distribution or payment with respect to or redeem, retire
or purchase or repurchase any of its equity interests (other than repurchases pursuant to the terms of employee stock purchase plans, employee restricted stock agreements or similar plans), or (b) directly or indirectly make any Investment
(including, without limitation, any additional Investment in any Subsidiary) other than Permitted Investments. Without limiting the foregoing, Borrower shall not, and shall not permit any of its Subsidiaries to, purchase or carry Margin Stock. 

7.8 Transactions with Affiliates. Directly or indirectly enter into or permit to exist any material transaction with any Affiliate of
any Credit Party, except for (a) transactions that are in the Ordinary Course of Business, upon fair and reasonable terms that are no less favorable to Borrower than would be obtained in an arm’s length transaction with a non-affiliated
Person, (b) transactions with Subsidiaries and that are not otherwise prohibited by Article 7 of this Agreement, (c) transactions permitted by Section 7.7 of this Agreement, (d) bona fide equity or bridge financings
with Borrower’s investors, provided that any such bridge financings must satisfy the requirements of Subordinated Debt, (e) the granting of registration and other customary rights in connection with the issuance of equity interests by
Borrower, and provided such rights do not include any right to payments in cash (other than typical liquidation preference and similar cash payments), right of redemption or other put right prior to the date that 91 days after the payment in full of
the Obligations, and (f) compensation and indemnification of, and other employment agreements and arrangements, employee benefit plans, and stock incentive plans with, directors, officers, employees and consultants of Borrower entered into in
the Ordinary Course of Business. 
 7.9 Subordinated Debt. (a) Make or permit any payment on any Subordinated Debt, except to the
extent expressly permitted to be made pursuant to the terms of the Subordination Agreement to which such Subordinated Debt is subject, or (b) amend any provision in any document relating to the Subordinated Debt other than as may be expressly
permitted pursuant to the terms of any applicable Subordination Agreement to which such Subordinated Debt is subject. 
 7.10
Compliance. Become an “investment company” or a company controlled by an “investment company”, under the Investment Company Act of 1940, as amended or undertake as one of its important activities extending credit to
purchase or carry margin stock (as defined in Regulation U of the Board of Governors of the Federal Reserve System), or use the proceeds of any Credit Extension for that purpose; (i) fail, or permit any ERISA Affiliate to fail, to meet
“minimum funding standards” (as defined in Section 412 of the Internal Revenue Code or Section 302 of ERISA), whether or not 

  
 16 

 
waived, (ii) permit (with respect to Borrower, any Subsidiary of Borrower or any ERISA Affiliate) a “reportable event” as defined in Section 4043(c) of ERISA (or the
regulations issued thereunder) (other than an event for which the 30-day notice requirement is waived) to occur, (iii) engage in any “prohibited transaction” within the meaning of Section 406 of ERISA or Section 4975 of the
Internal Revenue Code that could result in liability in excess of $150,000 in the aggregate or that could reasonably be expected to result in a Material Adverse Change; (iv) fail to comply with the Federal Fair Labor Standards Act that could
result in liability in excess of $150,000 in the aggregate or that could reasonably be expected to result in a Material Adverse Change; (v) permit (with respect to Borrower, any Subsidiary of Borrower or any ERISA Affiliate) the withdrawal from
participation in any multiemployer plan as defined in Section 4001(a)(3) of ERISA, or (vi) incur, or permit any ERISA Affiliate to incur, any liability under Title IV of ERISA with respect to the termination of any employee pension benefit
plan subject to the provisions of Title IV of ERISA (other than with respect to any “standard termination” under Section 4041(b) of ERISA). 

7.11 Amendments to Organization Documents and Material Agreements. Amend, modify or waive any provision of (a) any Material
Agreement in a manner that is materially adverse to Agent or any Lender, that pertains to restricting rights to assign or grant a security interest in such Material Agreement, or that could or could reasonably be expected to result in a Material
Adverse Change, or (b) any Organizational Document (other than a change in registered agents, or a change that could not adversely affect the rights of Agent or Lenders hereunder, but, for the avoidance of doubt, under no circumstances a change
of its name, type of organization or jurisdiction of organization), in each case, without the prior written consent of Agent. Borrower shall provide notice, and upon request copies, to Agent of all amendments, waivers and modifications of any
Material Agreement or Organizational Documents. 
 7.12 Compliance with Anti-Terrorism Laws. Directly or indirectly, knowingly
enter into any documents, instruments, agreements or contracts with any Person listed on the OFAC Lists. Borrower shall immediately notify Agent if Borrower has knowledge that Borrower or any Subsidiary or Affiliate is listed on the OFAC Lists or
(a) is convicted on, (b) pleads nolo contendere to, (c) is indicted on, or (d) is arraigned and held over on charges involving money laundering or predicate crimes to money laundering. Borrower will not, nor will Borrower
permit any Subsidiary or Affiliate to, directly or indirectly, (i) conduct any business or engage in any transaction or dealing with any Blocked Person, including, without limitation, the making or receiving of any contribution of funds, goods
or services to or for the benefit of any Blocked Person, (ii) deal in, or otherwise engage in any transaction relating to, any property or interests in property blocked pursuant to Executive Order No. 13224, any similar executive order or
other Anti-Terrorism Law, or (iii) engage in or conspire to engage in any transaction that evades or avoids, or has the purpose of evading or avoiding, or attempts to violate, any of the prohibitions set forth in Executive Order No. 13224
or other Anti-Terrorism Law. Agent hereby notifies Borrower that pursuant to the requirements of Anti-Terrorism Laws, and Agent’s policies and practices, Agent is required to obtain, verify and record certain information and documentation that
identifies Borrower and its principals, which information includes the name and address of Borrower and its principals and such other information that will allow Agent to identify such party in accordance with Anti-Terrorism Laws. 

8 LIFE SCIENCES PROVISIONS ; SBIC RELATED PROVISIONS 

8.1 Life Sciences Covenants. 

(a) As used in this Agreement, the following terms have the following meanings: 

“DEA” means the Drug Enforcement Administration of the United States of America, and any successor agency thereof. 

“Drug Application” means a new drug application, an abbreviated drug application, or a product license application for any
Product, as appropriate, as those terms are defined in the FDCA. 
 “FDA” means the Food and Drug Administration of
the United States of America, or any successor entity thereto. 
 “FDCA” means the Federal Food, Drug and Cosmetic Act, as
amended, 21 U.S.C. Section 301 et seq., and all regulations promulgated thereunder. 

  
 17 

 “Material Intangible Property” means all of Borrower’s Intellectual
Property and license or sublicense agreements or other agreements with respect to rights in Intellectual Property that are material to the condition (financial or other), business or operations of Borrower. 

“Permitted License” means (a) any non-exclusive license of patent rights of Borrower or its Subsidiaries granted to
third parties in the Ordinary Course of Business and that does not result in a legal transfer of title to the licensed property, (b) any exclusive license of patent rights of Borrower or its Subsidiaries that does not result in a legal transfer
of title to the licensed property and is exclusive solely as to discrete geographical areas outside of the United States, and in each of (a) and (b) is for fair value consideration and (c) the Existing Sublicense. 

“Products” means any products manufactured, sold, developed, tested or marketed by any Borrower or any of its Subsidiaries,
including without limitation, those products set forth on the Products Schedule (as updated from time to time in accordance with Section 8.1(d)); provided, however, that if Borrower shall fail to comply with the
obligations under Section 8.1(d) to give notice to Agent and update the Products Schedule prior to manufacturing, selling, developing, testing or marketing any new Product, any such improperly undisclosed Product shall be deemed
to be included in this definition. 
 “Registered Intellectual Property” means any registered patent, registered trademark
or servicemark, registered copyright, registered mask work, or any pending application for any of the foregoing. 
 (b)
Notwithstanding the terms of Section 7.1 of this Agreement to the contrary, Borrower shall be permitted to make Transfers in the form of Permitted Licenses. 

(c) Borrower represents and warrants as follows at all times unless expressly provided below: 

(i) Intellectual Property and License Agreements. A list of all of Intellectual Property of each Credit Party and all license
agreements, sublicenses, or other rights of any Credit Party to use Intellectual Property (including all in-bound license agreements, but excluding over-the-counter software that is commercially available to the public), as of the Closing Date and,
as updated pursuant to Section 8.1(d), is set forth on the Intangible Assets Schedule, which indicates, for each item of property: (A) the name of the Credit Party owning such Intellectual Property or licensee to such license
agreement; (B) the Credit Party’s identifier for such property (i.e., name of patent, license, etc.), (C) whether such property is Intellectual Property (or application therefor) owned by a Credit Party or is property to which a
Credit Party has rights pursuant to a license agreement, and (D) the expiration date of such Intellectual Property or license agreement. In the case of any Material Intangible Property that is a license agreement, the Intangible Assets
Schedule further indicates, for each: (1) the name and address of the licensor, (2) the name and date of the agreement pursuant to which such item of Material Intangible Property is licensed, (3) whether or not such license
agreement grants an exclusive license to a Credit Party, (4) whether there are any purported restrictions in such license agreement as to the ability of a Credit Party to grant a security interest in and/or to transfer any of its rights as a
licensee under such license agreement, and (5) whether a default under or termination of such license agreement could interfere with Agent’s right to sell or assign such license or any other Collateral. Except for Permitted Licenses noted
on the Intangible Assets Schedule, each Credit Party is the sole owner of its Intellectual Property, free and clear of any Liens (other than Permitted Liens). Each Patent is valid and enforceable and no part of the Material Intangible
Property has been judged invalid or unenforceable, in whole or in part, and to the best of Borrower’s knowledge, no claim has been made that any part of the Intellectual Property violates the rights of any third party. 

(ii) Regulatory Status. 

(A) All Products and all Required Permits are listed on the Products Schedule and Required Permits Schedule (as updated from
time to time pursuant to Section 8.1(d)), and Borrower has delivered to Agent a copy of all Required Permits requested by Agent as of the date hereof or to the extent requested by Agent pursuant to Section 8.1(d). 

(B) Without limiting the generality of Section 8.1 above, with respect to any Product being tested or manufactured, Borrower and
its Subsidiaries have received, and such Product is the subject of, all Required Permits needed in connection with the testing or manufacture of such Product as such testing or manufacturing is currently being conducted by or on behalf of Borrower,
and Borrower and its Subsidiaries have not received any notice from 

  
 18 

 
any applicable Governmental Authority, specifically including the FDA, that such Governmental Authority is conducting an investigation or review of (1) Borrower’s or such
Subsidiary’s manufacturing facilities and processes for such Product which have disclosed any material deficiencies or violations of Laws and/or the Required Permits related to the manufacture of such Product, or (2) any such Required
Permit or that any such Required Permit has been revoked or withdrawn, nor has any such Governmental Authority issued any order or recommendation stating that the development, testing and/or manufacturing of such Product should cease. 

(C) Without limiting the generality of Section 8.1 above, with respect to any Product marketed or sold by Borrower or its
Subsidiaries, Borrower and its Subsidiaries have received, and such Product is the subject of, all Required Permits needed in connection with the marketing and sales of such Product as currently being marketed or sold by Borrower or its
Subsidiaries, and Borrower and its Subsidiaries have not received any notice from any applicable Governmental Authority, specifically including the FDA, that such Governmental Authority is conducting an investigation or review of any such Required
Permit or approval or that any such Required Permit has been revoked or withdrawn, nor has any such Governmental Authority issued any order or recommendation stating that such marketing or sales of such Product cease or that such Product be
withdrawn from the marketplace. 
 (D) Without limiting the generality of Section 8.1 above, (i) there have been no adverse
clinical test results which have or could reasonably be expected to result in a Material Adverse Change, and (ii) there have been no Product recalls or voluntary Product withdrawals from any market. 

(E) On the Closing Date and the date of each Credit Extension, Borrower and its Subsidiaries have not experienced any significant failures in
its manufacturing of any Product such that the amount of such Product successfully manufactured by Borrower or its Subsidiaries in accordance with all specifications thereof and the required payments related thereto in any month shall decrease
significantly with respect to the quantities of such Product produced in the prior month. 
 (d) Borrower covenants and agrees as follows:

 (i) [reserved] 
 (ii)
Borrower shall own, or be licensed to use or otherwise have the right to use, all Material Intangible Property. All Material Intangible Property of Borrower is and shall be fully protected and/or duly and properly registered, filed or issued in the
appropriate office and jurisdictions for such registrations, filings or issuances, except where the failure to do so would not reasonably be expected to result in a Material Adverse Change. Borrower shall not become a party to, nor become bound by,
any material license or other agreement with respect to which Borrower is the licensee that prohibits or otherwise restricts Borrower from granting a security interest in Borrower’s interest in such license or agreement or other property.
Borrower shall at all times conduct its business without infringement or claim of infringement of any Intellectual Property rights of others. Borrower shall do the following, to the extent it determines, in the exercise of its reasonable business
judgment, that it is prudent to do so: (A) protect, defend and maintain the validity and enforceability of its Material Intangible Property; (B) promptly advise Agent in writing of material infringements of its Material Intangible
Property; and (C) not allow, without Agent’s prior written consent, any Material Intangible Property to be abandoned, invalidated, forfeited or dedicated to the public or to become unenforceable. If Borrower (1) obtains any patent,
registered trademark or servicemark, registered copyright, registered mask work, or any pending application for any of the foregoing, whether as owner, licensee or otherwise, or (2) applies for any patent or the registration of any trademark or
servicemark, then Borrower shall concurrently provide written notice thereof to Agent and shall execute such documents and take such other actions as Agent shall request in its good faith business judgment to perfect and maintain a first priority
perfected security interest in favor of Agent, for the ratable benefit of Lenders, in the IP Proceeds (as defined in Exhibit A) pertaining thereto. Borrower shall promptly provide to Agent copies of all applications that it files for
patents or for the registration of trademarks, servicemarks, copyrights or mask works. 
 (iii) In connection with the development, testing,
manufacture, marketing or sale of each and any Product by a Credit Party, such Credit Party shall comply fully and completely in all respects with all Required Permits at all times issued by any Governmental Authority the noncompliance with which
could have a Material Adverse Change, specifically including the FDA, with respect to such development, testing, manufacture, marketing or sales of such Product by such Credit Party as such activities are at any such time being conducted by such
Credit Party. 

  
 19 

 (iv) Within ten (10) days of (A) acquiring and/or developing any new Registered
Intellectual Property, or (B) entering or becoming bound by any additional license or sublicense agreement or other agreement with respect to rights in Intellectual Property (other than over-the-counter software that is commercially available
to the public), deliver to Agent an updated Intangible Assets Schedule reflecting same, and upon any other material change in Borrower’s Material Intangible Property from that listed on the Intangible Assets Schedule. Borrower
shall take such commercially reasonable steps as Agent reasonably requests to obtain the consent of, or waiver by, any person whose consent or waiver is necessary for (x) all licenses or agreements (except for the Existing Licenses) to be
deemed “Collateral” and for Agent to have a security interest in it that might otherwise be restricted or prohibited by Law or by the terms of any such license or agreement, whether now existing or entered into in the future, and
(y) Agent to have the ability in the event of a liquidation of any Collateral to dispose of such Collateral in accordance with Agent’s rights and remedies under this Agreement and the other Financing Documents. 

(v) If, after the Closing Date, Borrower determines to manufacture, sell, develop, test or market any new Product, Borrower shall give prior
written notice to Agent of such determination (which shall include a brief description of such Product, plus a list of all Required Permits relating to such new Product (and a copy of such Required Permits if requested by Agent) and/or
Borrower’s manufacture, sale, development, testing or marketing thereof issued or outstanding as of the date of such notice), along with a copy of an updated Intangible Assets Schedule, Products Schedule and Required Permits
Schedule; provided, however, that if Borrower shall at any time obtain any new or additional Required Permits from the FDA, DEA, or parallel state or local authorities, or foreign counterparts of the FDA, DEA, or parallel state or
local authorities, with respect to any Product which has previously been disclosed to Agent, Borrower shall promptly give written notice to Agent of such new or additional Required Permits (along with a copy thereof if requested by Agent). 

(e) In addition to the events listed in Article 10, any one of the following shall also constitute an Event of Default under
this Agreement: (i) an order by FDA or similar Governmental Authority requiring the withdrawal of any Product or Product category from the market or to enjoin Borrower, its Subsidiaries or any representative of Borrower or its Subsidiaries from
manufacturing, marketing, selling or distributing any Product or Product category and such order could reasonably be expected to result in a Material Adverse Change, (ii) the institution of any action or proceeding by any DEA, FDA, or any other
Governmental Authority to revoke, suspend, reject, withdraw, limit, or restrict any Required Permit held by Borrower, its Subsidiaries or any representative of Borrower or its Subsidiaries, which, in each case, could reasonably be expected to result
in Material Adverse Change, (iii) the commencement of any enforcement action against Borrower, its Subsidiaries or any representative of Borrower or its Subsidiaries (with respect to the business of Borrower or its Subsidiaries) by DEA, FDA, or
any other Governmental Authority, which reasonably could be expected to result in a Material Adverse Change, (iv) the recall of any Products from the market, the voluntary withdrawal of any Products from the market, or actions to discontinue
the sale of any Products, which could reasonably be expected to result in a Material Adverse Change, or (v) the occurrence of adverse test results in connection with a Product which could reasonably be expected to result in Material Adverse
Change. 
 8.2 SBIC Related Provisions. 

(a) SBIC Acknowledgement. Borrower acknowledges that Agent, and any Lender with the word “SBIC” in its name,
is a Federal licensee under the Small Business Investment Act of 1958, as amended (“SBA Act”). The term “SBA” as used herein means the U.S. Small Business Administration. 

(b) As a condition to any Credit Extension, Borrower shall, upon request of Agent or any Lender, complete and deliver to Agent
and such Lender SBA Forms 480, 652 and 1031, the SBA Economic Impact Assessment. Any information provided by the Borrower to Agent or any Lender on each such form is and will be true, accurate and complete in all material respects. 

(c) Within forty-five (45) days after the end of each fiscal year of Borrower, and at such other times as Agent or any
Lender may reasonably request to the extent related to SBA regulations, Borrower shall provide to Agent and such Lender such forms and financial and other information with respect to any business or financial condition of Borrower or any of its
Subsidiaries required by the SBA, including, but not limited to (i) forms and information with respect to Agent’s or any Lender’s reporting requirements under SBA Form 468, (ii) information regarding the full-time equivalent jobs
created or retained in connection with any Lender’s investment in Borrower, the impact of the financing on Borrower’s business in terms of revenues and profits and on taxes paid by Borrower and its employees, and (iii) a list of
holders of the Obligations. 

  
 20 

 (d) Upon request of Agent or any Lender, the Borrower shall promptly (and in any
event within twenty (20) days of such request) furnish to Agent and such Lender all information as Agent or any Lender may reasonably request, to the extent reasonably available to the Borrower, in order for Agent or any Lender to comply with
the requirements of 13 C.F.R. Section 107.620 or to prepare or file SBA Form 468 and any other information requested or required by the SBA or any other similar Governmental Authority asserting jurisdiction over Agent or such Lender. Each
Borrower shall afford to Agent and such Lender and examiners of the SBA reasonable access, during normal business hours and with prior reasonable notice, to the books, records and properties of such Borrower for the purpose of verifying the
certifications made in accordance with 13 C.F.R. Section 107.610 and for all other purposes required by the SBA. 
 (e)
No Borrower presently engages in, and it will not hereafter engage in, any activities, and no Borrower will use directly or indirectly, the proceeds from the Credit Extensions made on the Closing Date or otherwise pursuant to the Financing
Documents, for any purpose for which a small business investment company is prohibited from using funds by the SBA Act and the regulations thereunder, including 13 C.F.R. Section 107.720. For a period of twelve (12) months following the
Closing Date, no Borrower shall knowingly cause the nature of its business activity to change if such change would render such Borrower ineligible for financing pursuant to 13 C.F.R. Section 107.720. So long as any Obligations are owing to
Agent or any Lender under the Financing Documents, the Borrower will at all times comply with all non-discrimination requirements applicable to the Borrower under federal law. 

9 RESERVED 
 10
EVENTS OF DEFAULT 
 10.1 Events of Default. The occurrence of any of the following conditions and/or events, whether
voluntary or involuntary, by operation of law or otherwise, shall constitute an “Event of Default” and Credit Parties shall thereupon be in default under this Agreement and each of the other Financing Documents: 

(a) Borrower fails to (i) make any payment of principal or interest on any Credit Extension on its due date, or
(ii) pay any other Obligations within three (3) Business Days after such Obligations are due and payable (which three (3) Business Day grace period shall not apply to payments due on the Maturity Date or the date of acceleration
pursuant to Section 10.2 hereof); 
 (b) Any Credit Party defaults in the performance of or compliance with any
term contained in this Agreement or in any other Financing Document (other than occurrences described in other provisions of this Section 10.1 for which a different grace or cure period is specified or for which no grace or cure period
is specified and thereby constitute immediate Events of Default) and such default is not remedied by the Credit Party or waived by Agent within ten (10) days after the earlier of (i) the date of receipt by any Borrower of notice from Agent
or Required Lenders of such default, or (ii) the date an officer of such Credit Party becomes aware, or through the exercise of reasonable diligence should have become aware, of such default; provided, however, that if the default
cannot by its nature be cured within the ten (10) day period or cannot after diligent attempts by Borrower be cured within such ten (10) day period, and such default is likely to be cured within a reasonable time, then Borrower shall have
an additional period (which shall not in any case exceed thirty (30) total days from the date such ten (10) day period ends) to attempt to cure such default, and within such reasonable time period the failure to cure the default shall not
be deemed an Event of Default (but no Credit Extensions shall be made during such cure period). For the avoidance of doubt, grace periods provided under this Section shall not apply to covenants set forth in subsection (c) below; 

(c) Any Credit Party: (i) defaults in the performance of or compliance with any term contained in Section 6.4,
6.5, 6.6, 6.8 or 6.10 or Article 7 or Article 8; or (ii) fails to perform or observe any term, covenant or agreement contained in Section 6.2 and such default shall continue unremedied for a period of three
(3) Business Days. 

  
 21 

 (d) Any representation, warranty, certification or statement made by any Credit
Party, or any other Person acting for or on behalf of a Credit Party (i) in any Financing Document or in any certificate, financial statement or other document delivered pursuant to any Financing Document or (ii) to induce Agent and/or
Lenders to enter into this Agreement or any Financing Document is incorrect in any respect (or in any material respect if such representation, warranty, certification or statement is not by its terms already qualified as to materiality) when made
(or deemed made); 
 (e) (i) any Credit Party defaults under or breaches any Material Agreement if the effect of such default
or breach (after any applicable grace period contained therein) is to give rise to the ability of a third party or the parties thereto to terminate such Material Agreement, or a Material Agreement shall be terminated by a third party or parties
party thereto prior to the expiration thereof, or there is a loss of a material right of a Credit Party under any Material Agreement to which it is a party, in each case which could reasonably be expected to result in a Material Adverse Change,
(ii) (A) any Credit Party fails to make (after any applicable grace period) any payment when due (whether due because of scheduled maturity, required prepayment provisions, acceleration, demand or otherwise) on any Indebtedness (other than
the Obligations) of such Credit Party or such Subsidiary having an aggregate principal amount (including undrawn committed or available amounts and including amounts owing to all creditors under any combined or syndicated credit arrangement) of more
than Two Hundred Fifty Thousand Dollars ($250,000) (“Material Indebtedness”), (B) any other event shall occur or condition shall exist under any contractual obligation relating to any such Material Indebtedness, if the effect
of such event or condition (after any applicable grace or notice period contained therein) is to accelerate, or to permit the acceleration of (without regard to any subordination terms with respect thereto), the maturity of such Material
Indebtedness or (C) any such Material Indebtedness shall become or be declared to be due and payable, or be required to be prepaid, redeemed, defeased or repurchased (other than by a regularly scheduled required prepayment), prior to the stated
maturity thereof, (iii) any Credit Party defaults (beyond any applicable grace period) under any obligation for payments due or otherwise under any lease agreement for such Credit Party’s principal place of business or any place of
business that meets the criteria for the requirement of an Access Agreement under Section 7.2 or for which an Access Agreement exists or was required to be delivered which default is not cured or resolved, (iv) the occurrence of any
breach or default under any terms or provisions of any Subordinated Debt Document or under any agreement subordinating the Subordinated Debt to all or any portion of the Obligations, or the occurrence of any event requiring the prepayment of any
Subordinated Debt, or the delivery of any notice with respect to any Subordinated Debt, or (v) any Borrower makes any payment on account of any Indebtedness that has been subordinated to any of the Obligations, other than payments specifically
permitted by the terms of such subordination; 
 (f) (i) any Credit Party shall generally not pay its debts as such debts
become due, shall admit in writing its inability to pay its debts generally, shall make a general assignment for the benefit of creditors, or shall cease doing business as a going concern, (ii) any proceeding shall be instituted by or against
any Credit Party seeking to adjudicate it a bankrupt or insolvent or seeking liquidation, winding up, reorganization, arrangement, adjustment, protection, relief, composition of it or its debts or any similar order, in each case under any law
relating to bankruptcy, insolvency or reorganization or relief of debtors or seeking the entry of an order for relief or the appointment of a custodian, receiver, trustee, conservator, liquidating agent, liquidator, other similar official or other
official with similar powers, in each case for it or for any substantial part of its property and, in the case of any such proceedings instituted against (but not by or with the consent of) such Credit Party, either such proceedings shall remain
undismissed or unstayed for a period of thirty (30) days or more or any action sought in such proceedings shall occur or (iii) any Credit Party shall take any corporate or similar action or any other action to authorize any action
described in clause (i) or (ii) above; 
 (g) (i) The service of process seeking to attach, execute or
levy upon, seize or confiscate any Collateral Account, any Material Intellectual Property, or any funds of any Credit Party on deposit with Agent, any Lender or any Affiliate of Agent or any Lender, or (ii) a notice of lien, levy, or assessment
is filed against any assets of a Credit Party by any government agency, and the same under subclauses (i) and (ii) hereof are not discharged or stayed (whether through the posting of a bond or otherwise) prior to the earlier to occur of
twenty (20) days after the occurrence thereof or such action becoming effective; 

  
 22 

 (h) (i) any court order enjoins, restrains, or prevents Borrower from
conducting any material part of its business, (ii) the institution by any Governmental Authority of criminal proceedings against any Credit Party, or (iii) one or more judgments or orders for the payment of money (not paid or fully covered
by insurance and as to which the relevant insurance company has acknowledged coverage in writing) aggregating in excess of $400,000 shall be rendered against any or all Credit Parties and either (A) enforcement proceedings shall have been
commenced by any creditor upon any such judgments or orders, or (B) there shall be any period of ten (10) consecutive days during which a stay of enforcement of any such judgments or orders, by reason of a pending appeal, bond or
otherwise, shall not be in effect; 
 (i) any Lien created by any of the Financing Documents shall at any time fail to
constitute a valid and perfected Lien on all of the Collateral purported to be encumbered thereby, subject to no prior or equal Lien except Permitted Liens, or any Credit Party shall so assert; any material provision of any Financing Document shall
fail to be valid and binding on, or enforceable against, a Credit Party, or any Credit Party shall so assert; 
 (j) (i) A
Change in Control occurs or (ii) any Credit Party or direct or indirect equity owner in a Credit Party shall enter into agreement which contemplates a Change in Control unless, in the case of either (i) or (ii) such Change in Control
involves or such agreement provides, as a condition precedent to the consummation of such agreement, for either (x) the indefeasible payment in full in cash of all Obligations or (y) the consent of Agent and Lenders; 

(k) Any Required Permit shall have been revoked, rescinded, suspended, modified in a materially adverse manner or not renewed
for a full term, and such decision or such revocation, rescission, suspension, modification or non-renewal has, or could reasonably be expected to have, a Material Adverse Change, or, in the case of a Material Required Permit, such revocation,
rescission, suspension, modification, or non-renewal adversely affects the legal qualifications of any Credit Party to hold such Material Required Permit in any applicable jurisdiction and such revocation, rescission, suspension, modification or
non-renewal could reasonably be expected to materially affect the status of or legal qualifications of any Credit Party to hold any Material Required Permit in any other jurisdiction; 

(l) If any Borrower is or becomes an entity whose equity is registered with the SEC, and/or is publicly traded on and/or
registered with a public securities exchange, such Borrower’s equity fails to remain registered with the SEC in good standing, and/or such equity fails to remain publicly traded on and registered with a public securities exchange (other than as
a result of transaction voluntarily undertaken by Borrower to become a privately-held not publicly-traded entity); 
 (m) The
occurrence of any fact, event or circumstance that could reasonably be expected to result in a Material Adverse Change; or 

(n) an Event of Default described in Section 8.1(e) hereof shall have occurred and be continuing. 

All cure periods provided for in this Section 10.1 shall run concurrently with any cure period provided for in any applicable Financing
Documents under which the default occurred. 
 10.2 Rights and Remedies. 

(a) Upon the occurrence and during the continuance of an Event of Default, Agent may, and at the written direction of any
Lender shall, without notice or demand, do any or all of the following: (i) deliver notice of the Event of Default to Borrower, (ii) by notice to any Borrower declare all Obligations immediately due and payable (but if an Event of Default
described in Section 10.1(f) occurs all Obligations shall be immediately due and payable without any action by Agent or the Lenders), or (iii) by notice to any Borrower suspend or terminate the obligations, if any, of the Lenders to
advance money or extend credit for Borrower’s benefit under this Agreement or under any other Financing Document (but if an Event of Default described in Section 10.1(f) occurs all obligations, if any, of the Lenders to advance
money or extend credit for Borrower’s benefit under this Agreement or under any other agreement between Borrower and Agent and/or the Lenders shall be immediately terminated without any action by Agent or the Lenders). 

  
 23 

 (b) Without limiting the rights of Agent and Lenders set forth in
Section 10.2(a) above, upon the occurrence and during the continuance of an Event of Default, Agent shall have the right, without notice or demand, to do any or all of the following: 

(i) with or without legal process, enter any premises where the Collateral may be and take possession of and remove the Collateral from the
premises or store it on the premises, and foreclose upon and/or sell, lease or liquidate, the Collateral, in whole or in part; 
 (ii) apply
to the Obligations (A) any balances and deposits of any Credit Party that Agent or any Lender or any Affiliate of Agent or a Lender holds or controls, or (B) any amount held or controlled by Agent or any Lender or any Affiliate of Agent or
a Lender owing to or for the credit or the account of any Credit Party; 
 (iii) settle, compromise or adjust and grant releases with
respect to disputes and claims directly with Account Debtors for amounts on terms and in any order that Agent considers advisable, notify any Person owing any Credit Party money of Agent’s security interest in such funds, and verify the amount
of such Account; 
 (iv) make any payments and do any acts it considers necessary or reasonable to protect the Collateral and/or its
security interest in the Collateral. Borrower shall assemble the Collateral if Agent requests and make it available as Agent designates. Agent may also render any or all of the Collateral unusable at a Credit Party’s premises and may dispose of
such Collateral on such premises without liability for rent or costs. Borrower grants Agent a license to enter and occupy any of its premises, without charge, to exercise any of Agent’s rights or remedies; 

(v) pay, purchase, contest, or compromise any Lien which appears to be prior or superior to its security interest and pay all expenses
incurred; 
 (vi) ship, reclaim, recover, store, finish, maintain, repair, prepare for sale, and/or advertise for sale, the Collateral.
Agent is hereby granted a non-exclusive, royalty-free license or other right to use, without charge, for the limited purpose described in this clause (vi) and for so long as may be required therefor, Borrower’s labels, patents, copyrights,
mask works, rights of use of any name, trade secrets, trade names, trademarks, service marks, and advertising matter, or any similar property as it pertains to the Collateral, in completing production of, advertising for sale, and selling any
Collateral (and including in such license access to all media in which any of the licensed items may be recorded or stored and to all computer software and programs used for the compilation or printout thereof) and, in connection with Agent’s
exercise of its rights under this Article 10, Borrower’s rights under all licenses and all franchise agreements shall be deemed to inure to Agent for the benefit of the Lenders; 

(vii) place a “hold” on any account maintained with Agent or the Lenders or any Affiliate of Agent or a Lender (other than the
accounts excluded from the requirement of perfection and control as more particularly described in Section 6.6 hereof) and/or deliver a notice of exclusive control, any entitlement order, or other directions or instructions pursuant to
any Control Agreement or similar agreements providing control of any Collateral; 
 (viii) demand and receive possession of the Books of
Borrower and the other Credit Parties; and 
 (ix) exercise all other rights and remedies available to Agent under the Financing Documents
or at law or equity, including all remedies provided under the Code (including disposal of the Collateral pursuant to the terms thereof). 

10.3 Notices. Any notice that Agent is required to give to a Credit Party under the UCC of the time and place of any public sale or the
time after which any private sale or other intended disposition of the Collateral is to be made shall be deemed to constitute reasonable notice if such notice is given in accordance with this Agreement at least ten (10) days prior to such
action. 
 10.4 Protective Payments. If any Credit Party fails to pay or perform any covenant or obligation under this Agreement or
any other Financing Document, Agent may pay or perform such covenant or obligation, and all amounts so paid by Agent are Protective Advances and immediately due and payable, bearing interest at the then highest applicable rate for the Credit
Facilities hereunder, and secured by the Collateral. No such payments or performance by Agent shall be construed as an agreement to make similar payments or performance in the future or constitute Agent’s waiver of any Event of Default. 

  
 24 

 10.5 Liability for Collateral No Waiver; Remedies Cumulative. So long as Agent and the
Lenders comply with reasonable banking practices regarding the safekeeping of the Collateral in the possession or under the control of Agent and the Lenders, Agent and the Lenders shall not be liable or responsible for: (a) the safekeeping of
the Collateral; (b) any loss or damage to the Collateral; (c) any diminution in the value of the Collateral; or (d) any act or default of any carrier, warehouseman, bailee, or other Person. Borrower bears all risk of loss, damage or
destruction of the Collateral. Agent’s failure, at any time or times, to require strict performance by Borrower of any provision of this Agreement or any other Financing Document shall not waive, affect, or diminish any right of Agent
thereafter to demand strict performance and compliance herewith or therewith. No waiver hereunder shall be effective unless signed by Agent and then is only effective for the specific instance and purpose for which it is given. Agent’s rights
and remedies under this Agreement and the other Financing Documents are cumulative. Agent has all rights and remedies provided under the Code, by Law, or in equity. Agent’s exercise of one right or remedy is not an election, and Agent’s
waiver of any Event of Default is not a continuing waiver. Agent’s delay in exercising any remedy is not a waiver, election, or acquiescence. 

10.6 Application of Payments and Proceeds. Notwithstanding anything to the contrary contained in this Agreement, upon the occurrence and
during the continuance of an Event of Default, (i) Borrower, for itself and the other Credit Parties, irrevocably waives the right to direct the application of any and all payments at any time or times thereafter received by Agent from or on
behalf of Borrower of all or any part of the Obligations, and, as between Borrower and the Credit Parties on the one hand and Agent and Lenders on the other, Agent shall have the continuing and exclusive right to apply and to reapply any and all
payments received against the Obligations in such manner as Agent may deem advisable notwithstanding any previous application by Agent, and (ii) unless the Agent and the Lenders shall agree otherwise, the proceeds of any sale of, or other
realization upon all or any part of the Collateral shall be applied: first, to the Protective Advances; second, to accrued and unpaid interest on the Obligations (including any interest which, but for the provisions of the United
States Bankruptcy Code, would have accrued on such amounts); third, to the principal amount of the Obligations outstanding; and fourth, to any other indebtedness or obligations of the Credit Parties owing to Agent or any Lender under
the Financing Documents. Borrower shall remain fully liable for any deficiency. Any balance remaining shall be delivered to Borrower or to whoever may be lawfully entitled to receive such balance or as a court of competent jurisdiction may direct.
Unless the Agent and the Lenders shall agree otherwise, in carrying out the foregoing, (x) amounts received shall be applied in the numerical order provided until exhausted prior to the application to the next succeeding category, and
(y) each of the Persons entitled to receive a payment in any particular category shall receive an amount equal to its pro rata share of amounts available to be applied pursuant thereto for such category. 

10.7 Waivers. 

(a) Except as otherwise provided for in this Agreement and to the fullest extent permitted by applicable law, each Borrower
waives: (i) presentment, demand and protest, and notice of presentment, dishonor, intent to accelerate, acceleration, protest, default, nonpayment, maturity, release, compromise, settlement, extension or renewal of any or all Financing
Documents and hereby ratifies and confirms whatever Agent or Lenders may do in this regard; (ii) all rights to notice and a hearing prior to Agent’s or any Lender’s entry upon the premises of a Borrower, the taking possession or
control of, or to Agent’s or any Lender’s replevy, attachment or levy upon, any Collateral or any bond or security which might be required by any court prior to allowing Agent or any Lender to exercise any of its remedies; and
(iii) the benefit of all valuation, appraisal and exemption Laws. Each Borrower acknowledges that it has been advised by counsel of its choices and decisions with respect to this Agreement, the other Financing Documents and the transactions
evidenced hereby and thereby. 
 (b) Each Borrower for itself and all its successors and assigns, (i) agrees that its
liability shall not be in any manner affected by any indulgence, extension of time, renewal, waiver, or modification granted or consented to by Lender; (ii) consents to any indulgences and all extensions of time, renewals, waivers, or
modifications that may be granted by Agent or any Lender with respect to the payment or other provisions of the Financing Documents, and to any substitution, exchange or release of the Collateral, or any part thereof, with or without substitution,
and agrees to the addition or release of any Borrower, endorsers, guarantors, or sureties, or whether primarily or secondarily liable, without notice to any other Borrower and without affecting its liability hereunder; and (iii) to the fullest
extent permitted by law, expressly waives the benefit of any statute or rule of law or equity now provided, or which may hereafter be provided, which would produce a result contrary to or in conflict with the foregoing. 

  
 25 

 (c) To the extent that Agent or any Lender may have acquiesced in any
noncompliance with any requirements or conditions precedent to the closing of the Credit Facilities or to any subsequent disbursement of Credit Extensions, such acquiescence shall not be deemed to constitute a waiver by Agent or any Lender of such
requirements with respect to any future Credit Extensions and Agent may at any time after such acquiescence require Borrower to comply with all such requirements. Any forbearance by Agent or a Lender in exercising any right or remedy under any of
the Financing Documents, or otherwise afforded by applicable law, including any failure to accelerate the maturity date of the Credit Facilities, shall not be a waiver of or preclude the exercise of any right or remedy nor shall it serve as a
novation of the Financing Documents or as a reinstatement of the Obligations or a waiver of such right of acceleration or the right to insist upon strict compliance of the terms of the Financing Documents. Agent’s or any Lender’s
acceptance of payment of any sum secured by any of the Financing Documents after the due date of such payment shall not be a waiver of Agent’s and such Lender’s right to either require prompt payment when due of all other sums so secured
or to declare a default for failure to make prompt payment. The procurement of insurance or the payment of taxes or other Liens or charges by Agent as the result of an Event of Default shall not be a waiver of Agent’s right to accelerate the
maturity of the Obligations, nor shall Agent’s receipt of any condemnation awards, insurance proceeds, or damages under this Agreement operate to cure or waive any Credit Party’s default in payment of sums secured by any of the Financing
Documents. 
 (d) Without limiting the generality of anything contained in this Agreement or the other Financing Documents,
each Borrower agrees that if an Event of Default is continuing (i) Agent and Lenders shall not be subject to any “one action” or “election of remedies” law or rule, and (ii) all Liens and other rights, remedies or
privileges provided to Agent or Lenders shall remain in full force and effect until Agent or Lenders have exhausted all remedies against the Collateral and any other properties owned by Borrower and the Financing Documents and other security
instruments or agreements securing the Obligations have been foreclosed, sold and/or otherwise realized upon in satisfaction of Borrower’s obligations under the Financing Documents. 

(e) Neither Agent nor any Lender shall be under any obligation to marshal any assets in payment of any or all of the
Obligations. Nothing contained herein or in any other Financing Document shall be construed as requiring Agent or any Lender to resort to any part of the Collateral for the satisfaction of any of Borrower’s obligations under the Financing
Documents in preference or priority to any other Collateral, and Agent may seek satisfaction out of all of the Collateral or any part thereof, in its absolute discretion in respect of Borrower’s obligations under the Financing Documents. To the
fullest extent permitted by law, each Borrower, for itself and its successors and assigns, waives in the event of foreclosure of any or all of the Collateral any equitable right otherwise available to any Credit Party which would require the
separate sale of any of the Collateral or require Agent or Lenders to exhaust their remedies against any part of the Collateral before proceeding against any other part of the Collateral; and further in the event of such foreclosure each Borrower
does hereby expressly consent to and authorize, at the option of Agent, the foreclosure and sale either separately or together of each part of the Collateral. 

10.8 Injunctive Relief. The parties acknowledge and agree that, in the event of a breach or threatened breach of any Credit Party’s
obligations under any Financing Documents, Agent and Lenders may have no adequate remedy in money damages and, accordingly, shall be entitled to an injunction (including, without limitation, a temporary restraining order, preliminary injunction,
writ of attachment, or order compelling an audit) against such breach or threatened breach, including, without limitation, maintaining any cash management and collection procedure described herein. However, no specification in this Agreement of a
specific legal or equitable remedy shall be construed as a waiver or prohibition against any other legal or equitable remedies in the event of a breach or threatened breach of any provision of this Agreement. Each Credit Party waives, to the fullest
extent permitted by law, the requirement of the posting of any bond in connection with such injunctive relief. By joining in the Financing Documents as a Credit Party, each Credit Party specifically joins in this Section 10.8 as if this
Section 10.8 were a part of each Financing Document executed by such Credit Party. 

  
 26 

 11 NOTICES 

All notices, consents, requests, approvals, demands, or other communications (collectively, “Communication”) by any party to
this Agreement or any other Financing Document must be in writing and shall be deemed to have been validly served, given, or delivered: (a) upon the earlier of actual receipt and three (3) Business Days after deposit in the U.S. mail,
first class, registered or certified mail return receipt requested, with proper postage prepaid; (b) upon transmission, when sent by electronic mail (if an email address is specified herein) or facsimile transmission, if transmitted on a
Business Day; (c) one (1) Business Day after deposit with a reputable overnight courier with all charges prepaid; or (d) when delivered, if hand-delivered by messenger, all of which shall be addressed to the party to be notified and
sent to the address, facsimile number, or email address indicated below. Any of Agent, Lender or Borrower may change its mailing or electronic mail address or facsimile number by giving the other party written notice thereof in accordance with the
terms of this Article 11. 
 If to Borrower: 

ZS Pharma, Inc. 
 508 Wrangler
Drive, Suite 100 
 Coppell, TX 75019 

Attention: Chief Financial Officer, Todd Creech 

Fax: (972) 393-1586 
 E-Mail:
tcreech@zspharma.com 
 If to Agent or Lenders: 

MidCap Financial SBIC, LP 
 7255
Woodmont Avenue, Suite 200 
 Bethesda, Maryland 20814 

Attention: Portfolio Management- Life Sciences 

Fax: (301) 941-1450 
 E-Mail:
lviera@midcapfinancial.com 
 with a copy to: 

MC Serviceco, LLC 
 7255 Woodmont
Avenue, Suite 200 
 Bethesda, Maryland 20814 

Attention: General Counsel 
 Fax:
(301) 941-1450 
 E-Mail: legalnotices@midcapfinancial.com 

12 CHOICE OF LAW, VENUE AND JURY TRIAL WAIVER 

12.1 THIS AGREEMENT, EACH SECURED PROMISSORY NOTE AND EACH OTHER FINANCING DOCUMENT, AND THE RIGHTS, REMEDIES AND OBLIGATIONS OF THE PARTIES
HERETO AND THERETO, AND ANY CLAIM, CONTROVERSY OR DISPUTE ARISING UNDER OR RELATED TO THIS AGREEMENT OR SUCH FINANCING DOCUMENT, THE RELATIONSHIP OF THE PARTIES, AND/OR THE INTERPRETATION AND ENFORCEMENT OF THE RIGHTS AND DUTIES OF THE PARTIES AND
ALL OTHER MATTERS RELATING HERETO, THERETO OR ARISING THEREFROM (WHETHER SOUNDING IN CONTRACT LAW, TORT LAW OR OTHERWISE), SHALL BE GOVERNED BY, AND CONSTRUED AND INTERPRETED IN ACCORDANCE WITH, THE LAWS OF THE STATE OF MARYLAND, WITHOUT REFERENCE
TO ITS CONFLICT OF LAW PROVISIONS. NOTWITHSTANDING THE FOREGOING, AGENT AND LENDERS SHALL HAVE THE RIGHT TO BRING ANY ACTION OR PROCEEDING AGAINST BORROWER OR ITS PROPERTY IN THE COURTS OF ANY OTHER JURISDICTION WHICH AGENT AND LENDERS (IN
ACCORDANCE WITH THE PROVISIONS OF SECTION 12.1) DEEM NECESSARY OR APPROPRIATE TO REALIZE ON THE COLLATERAL OR TO OTHERWISE ENFORCE AGENT’S AND LENDERS’ RIGHTS AGAINST BORROWER OR ITS PROPERTY. BORROWER EXPRESSLY SUBMITS AND CONSENTS
IN ADVANCE TO SUCH JURISDICTION IN ANY ACTION OR SUIT COMMENCED IN ANY SUCH COURT, AND BORROWER HEREBY WAIVES ANY OBJECTION THAT IT MAY HAVE BASED UPON LACK OF PERSONAL JURISDICTION, IMPROPER VENUE, OR FORUM NON CONVENIENS AND HEREBY CONSENTS TO THE
GRANTING OF SUCH LEGAL OR EQUITABLE RELIEF AS IS DEEMED APPROPRIATE BY SUCH COURT. BORROWER HEREBY WAIVES PERSONAL SERVICE OF THE SUMMONS, COMPLAINTS, AND OTHER PROCESS ISSUED IN SUCH ACTION OR SUIT AND AGREES THAT SERVICE OF SUCH SUMMONS,

  
 27 

 
COMPLAINTS, AND OTHER PROCESS MAY BE MADE BY REGISTERED OR CERTIFIED MAIL ADDRESSED TO BORROWER AT THE ADDRESS SET FORTH IN ARTICLE 11 OF THIS AGREEMENT AND THAT SERVICE SO MADE SHALL BE
DEEMED COMPLETED UPON THE EARLIER TO OCCUR OF BORROWER’S ACTUAL RECEIPT THEREOF OR THREE (3) DAYS AFTER DEPOSIT IN THE U.S. MAIL, PROPER POSTAGE PREPAID. 

12.2 TO THE FULLEST EXTENT PERMITTED BY APPLICABLE LAW, BORROWER, AGENT AND LENDERS EACH WAIVE THEIR RIGHT TO A JURY TRIAL OF ANY CLAIM OR
CAUSE OF ACTION ARISING OUT OF OR BASED UPON THIS AGREEMENT, THE OTHER FINANCING DOCUMENTS OR ANY TRANSACTION CONTEMPLATED HEREBY, INCLUDING CONTRACT, TORT, BREACH OF DUTY AND ALL OTHER CLAIMS. THIS WAIVER IS A MATERIAL INDUCEMENT FOR BOTH PARTIES
TO ENTER INTO THIS AGREEMENT. EACH PARTY HAS REVIEWED THIS WAIVER WITH ITS COUNSEL. 
 12.3 Borrower, Agent and each Lender agree that
each Credit Extension (including those made on the Closing Date) shall be deemed to be made in, and the transactions contemplated hereunder and in any other Financing Document shall be deemed to have been performed in, the State of Maryland. 

13 GENERAL PROVISIONS 

13.1 Successors and Assigns. 

(a) This Agreement binds and is for the benefit of the successors and permitted assigns of each party. Borrower may not assign
this Agreement or any rights or obligations under it without Agent’s prior written consent (which may be granted or withheld in Agent’s discretion). Any Lender may at any time assign to one or more Eligible Assignees all or any portion of
such Lender’s Applicable Commitment and/or Credit Extensions, together with all related obligations of such Lender hereunder, and Lender shall provide prompt written notice thereof to Borrower, which notice shall include the name of the
Eligible Assignee and a description of the amount of such Lender’s Applicable Commitment and/or Credit Extensions being assigned to such Eligible Assignee. Borrower and Agent shall be entitled to continue to deal solely and directly with such
Lender in connection with the interests so assigned until Agent shall have received and accepted an effective assignment agreement in form and substance acceptable to Agent, executed, delivered and fully completed by the applicable parties thereto,
and shall have received such other information regarding such Eligible Assignee as Agent reasonably shall require. Notwithstanding anything set forth in this Agreement to the contrary, any Lender may at any time pledge or assign a security interest
in all or any portion of its rights under this Agreement to secure obligations of such Lender, including any pledge or assignment to secure obligations to a Federal Reserve Bank; provided, however, that no such pledge or assignment shall
release such Lender from any of its obligations hereunder or substitute any such pledgee or assignee for such Lender as a party hereto. If requested by Agent, Borrower agrees to (i) execute any documents reasonably required to effectuate and
acknowledge each assignment of an Applicable Commitment or Credit Extension to an assignee hereunder, (ii) make Borrower’s management available to meet with Agent and prospective participants and assignees (capable of becoming an Eligible
Assignee in the reasonable discretion of Agent or any Lender) of Applicable Commitments or Credit Extensions and (iii) assist Agent or the Lenders in the preparation of information relating to the financial affairs of Borrower as any
prospective participant or assignee of an Applicable Commitment or Credit Extension reasonably may request. 
 (b) From and
after the date on which the conditions described above have been met, (i) such Eligible Assignee shall be deemed automatically to have become a party hereto and, to the extent of the interests assigned to such Eligible Assignee pursuant to such
assignment agreement, shall have the rights and obligations of a Lender hereunder, and (ii) the assigning Lender, to the extent that rights and obligations hereunder have been assigned by it pursuant to such assignment agreement, shall be
released from its rights and obligations hereunder (other than those that survive termination). Upon the request of the Eligible Assignee (and, as applicable, the assigning Lender) pursuant to an effective assignment agreement, each Borrower shall
execute and deliver to Agent for delivery to the Eligible Assignee (and, as applicable, the assigning Lender) secured notes in the aggregate principal amount of the Eligible Assignee’s Credit Extensions or Applicable Commitments (and, as
applicable, secured promissory notes in the principal amount of that portion of the principal amount of the Credit Extensions or Applicable Commitments retained by the assigning Lender). 

  
 28 

 (c) Agent, acting solely for this purpose as a non-fiduciary agent of Borrower,
shall maintain at its offices located in Bethesda, Maryland a copy of each assignment agreement delivered to it and a Register for the recordation of the names and addresses of each Lender, and the commitments of, and principal amount (and stated
interest) of the Credit Extensions owing to, such Lender pursuant to the terms hereof (the “Register”). The entries in such Register shall be conclusive (absent manifest error), and Borrower, Agent and Lenders may treat each Person whose
name is recorded therein pursuant to the terms hereof as a Lender hereunder for all purposes of this Agreement, notwithstanding notice to the contrary. Such Register shall be available for inspection by Borrower and any Lender, at any reasonable
time upon reasonable prior notice to Agent. Each Lender that sells a participation shall, acting solely for this purpose as a non-fiduciary agent of the Borrower maintain a register on which it enters the name and address of each participant and the
principal amounts (and stated interest) of each participant’s interest in the Obligations (each, a “Participant Register”). The entries in the Participant Registers shall be conclusive (absent manifest error). Each Participant
Register shall be available for inspection by Borrower and the Agent at any reasonable time upon reasonable prior notice to the applicable Lender; provided, that no Lender shall have any obligation to disclose all or any portion of the Participant
Register (including the identity of any participant or any information relating to a participant’s interest in any commitments, loans, letters of credit or its other obligations under any Loan Document) to any Person (including Borrower) except
to the extent that such disclosure is necessary to establish that such commitment, loan, letter of credit or other obligation is in registered form under Section 5f.103-1(c) of the United States Treasury Regulations. For the avoidance of doubt,
the Agent (in its capacity as Agent) shall have no responsibility for maintaining a Participant Register. 
 (d)
Notwithstanding anything to the contrary contained in this Agreement, the Credit Extensions (including any Secured Promissory Notes evidencing such Credit Extensions) are intended to be registered obligations, the right, title and interest of the
Lenders and their assignees in and to such Credit Extensions shall be transferable only upon notation of such transfer in the Register and no assignment thereof shall be effective until recorded therein. This Agreement shall be construed so that the
Credit Extensions are at all times maintained in “registered form” within the meaning of Sections 163(f), 871(h)(2) and 881(c)(2) of the Internal Revenue Code of 1986 as amended and Section 5f.103-1(c) of the United States Treasury
Regulations. 
 (e) Notwithstanding anything to the contrary contained in this Agreement, a participant shall not be entitled
to receive any greater payment under Section 2.6(h) than the applicable Lender would have been entitled to receive with respect to the participation sold to such participant, except to the extent such entitlement to receive a greater payments
results from a change in Law that occurs after the participant acquired the applicable participation. A participant shall not be entitled to the benefits of Section 2.6(h) unless Borrower is notified of the participation sold to such
participant and such participant agrees, for the benefit of Borrower, to comply with Section 2.6(h) as though it were a Lender. 

13.2 Indemnification.  

(a) Borrower hereby agrees to promptly pay (i) all reasonable, out-of-pocket costs and expenses of Agent (including,
without limitation, the reasonable, out-of-pocket costs and expenses and reasonable out-of-pocket fees of counsel to, and independent appraisers and consultants retained by Agent) in connection with the examination, review, due diligence
investigation, documentation, negotiation, closing and syndication of the transactions contemplated by the Financing Documents, in connection with the performance by Agent of its rights and remedies under the Financing Documents and in connection
with the continued administration of the Financing Documents including (A) any amendments, modifications, consents and waivers to and/or under any and all Financing Documents, and (B) any periodic public record searches conducted by or at
the request of Agent (including, without limitation, title investigations, UCC searches, fixture filing searches, judgment, pending litigation and tax lien searches and searches of applicable corporate, limited liability, partnership and related
records concerning the continued existence, organization and good standing of certain Persons); (ii) without limitation of the preceding clause (i), all costs and expenses of Agent in connection with the creation, perfection and maintenance of
Liens pursuant to the Financing Documents; (iii) without limitation of the preceding clause (i), all costs and expenses of Agent in connection with (A) protecting, storing, insuring, handling, maintaining or selling any Collateral,
(B) any litigation, dispute, suit or proceeding relating to any Financing Document, and (C) any workout, collection, bankruptcy, insolvency and other enforcement proceedings under any and all of the Financing Documents; and (iv) all
costs and expenses incurred by Agent or Lenders in connection with any litigation, dispute, suit or proceeding relating to any Financing Document and in connection with any workout, collection, bankruptcy,

  
 29 

 
insolvency and other enforcement proceedings under any and all Financing Documents, whether or not Agent or Lenders are a party thereto. Notwithstanding anything to the contrary in this
Section 13.2(a), this Section 13.2(a) shall not apply with respect to Taxes other than any Taxes that represent costs and expenses arising from any non-Tax claim. 

(b) Borrower hereby agrees to indemnify, pay and hold harmless Agent and Lenders and the officers, directors, employees,
trustees, agents, investment advisors, collateral managers, servicers, and counsel of Agent and Lenders (collectively called the “Indemnitees”) from and against any and all liabilities, obligations, losses, damages, penalties,
actions, judgments, suits, claims, costs, expenses and disbursements of any kind or nature whatsoever (including the fees and disbursements of counsel for such Indemnitee) in connection with any investigative, response, remedial, administrative or
judicial matter or proceeding, whether or not such Indemnitee shall be designated a party thereto and including any such proceeding initiated by or on behalf of a Credit Party, and the reasonable out-of-pocket expenses of investigation by engineers,
environmental consultants and similar technical personnel and any commission, fee or compensation claimed by any broker (other than any broker retained by Agent or Lenders) asserting any right to payment for the transactions contemplated hereby,
which may be imposed on, incurred by or asserted against such Indemnitee as a result of or in connection with the transactions contemplated hereby and the use or intended use of the proceeds of the Credit Facilities, except that Borrower shall have
no obligation hereunder to an Indemnitee with respect to any liability resulting from the gross negligence or willful misconduct of such Indemnitee, as determined by a final non-appealable judgment of a court of competent jurisdiction. To the extent
that the undertaking set forth in the immediately preceding sentence may be unenforceable, Borrower shall contribute the maximum portion which it is permitted to pay and satisfy under applicable Law to the payment and satisfaction of all such
indemnified liabilities incurred by the Indemnitees or any of them. No Indemnitee shall be liable for any damages arising from the use by unintended recipients of any information or other materials distributed by it through telecommunications,
electronic or other information transmission systems in connection with this Agreement or the other Financing Documents or the transactions contemplated hereby or thereby, unless resulting from such Indemnitee’s gross negligence or willful
misconduct as determined by a final non-appealable order of a court of competent jurisdiction. Notwithstanding anything to the contrary in this Section 13.2(b), this Section 13.2(b) shall not apply with respect
to Taxes other than any Taxes that represent liabilities, obligations, losses, damages, penalties, actions, judgments, suits, claims, costs, expenses and disbursements arising from any non-Tax claim. 

(c) Notwithstanding any contrary provision in this Agreement, the obligations of Borrower under this Section 13.2
shall survive the payment in full of the Obligations and the termination of this Agreement. NO INDEMNITEE SHALL BE RESPONSIBLE OR LIABLE TO ANY CREDIT PARTY OR TO ANY OTHER PARTY TO ANY FINANCING DOCUMENT, ANY SUCCESSOR, ASSIGNEE OR THIRD PARTY
BENEFICIARY OR ANY OTHER PERSON ASSERTING CLAIMS DERIVATIVELY THROUGH SUCH PARTY, FOR INDIRECT, PUNITIVE, EXEMPLARY OR CONSEQUENTIAL DAMAGES WHICH MAY BE ALLEGED AS A RESULT OF CREDIT HAVING BEEN EXTENDED, SUSPENDED OR TERMINATED UNDER THIS
AGREEMENT OR ANY OTHER FINANCING DOCUMENT OR AS A RESULT OF ANY OTHER TRANSACTION CONTEMPLATED HEREUNDER OR THEREUNDER. 
 13.3 Time of
Essence. Time is of the essence for the payment and performance of the Obligations in this Agreement. 
 13.4 Severability of
Provisions. Each provision of this Agreement is severable from every other provision in determining the enforceability of any provision. 

13.5 Correction of Financing Documents. Agent and the Lenders may correct patent errors and fill in any blanks in this Agreement and the
other Financing Documents consistent with the agreement of the parties. 
 13.6 Integration. This Agreement and the Financing
Documents represent the entire agreement about this subject matter and supersede prior negotiations or agreements. All prior agreements, understandings, representations, warranties, and negotiations between the parties about the subject matter of
this Agreement and the Financing Documents merge into this Agreement and the Financing Documents. 

  
 30 

 13.7 Counterparts. This Agreement may be executed in any number of counterparts and by
different parties on separate counterparts, each of which, when executed and delivered, is an original, and all taken together, constitute one Agreement. Delivery of an executed signature page of this Agreement by facsimile transmission or
electronic transmission shall be as effective as delivery of a manually executed counterpart hereof. 
 13.8 Survival. All
covenants, representations and warranties made in this Agreement continue in full force until this Agreement has terminated pursuant to its terms and all Obligations (other than inchoate indemnity obligations and any other obligations which, by
their terms, are to survive the termination of this Agreement) have been satisfied. The obligation of Borrower in Section 13.2 to indemnify each Lender and Agent shall survive until the statute of limitations with respect to such claim
or cause of action shall have run. All powers of attorney and appointments of Agent or any Lender as Borrower’s attorney in fact hereunder, and all of Agent’s and Lenders’ rights and powers in respect thereof, are coupled with an
interest, are irrevocable until all Obligations (other than inchoate indemnity obligations and any other obligations which, by their terms, are to survive the termination of this Agreement) have been fully repaid and performed and Agent’s and
the Lenders’ obligation to provide Credit Extensions terminates. 
 13.9 Confidentiality. In handling any confidential
information of Borrower, each of the Lenders and Agent shall use all reasonable efforts to maintain, in accordance with its customary practices, the confidentiality of information obtained by it pursuant to any Financing Document and designated in
writing by any Credit Party as confidential, but disclosure of information may be made: (a) to the Lenders’ and Agent’s Subsidiaries or Affiliates; (b) to prospective transferees or purchasers of any interest in the Credit
Extensions, so long as such transferees or purchasers are bound to such Lender or Agent by obligations of confidentiality; (c) as required by Law, regulation, subpoena, order or other legal, administrative, governmental or regulatory request;
(d) to regulators or as otherwise required in connection with an examination or audit, or to any nationally recognized rating agency; (e) as Agent or any Lender considers appropriate in exercising remedies under the Financing Documents;
(f) to financing sources that are advised of the confidential nature of such information, are instructed to keep such information confidential and have agreed to do so; (g) to third party service providers of the Lenders and/or Agent so
long as such service providers are bound to such Lender or Agent by obligations of confidentiality; (h) to the extent necessary or customary for inclusion in league table measurements; and (i) in connection with any litigation or other
proceeding to which such Lender or Agent or any of their Affiliates is a party or bound, or to the extent necessary to respond to public statements or disclosures by Credit Parties or their Affiliates referring to a Lender or Agent or any of their
Affiliates. Confidential information does not include information that either: (i) is in the public domain or in the Lenders’ and/or Agent’s possession when disclosed to the Lenders and/or Agent, or becomes part of the public domain
after disclosure to the Lenders and/or Agent; or (ii) is disclosed to the Lenders and/or Agent by a third party, if the Lenders and/or Agent does not know that the third party is prohibited from disclosing the information. Agent and/or Lenders
may use confidential information for any purpose, including, without limitation, for the development of client databases, reporting purposes, and market analysis, so long as Agent and/or Lenders, as applicable, do not disclose Borrower’s
identity or the identity of any Person associated with Borrower unless otherwise permitted by this Agreement. The provisions of the immediately preceding sentence shall survive the termination of this Agreement. The agreements provided under this
Section 13.9 supersede all prior agreements, understanding, representations, warranties, and negotiations between the parties about the subject matter of this Section 13.9. 

13.10 Right of Set-off. Borrower hereby grants to Agent and to each Lender, a lien, security interest and right of set-off as security
for all Obligations to Agent and each Lender hereunder, whether now existing or hereafter arising upon and against all deposits, credits, collateral and property, now or hereafter in the possession, custody, safekeeping or control of Agent or the
Lenders or any entity under the control of Agent or the Lenders (including an Agent or Lender Affiliate) or in transit to any of them. At any time after the occurrence and during the continuance of an Event of Default, without demand or notice,
Agent or the Lenders may set-off the same or any part thereof and apply the same to any liability or obligation of Borrower even though unmatured and regardless of the adequacy of any other collateral securing the Obligations. ANY AND ALL RIGHTS TO
REQUIRE AGENT TO EXERCISE ITS RIGHTS OR REMEDIES WITH RESPECT TO ANY OTHER COLLATERAL WHICH SECURES THE OBLIGATIONS, PRIOR TO EXERCISING ITS RIGHT OF SET-OFF WITH RESPECT TO SUCH DEPOSITS, CREDITS OR OTHER PROPERTY OF BORROWER, ARE HEREBY KNOWINGLY,
VOLUNTARILY AND IRREVOCABLY WAIVED. 
 13.11 Publicity. Borrower will not directly or indirectly publish, disclose or otherwise use in
any public disclosure, advertising material, promotional material, press release or interview, any reference to the name, logo or any trademark of Agent or any Lender or any of their Affiliates or any reference to this Agreement or the financing
evidenced hereby, in any case except as required by applicable Law, subpoena or judicial or similar order, in which case Borrower shall 

  
 31 

 
endeavor to give Agent prior written notice of such publication or other disclosure, except as regards disclosures in public filings made in accordance with applicable securities laws. Each
Lender and Borrower hereby authorizes each Lender to publish the name of such Lender and Borrower, the existence of the financing arrangements referenced under this Agreement, the primary purpose and/or structure of those arrangements, the amount of
credit extended under each facility, the title and role of each party to this Agreement, and the total amount of the financing evidenced hereby in any “tombstone”, comparable advertisement or press release which such Lender elects to
submit for publication. In addition, each Lender and Borrower agrees that each Lender may provide lending industry trade organizations with information necessary and customary for inclusion in league table measurements after the Closing Date. With
respect to any of the foregoing, such authorization shall be subject to such Lender providing Borrower and the other Lenders with an opportunity to review and confer with such Lender regarding, and approve, the contents of any such tombstone,
advertisement or information, as applicable, prior to its initial submission for publication, but subsequent publications of the same tombstone, advertisement or information shall not require Borrower’s approval. 

13.12 No Strict Construction. The parties hereto have participated jointly in the negotiation and drafting of this Agreement. In
the event an ambiguity or question of intent or interpretation arises, this Agreement shall be construed as if drafted jointly by the parties hereto and no presumption or burden of proof shall arise favoring or disfavoring any party by virtue of the
authorship of any provisions of this Agreement. 
 13.13 Approvals. Unless expressly provided herein to the contrary, any approval,
consent, waiver or satisfaction of Agent or Lenders with respect to any matter that is the subject of this Agreement or the other Financing Documents may be granted or withheld by Agent and Lenders in their sole and absolute discretion and credit
judgment. 
 13.14 Amendments; Required Lenders; Inter-Lender Matters. 

(a) No amendment, modification, termination or waiver of any provision of this Agreement or any other Financing Document, no approval or
consent hereunder or thereunder, or any consent to any departure by Borrower herefrom or therefrom (in each case, other than amendments, waivers, approvals or consents deemed ministerial by Agent), shall in any event be effective unless the same
shall be in writing and signed by Borrower, Agent and Required Lenders. Except as set forth in clause (b) below, all such amendments, modifications, terminations or waivers requiring the consent of the “Lenders” shall require the
written consent of Required Lenders. 
 (b) No amendment, modification, termination or waiver of any provision of this Agreement or any other
Financing Document shall, unless in writing and signed by Agent and by each Lender directly affected thereby: (i) increase or decrease the Applicable Commitment of any Lender (which shall be deemed to affect all Lenders), (ii) reduce the
principal of or rate of interest on any Obligation or the amount of any fees payable hereunder, (iii) postpone the date fixed for or waive any payment of principal of or interest on any Credit Extension, or any fees or reimbursement obligation
hereunder, (iv) release all or substantially all of the Collateral, or consent to a transfer of any of the Intellectual Property, in each case, except as otherwise expressly permitted in the Financing Documents (which shall be deemed to affect
all Lenders), (v) subordinate the lien granted in favor of Agent securing the Obligations (which shall be deemed to affect all Lenders, except as otherwise provided below), (vi) release a Credit Party from, or consent to a Credit
Party’s assignment or delegation of, such Credit Party’s obligations hereunder and under the other Financing Documents or any Guarantor from its guaranty of the Obligations (which shall be deemed to affect all Lenders) or (vii) amend,
modify, terminate or waive this Section 13.14(b) or the definition of “Required Lenders” or “Pro Rata Share” or any other provision hereof specifying the number or percentage of Lenders required to amend, waive or
otherwise modify any rights hereunder or make any determination or grant any consent hereunder, without the consent of each Lender. For purposes of the foregoing, no Lender shall be deemed affected by (i) waiver of the imposition of the Default
Rate or imposition of the Default Rate to only a portion of the Obligations, (ii) waiver of the accrual of late charges, (iii) waiver of any fee solely payable to Agent under the Financing Documents, (iv) subordination of a lien
granted in favor of Agent provided such subordination is limited to equipment being financed by a third party providing Permitted Indebtedness. Notwithstanding any provision in this Section 13.14 to the contrary, no amendment,
modification, termination or waiver affecting or modifying the rights or obligations of Agent hereunder shall be effective unless signed by Agent and Required Lenders. Any amendment, modification, supplement, termination, waiver or consent pursuant
to this Section shall apply equally to, and shall be binding upon, all the Lenders and Agent. 

  
 32 

 (c) Agent shall not grant its written consent to any deviation or departure by Borrower or any
Credit Party from the provisions of Article 7 without the prior written consent of the Required Lenders. Required Lenders shall have the right to direct Agent to take any action described in Section 10.2(b). Upon the occurrence of
any Event of Default, Agent shall have the right to exercise any and all remedies referenced in Section 10.2 without the written consent of Required Lenders following the occurrence of an “Exigent Circumstance” (as defined
below). All matters requiring the satisfaction or acceptance of Agent in the definition of Subordinated Debt shall further require the satisfaction and acceptance of each Required Lender. Any reference in this Agreement to an allocation between or
sharing by the Lenders of any right, interest or obligation “ratably,” “proportionally” or in similar terms shall refer to Pro Rata Share unless expressly provided otherwise. As used in this Section 13.14(c),
“Exigent Circumstance” means any event or circumstance that, in the reasonable judgment of Agent, imminently threatens the ability of Agent to realize upon all or any material portion of the Collateral, such as, without
limitation, fraudulent removal, concealment, or abscondment thereof, destruction or material waste thereof, or failure of Borrower after reasonable demand to maintain or reinstate adequate casualty insurance coverage, or which, in the judgment of
Agent, could result in a material diminution in value of the Collateral. 
 13.15 Borrower Liability. If there is more than one entity
comprising Borrower, then (a) any Borrower may, acting singly, request Credit Extensions hereunder, (b) each Borrower hereby appoints the other as agent for the other for all purposes hereunder, including with respect to requesting Credit
Extensions hereunder, (c) each Borrower shall be jointly and severally obligated to pay and perform all obligations under the Financing Documents, including, but not limited to, the obligation to repay all Credit Extensions made hereunder and
all other Obligations, regardless of which Borrower actually receives said Credit Extensions, as if each Borrower directly received all Credit Extensions, and (d) each Borrower waives (i) any suretyship defenses available to it under the
Code or any other applicable law, and (ii) any right to require the Lenders or Agent to: (A) proceed against any Borrower or any other person; (B) proceed against or exhaust any security; or (C) pursue any other remedy. The
Lenders or Agent may exercise or not exercise any right or remedy they have against any Credit Party or any security (including the right to foreclose by judicial or non-judicial sale) without affecting any other Credit Party’s liability or any
Lien against any other Credit Party’s assets. Notwithstanding any other provision of this Agreement or other related document, until payment in full of the Obligations and termination of the Applicable Commitments, each Borrower
irrevocably waives all rights that it may have at law or in equity (including, without limitation, any law subrogating Borrower to the rights of the Lenders and Agent under this Agreement) to seek contribution, indemnification or any other form of
reimbursement from any other Credit Party, or any other Person now or hereafter primarily or secondarily liable for any of the Obligations, for any payment made by any Credit Party with respect to the Obligations in connection with this Agreement or
otherwise and all rights that it might have to benefit from, or to participate in, any security for the Obligations as a result of any payment made by a Credit Party with respect to the Obligations in connection with this Agreement or
otherwise. Any agreement providing for indemnification, reimbursement or any other arrangement prohibited under this Section 13.15 shall be null and void. If any payment is made to a Credit Party in contravention of this
Section 13.15, such Credit Party shall hold such payment in trust for the Lenders and Agent and such payment shall be promptly delivered to Agent for application to the Obligations, whether matured or unmatured. 

13.16 Reinstatement. This Agreement shall remain in full force and effect and continue to be effective should any petition or other
proceeding be filed by or against any Credit Party for liquidation or reorganization, should any Credit Party become insolvent or make an assignment for the benefit of any creditor or creditors or should an interim receiver, receiver, receiver and
manager or trustee be appointed for all or any significant part of any Credit Party’s assets, and shall continue to be effective or to be reinstated, as the case may be, if at any time payment and performance of the Obligations, or any part
thereof, is, pursuant to applicable law, rescinded or reduced in amount, or must otherwise be restored or returned by any obligee of the Obligations, whether as a fraudulent preference reviewable transaction or otherwise, all as though such payment
or performance had not been made. In the event that any payment, or any part thereof, is rescinded, reduced, restored or returned, the Obligations shall be reinstated and deemed reduced only by such amount paid and not so rescinded, reduced,
restored or returned. 
 13.17. USA PATRIOT Act Notification. Agent (for itself and not on behalf of any Lender) and each Lender
hereby notifies each Borrower that pursuant to the requirements of the USA PATRIOT Act, it is required to obtain, verify and record certain information and documentation that identifies Borrower, which information includes the name and address of
Borrower and such other information that will allow Agent or such Lender, as applicable, to identify Borrower in accordance with the USA PATRIOT Act. 

  
 33 

 14 AGENT 

14.1 Appointment and Authorization of Agent. Each Lender hereby irrevocably appoints, designates and authorizes Agent to take such
action on its behalf under the provisions of this Agreement and each other Financing Document and to exercise such powers and perform such duties as are expressly delegated to it by the terms of this Agreement or any other Financing Document,
together with such powers as are reasonably incidental thereto. The provisions of this Article 14 are solely for the benefit of Agent and Lenders and none of Credit Parties nor any other Person shall have any rights as a third party
beneficiary of any of the provisions hereof. The duties of Agent shall be mechanical and administrative in nature. Notwithstanding any provision to the contrary contained elsewhere herein or in any other Financing Document, Agent shall not have any
duties or responsibilities, except those expressly set forth herein, nor shall Agent have or be deemed to have any fiduciary relationship with any Lender or participant, and no implied covenants, functions, responsibilities, duties, obligations or
liabilities shall be read into this Agreement or any other Financing Document or otherwise exist against Agent. Without limiting the generality of the foregoing sentence, the use of the term “agent” herein and in the other Financing
Documents with reference to Agent is not intended to connote any fiduciary or other implied (or express) obligations arising under agency doctrine of any applicable Law. Instead, such term is used merely as a matter of market custom, and is intended
to create or reflect only an administrative relationship between independent contracting parties. Without limiting the generality of the foregoing, Agent shall have the sole and exclusive right and authority (to the exclusion of the Lenders), and is
hereby authorized, to (a) act as collateral agent for Agent and each Lender for purposes of the perfection of all liens created by the Financing Documents and all other purposes stated therein, (b) manage, supervise and otherwise deal with
the Collateral, (c) take such other action as is necessary or desirable to maintain the perfection and priority of the liens created or purported to be created by the Financing Documents, (d) except as may be otherwise specified in any
Financing Document, exercise all remedies given to Agent and the other Lenders with respect to the Collateral, whether under the Financing Documents, applicable law or otherwise and (e) execute any amendment, consent or waiver under the
Financing Documents on behalf of any Lender that has consented in writing to such amendment, consent or waiver; provided, however, that Agent hereby appoints, authorizes and directs each Lender to act as collateral sub-agent for Agent
and the Lenders for purposes of the perfection of all liens with respect to the Collateral, including any deposit account maintained by a Credit Party with, and cash and cash equivalents held by, such Lender, and may further authorize and direct the
Lenders to take further actions as collateral sub-agents for purposes of enforcing such liens or otherwise to transfer the Collateral subject thereto to Agent, and each Lender hereby agrees to take such further actions to the extent, and only to the
extent, so authorized and directed. 
 14.2 Successor Agent. 

(a) Agent may at any time assign its rights, powers, privileges and duties hereunder to (i) another Lender, or
(ii) any Person to whom Agent, in its capacity as a Lender, has assigned (or will assign, in conjunction with such assignment of agency rights hereunder) fifty percent (50%) or more of the Credit Extensions or Applicable Commitments then
held by Agent (in its capacity as a Lender), in each case without the consent of the Lenders or Borrower. Following any such assignment, Agent shall give notice to the Lenders and Borrower. An assignment by Agent pursuant to this subsection
(a) shall not be deemed a resignation by Agent for purposes of subsection (b) below. 
 (b) Without limiting
the rights of Agent to designate an assignee pursuant to subsection (a) above, Agent may at any time give notice of its resignation to the Lenders and Borrower. Upon receipt of any such notice of resignation, Required Lenders shall have
the right to appoint a successor Agent. If no such successor shall have been so appointed by Required Lenders and shall have accepted such appointment within ten (10) Business Days after the retiring Agent gives notice of its resignation, then
the retiring Agent may, on behalf of the Lenders, appoint a successor Agent; provided, however, that if Agent shall notify Borrower and the Lenders that no Person has accepted such appointment, then such resignation shall nonetheless become
effective in accordance with such notice from Agent that no Person has accepted such appointment and, from and following delivery of such notice, (i) the retiring Agent shall be discharged from its duties and obligations hereunder and under the
other Financing Documents, and (ii) all payments, communications and determinations provided to be made by, to or through Agent shall instead be made by or to each Lender directly, until such time as Required Lenders appoint a successor Agent
as provided for above in this subsection (b). 
 (c) Upon (i) an assignment permitted by subsection
(a) above, or (ii) the acceptance of a successor’s appointment as Agent pursuant to subsection (b) above, such successor shall succeed to and become vested with all of the rights, powers, privileges and duties of the
retiring (or retired) Agent, and the retiring Agent shall be discharged from all of its duties and obligations hereunder and under the other Financing Documents (if not already discharged therefrom as provided above in this subsection (c)).
The fees payable by Borrower to a successor Agent shall be the same as those payable to its predecessor unless otherwise agreed between Borrower and such successor. After the retiring Agent’s resignation hereunder and under the other Financing
Documents, the provisions of this Article 14 shall continue in effect for the benefit of such retiring Agent and its sub-agents in respect of any actions taken or omitted to be taken by any of them while the retiring Agent was acting or was
continuing to act as Agent. 

  
 34 

 14.3 Delegation of Duties. Agent may execute any of its duties under this Agreement or any
other Financing Document by or through its, or its Affiliates’, agents, employees or attorneys-in-fact and shall be entitled to obtain and rely upon the advice of counsel and other consultants or experts concerning all matters pertaining to
such duties. Agent shall not be responsible for the negligence or misconduct of any agent or attorney-in-fact that it selects in the absence of gross negligence or willful misconduct. Any such Person to whom Agent delegates a duty shall benefit from
this Article 14 to the extent provided by Agent. 
 14.4 Liability of Agent. Except as otherwise provided herein, no
“Agent-Related Person” (as defined below) shall (a) be liable for any action taken or omitted to be taken by any of them under or in connection with this Agreement or any other Financing Document or the transactions contemplated
hereby (except for its own gross negligence or willful misconduct in connection with its duties expressly set forth herein), or (b) be responsible in any manner to any Lender or participant for any recital, statement, representation or warranty
made by any Credit Party or any officer thereof, contained herein or in any other Financing Document, or in any certificate, report, statement or other document referred to or provided for in, or received by Agent under or in connection with, this
Agreement or any other Financing Document, or the validity, effectiveness, genuineness, enforceability or sufficiency of this Agreement or any other Financing Document, or for any failure of any Credit Party or any other party to any Financing
Document to perform its obligations hereunder or thereunder. No Agent-Related Person shall be under any obligation to any Lender or participant to ascertain or to inquire as to the observance or performance of any of the agreements contained in, or
conditions of, this Agreement or any other Financing Document, or to inspect the Collateral, other properties or books or records of any Credit Party or any Affiliate thereof. The term “Agent-Related Person” means the Agent,
together with its Affiliates, and the officers, directors, employees, agents, advisors, auditors and attorneys-in-fact of such Persons; provided, however, that no Agent-Related Person shall be an Affiliate of Borrower. 

14.5 Reliance by Agent. Agent shall be entitled to rely, and shall be fully protected in relying, upon any writing, communication,
signature, resolution, representation, notice, consent, certificate, affidavit, letter, telegram, facsimile, telex or telephone message, electronic mail message, statement or other document or conversation believed by it to be genuine and correct
and to have been signed, sent or made by the proper Person or Persons, and upon advice and statements of legal counsel (including counsel to Borrower), independent accountants and other experts selected by Agent. Agent shall be fully justified in
failing or refusing to take any action under any Financing Document (a) if such action would, in the opinion of Agent, be contrary to law or any Financing Document, (b) if such action would, in the opinion of Agent, expose Agent to any
potential liability under any law, statute or regulation or (c) if Agent shall not first have received such advice or concurrence of all Lenders as it deems appropriate and, if it so requests, it shall first be indemnified to its satisfaction
by the Lenders against any and all liability and expense which may be incurred by it by reason of taking or continuing to take any such action. Agent shall in all cases be fully protected in acting, or in refraining from acting, under this Agreement
or any other Financing Document in accordance with a request or consent of all Lenders (or Required Lenders where authorized herein) and such request and any action taken or failure to act pursuant thereto shall be binding upon all the Lenders. 

14.6 Notice of Default. Agent shall not be deemed to have knowledge or notice of the occurrence of any Default and/or Event of Default,
unless Agent shall have received written notice from a Lender or Borrower, describing such default or Event of Default. Agent will notify the Lenders of its receipt of any such notice. While an Event of Default has occurred and is continuing, Agent
may (but shall not be obligated to) take such action, or refrain from taking such action, with respect to such Event of Default as Agent shall deem advisable or in the best interest of the Lenders, including without limitation, satisfaction of other
security interests, liens or encumbrances on the Collateral not permitted under the Financing Documents, payment of taxes on behalf of Borrower or any other Credit Party, payments to landlords, warehouseman, bailees and other Persons in possession
of the Collateral and other actions to protect and safeguard the Collateral, and actions with respect to insurance claims for casualty events affecting a Credit Party and/or the Collateral. 

14.7 Credit Decision; Disclosure of Information by Agent. Each Lender acknowledges that no Agent-Related Person has made any
representation or warranty to it, and that no act by Agent hereafter taken, including any consent to and acceptance of any assignment or review of the affairs of Borrower or any Affiliate thereof, shall be deemed to constitute any representation or
warranty by any Agent-Related Person to any Lender as to any matter, including whether Agent-Related Persons have disclosed material information in their possession. Each Lender represents to Agent that it has, independently

  
 35 

 
and without reliance upon any Agent-Related Person and based on such documents and information as it has deemed appropriate, made its own appraisal of, and investigation into, the business,
prospects, operations, property, financial and other condition and creditworthiness of the Credit Parties, and all applicable bank or other regulatory Laws relating to the transactions contemplated hereby, and made its own decision to enter into
this Agreement and to extend credit to Borrower hereunder. Each Lender also represents that it will, independently and without reliance upon any Agent-Related Person and based on such documents and information as it shall deem appropriate at the
time, continue to make its own credit analysis, appraisals and decisions in taking or not taking action under this Agreement and the other Financing Documents, and to make such investigations as it deems necessary to inform itself as to the
business, prospects, operations, property, financial and other condition and creditworthiness of Borrower. Except for notices, reports and other documents expressly required to be furnished to the Lenders by Agent herein, Agent shall not have any
duty or responsibility to provide any Lender with any credit or other information concerning the business, prospects, operations, property, financial and other condition or creditworthiness of any Credit Party which may come into the possession of
any Agent-Related Person. 
 14.8 Indemnification of Agent. Whether or not the transactions contemplated hereby are consummated, each
Lender shall, severally and pro rata based on its respective Pro Rata Share, indemnify upon demand each Agent-Related Person (to the extent not reimbursed by or on behalf of Borrower and without limiting or expanding the obligation of Borrower to do
so pursuant to Section 13.2), and hold harmless each Agent-Related Person from and against any and all Indemnified Liabilities (which shall not include legal expenses of Agent incurred in connection with the closing of the transactions
contemplated by this Agreement) incurred by it; provided, however, that no Lender shall be liable for the payment to any Agent-Related Person of any portion of such Indemnified Liabilities to the extent determined in a judgment by a court of
competent jurisdiction to have resulted from such Agent-Related Person’s own gross negligence or willful misconduct; provided, however, that no action taken in accordance with the directions of the Required Lenders shall be deemed to
constitute gross negligence or willful misconduct for purposes of this Section 14.8. Without limitation of the foregoing, each Lender shall, severally and pro rata based on its respective Pro Rata Share, reimburse Agent upon demand for
its ratable share of any costs or out-of-pocket expenses (including Protective Advances incurred after the closing of the transactions contemplated by this Agreement) incurred by Agent (in its capacity as Agent, and not as a Lender) in connection
with the preparation, execution, delivery, administration, modification, amendment or enforcement (whether through negotiations, legal proceedings or otherwise) of, or legal advice in respect of rights or responsibilities under, this Agreement, any
other Financing Document, or any document contemplated by or referred to herein, to the extent that Agent is not reimbursed for such expenses by or on behalf of Borrower and without limiting or expanding the obligation of Borrower to do so pursuant
to this Agreement or any other Loan Document. The undertaking in this Section 14.8 shall survive the payment in full of the Obligations, the termination of this Agreement and the resignation of Agent. 

14.9 Agent in its Individual Capacity. With respect to its Credit Extensions, MidCap shall have the same rights and powers under this
Agreement as any other Lender and may exercise such rights and powers as though it were not Agent, and the terms “Lender” and “Lenders” include MidCap in its individual capacity. MidCap and its Affiliates may lend money to,
invest in, and generally engage in any kind of business with, any Credit Party and any of their Affiliates and any person who may do business with or own securities of any Credit Party or any of their Affiliates, all as if MidCap were not Agent and
without any duty to account therefor to Lenders. MidCap and its Affiliates may accept fees and other consideration from a Credit Party for services in connection with this Agreement or otherwise without having to account for the same to Lenders.
Each Lender acknowledges the potential conflict of interest between MidCap as a Lender holding disproportionate interests in the Credit Extensions and MidCap as Agent, and expressly consents to, and waives, any claim based upon, such conflict of
interest. 
 14.10 Agent May File Proofs of Claim. In case of the pendency of any receivership, insolvency, liquidation, bankruptcy,
reorganization, arrangement, adjustment, composition or other judicial proceeding relative to any Credit Party, Agent (irrespective of whether the principal of any Credit Extension, shall then be due and payable as herein expressed or by declaration
or otherwise and irrespective of whether Agent shall have made any demand on such Credit Party) shall be entitled and empowered, by intervention in such proceeding or otherwise: 

(a) to file and prove a claim for the whole amount of the principal and interest owing and unpaid in respect of the Credit
Extensions and all other Obligations that are owing and unpaid and to file such other documents as may be necessary or advisable in order to have the claims of the Lenders and Agent (including any claim for the reasonable compensation, expenses,
disbursements and advances of the Lenders and Agent and their respective agents and counsel and all other amounts due the Lenders and Agent allowed in such judicial proceeding); and 

  
 36 

 (b) to collect and receive any monies or other property payable or deliverable on
any such claims and to distribute the same; 
 and any custodian, receiver, assignee, trustee, liquidator, sequestrator or other similar
official in any such judicial proceeding is hereby authorized by each Lender to make such payments to Agent and, in the event that Agent shall consent to the making of such payments directly to the Lenders, to pay to Agent any amount due for the
reasonable compensation, expenses, disbursements and advances of Agent and its agents and counsel, including Protective Advances. To the extent that Agent fails timely to do so, each Lender may file a claim relating to such Lender’s claim. 

14.11 Collateral and Guaranty Matters. Notwithstanding anything set forth in Section 13.14(b) of this Agreement to the
contrary, the Lenders irrevocably authorize Agent, at its option and in its discretion, to release (a) any Credit Party and any Lien on any Collateral granted to or held by Agent under any Financing Document upon the date that all Obligations
due hereunder have been fully and indefeasibly paid in full (other than inchoate indemnity obligations and other obligations that expressly survive the termination of this Agreement) and no Applicable Commitments or other obligations of any Lender
to provide funds to Borrower under this Agreement remain outstanding, and (b) any Lien on any Collateral that is transferred or to be transferred as part of or in connection with any transfer permitted hereunder or under any other Financing
Document. Upon request by Agent at any time, all Lenders will confirm in writing Agent’s authority to release its interest in particular types or items of Collateral pursuant to this Section 14.11. 

14.12 Advances; Payments; Non-Funding Lenders. 

(a) Advances; Payments. If Agent receives any payment for the account of Lenders on or prior to 11:00 a.m. (New York
time) on any Business Day, Agent shall pay to each applicable Lender such Lender’s Pro Rata Share of such payment on such Business Day. If Agent receives any payment for the account of Lenders after 11:00 a.m. (New York time) on any
Business Day, Agent shall pay to each applicable Lender such Lender’s Pro Rata Share of such payment on the next Business Day. To the extent that any Lender has failed to fund any Credit Extension (a “Non-Funding Lender”),
Agent shall be entitled to set-off the funding short-fall against that Non-Funding Lender’s Pro Rata Share of all payments received from Borrower. 

(b) Return of Payments. 

(i) If Agent pays an amount to a Lender under this Agreement in the belief or expectation that a related payment has been or will be received
by Agent from a Credit Party and such related payment is not received by Agent, then Agent will be entitled to recover such amount (including interest accruing on such amount at the Federal Funds Rate for the first Business Day and thereafter, at
the rate otherwise applicable to such Obligation) from such Lender on demand without set-off, counterclaim or deduction of any kind. 
 (ii)
If Agent determines at any time that any amount received by Agent under this Agreement must be returned to a Credit Party or paid to any other person pursuant to any insolvency law or otherwise, then, notwithstanding any other term or condition of
this Agreement or any other Financing Document, Agent will not be required to distribute any portion thereof to any Lender. In addition, each Lender will repay to Agent on demand any portion of such amount that Agent has distributed to such Lender,
together with interest at such rate, if any, as Agent is required to pay to a Credit Party or such other person, without set-off, counterclaim or deduction of any kind. 

14.13 Miscellaneous. 

(a) Neither Agent nor any Lender shall be responsible for the failure of any Non-Funding Lender to make a Credit Extension or
make any other advance required hereunder. The failure of any Non-Funding Lender to make any Credit Extension or any payment required by it hereunder shall not relieve any other Lender (each such other Lender,
an “Other Lender”) of its obligations to make the Credit Extension or payment required by it, but neither any Other Lender nor Agent shall be responsible for the failure of any Non-Funding Lender to make a Credit
Extension or make any other payment required hereunder. Notwithstanding anything set forth herein to the contrary, a Non-Funding Lender shall not have any voting or consent rights under or with respect to any Financing Document or constitute a
“Lender” (or be included in the calculation of “Required Lender” hereunder) for any voting or consent rights under or with respect to any Financing Document. At Borrower’s request, Agent or a person reasonably acceptable to
Agent shall have the right with Agent’s consent and in Agent’s sole discretion (but 

  
 37 

 
shall have no obligation) to purchase from any Non-Funding Lender, and each Non-Funding Lender agrees that it shall, at Agent’s request, sell and assign to Agent or such person, all of the
Applicable Commitments and all of the outstanding Credit Extensions of that Non-Funding Lender for an amount equal to the principal balance of the Credit Extensions held by such Non-Funding Lender and all accrued interest and fees with respect
thereto through the date of sale, such purchase and sale to be consummated pursuant to an executed assignment agreement reasonably acceptable to Agent. 

(b) Each Lender shall promptly remit to the other Lenders such sums as may be necessary to ensure the ratable repayment of each
Lender’s portion of any Credit Extension and the ratable distribution of interest, fees and reimbursements paid or made by any Credit Party. Notwithstanding the foregoing, if this Agreement requires payments of principal and interest to be made
directly to the Lenders, a Lender receiving a scheduled payment shall not be responsible for determining whether the other Lenders also received their scheduled payment on such date; provided, however, if it is determined that a Lender
received more than its ratable share of scheduled payments made on any date or dates, then such Lender shall remit to the Agent (for Agent to redistribute to itself and the Lenders in a manner to ensure the payment to Agent of any sums due Agent
hereunder and the ratable repayment of each Lender’s portion of any Credit Extension and the ratable distribution of interest, fees and reimbursements) such sums as may be necessary to ensure the ratable payment of such scheduled payments, as
instructed by Agent. If any payment or distribution of any kind or character, whether in cash, properties or securities and whether voluntary, involuntary, through the exercise of any right of set-off, or otherwise, shall be received by a Lender in
excess of its ratable share, then (i) the portion of such payment or distribution in excess of such Lender’s ratable share shall be received by such Lender in trust for application to the payments of amounts due on the other Lender’s
claims, or, in the case of Collateral, shall hold such Collateral for itself and as agent and bailee for the Agent and other Lenders and (ii) such Lender shall promptly advise the Agent of the receipt of such payment, and, within five
(5) Business Days of such receipt and, in the case of payments and distributions, such Lender shall purchase (for cash at face value) from the other Lenders (through the Agent), without recourse, such participations in the Credit Extension made
by the other Lenders as shall be necessary to cause such purchasing Lender to share the excess payment ratably with each of them in accordance with the respective Pro Rata Shares of the Lenders; provided, however, that if all or any
portion of such excess payment is thereafter recovered by or on behalf of a Credit Party from such purchasing Lender, the purchase shall be rescinded and the purchase price restored to the extent of such recovery, but without interest;
provided, further, that the provisions of this Section 14.13(b) shall not be construed to apply to (x) any payment made by a Credit Party pursuant to and in accordance with the express terms of this Agreement or the
other Financing Documents, or (y) any payment obtained by a Lender as consideration for the assignment of or sale of a participation in any of its Applicable Commitment pursuant to Section 13.1. Borrower agrees that any Lender so
purchasing a participation from another Lender pursuant to this Section 14.13(b) may exercise all its rights of payment (including the right of set-off) with respect to such participation as fully as if such Lender were the direct
creditor of the Borrower in the amount of such participation. No documentation other than notices and the like shall be required to implement the terms of this Section 14.13(b). The Agent shall keep records (which shall be conclusive and
binding in the absence of manifest error) of participations purchased pursuant to this Section 14.13(b) and shall in each case notify the Lenders following any such purchases. 

15 DEFINITIONS 

In addition to any terms defined elsewhere in this Agreement, or in any schedule or exhibit attached hereto, as used in this Agreement, the
following terms have the following meanings: 
 “Access Agreement” means a landlord consent, bailee letter or
warehouseman’s letter, in form and substance reasonably satisfactory to Agent, in favor of Agent executed by such landlord, bailee or warehouseman, as applicable, for any third party location. 

“Account” means any “account”, as defined in the Code, with such additions to such term as may hereafter be
made, and includes, without limitation, all accounts receivable and other sums owing to Borrower. 
 “Account Debtor” means
any “account debtor”, as defined in the Code, with such additions to such term as may hereafter be made. 

  
 38 

 “Affiliate” means, with respect to any Person, a Person that owns or controls
directly or indirectly the Person, any Person that controls or is controlled by or is under common control with the Person, and each of that Person’s senior executive officers, directors, limited and general partners and, for any Person that is
a limited liability company, that Person’s managers and members. 
 “Agent” means, MidCap, not in its individual
capacity, but solely in its capacity as agent on behalf of and for the benefit of the Lenders, together with its successors and assigns. 

“Agreement” has the meaning given it in the preamble of this Agreement. 

“Anti-Terrorism Laws” means any Laws relating to terrorism or money laundering, including Executive Order No. 13224
(effective September 24, 2001), the USA PATRIOT Act, the Laws comprising or implementing the Bank Secrecy Act, and the Laws administered by OFAC. 

“Applicable Commitment” has the meaning given it in Section 2.2. 

“Applicable Prepayment Fee”, for each Credit Facility, has the meaning given it in the Credit Facility Schedule for
such Credit Facility. 
 “Approved Fund” means any (a) investment company, fund, trust, securitization vehicle or
conduit that is (or will be) engaged in making, purchasing, holding or otherwise investing in commercial loans and similar extensions of credit in the Ordinary Course of Business, or (b) any Person (other than a natural person) which
temporarily warehouses loans for any Lender or any entity described in the preceding clause (a) and that, with respect to each of the preceding clauses (a) and (b), is administered or managed by (i) a Lender, (ii) an Affiliate of
a Lender or (iii) a Person (other than a natural person) or an Affiliate of a Person (other than a natural person) that administers or manages a Lender. 

“Blocked Person” means: (a) any Person listed in the annex to, or is otherwise subject to the provisions of, Executive
Order No. 13224, (b) a Person owned or controlled by, or acting for or on behalf of, any Person that is listed in the annex to, or is otherwise subject to the provisions of, Executive Order No. 13224, (c) a Person with which any
Lender is prohibited from dealing or otherwise engaging in any transaction by any Anti-Terrorism Law, (d) a Person that commits, threatens or conspires to commit or supports “terrorism” as defined in Executive Order No. 13224, or
(e) a Person that is named a “specially designated national” or “blocked person” on the most current list published by OFAC or other similar list. 

“Borrower” mean the entity(ies) described in the first paragraph of this Agreement and each of their successors and permitted
assigns. The term “each Borrower” shall refer to each Person comprising the Borrower if there is more than one such Person, or the sole Borrower if there is only one such Person. The term “any Borrower” shall refer to any Person
comprising the Borrower if there is more than one such Person, or the sole Borrower if there is only one such Person. 
 “Borrowing
Resolutions” means, with respect to any Person, those resolutions, in form and substance satisfactory to Agent, adopted by such Person’s Board of Directors or other appropriate governing body and delivered by such Person to Agent
approving the Financing Documents to which such Person is a party and the transactions contemplated thereby, as well as any other approvals as may be necessary or desired to approve the entering into the Financing Documents or the consummation of
the transactions contemplated thereby or in connection therewith. 
 “Books” means all of books and records of a Person,
including ledgers, federal and state tax returns, records regarding the Person’s assets or liabilities, the Collateral, business operations or financial condition, and all computer programs or storage or any equipment containing such
information. 
 “Business Day” means any day that is not (a) a Saturday or Sunday or (b) a day on which Agent is
closed. 
 “Cash Equivalents” means (a) any readily-marketable securities (i) issued by, or directly,
unconditionally and fully guaranteed or insured by the United States federal government or (ii) issued by any agency of the United States federal government the obligations of which are fully backed by the full faith and credit of the United
States federal government, (b) any readily-marketable direct obligations issued by any other agency of the United States federal government, any state of the United States or any political subdivision of any such state or any public
instrumentality thereof, in each case having a rating 

  
 39 

 
of at least “A-1” from S&P or at least “P-1” from Moody’s, (c) any commercial paper rated at least “A-1” by S&P or “P-1” by
Moody’s and issued by any Person organized under the laws of any state of the United States, (d) any Dollar-denominated time deposit, insured certificate of deposit, overnight bank deposit or bankers’ acceptance issued or accepted by
(i) any Lender or (ii) any commercial bank that is (A) organized under the laws of the United States, any state thereof or the District of Columbia, (B) “adequately capitalized” (as defined in the regulations of its
primary federal banking regulators) and (C) has Tier 1 capital (as defined in such regulations) in excess of $250,000,000 and (e) shares of any United States money market fund that (i) has substantially all of its assets invested
continuously in the types of investments referred to in clause (a), (b), (c) or (d) above with maturities as set forth in the proviso below, (ii) has net assets in excess of $500,000,000 and (iii) has
obtained from either S&P or Moody’s the highest rating obtainable for money market funds in the United States; provided, however, that the maturities of all obligations specified in any of clauses (a), (b), (c) or
(d) above shall not exceed 365 days. 
 “Change in Control” means one of the following events, transactions, or
occurrences: (a) any “person” (as such term is defined in Sections 3(a)(9) and 13(d)(3) of the Exchange Act), other than a trustee or other fiduciary holding securities under an employee benefit plan of Borrower, is or becomes a
beneficial owner (within the meaning Rule 13d-3 promulgated under the Exchange Act), directly or indirectly, of securities of Borrower, representing fifty percent (50%) or more of the combined voting power of Borrower’s then outstanding
securities; (b) the occurrence of any “change in control” or any term of similar effect under any Subordinated Debt Document; or (c) Borrower ceases to own and control, directly or indirectly, all of the economic and voting
rights associated with the outstanding voting capital stock (or other voting equity interest) of each of its Subsidiaries (other than minimal stock or equity interest required in the case of Foreign Subsidiary, to be owned by a foreign person or
entity of the country of organization of such Foreign Subsidiary in order to organize it in such county) except to the extent such cessation results from a transaction expressly permitted pursuant to Section 7.3 of this Agreement. 

“Chase Credit Card Security Account” means a deposit account of Borrower’s with JPMorgan Chase Bank, as depository
institution, in an amount not to exceed $150,000 and securing the company credit card. 
 “Closing Date” has the meaning
given it in the preamble of this Agreement. 
 “Code” means the Uniform Commercial Code enacted and in effect from time to
time in the State of Maryland; provided, however, that to the extent that the Code is used to define any term herein or in any Financing Document and such term is defined differently in different Articles or Divisions of the Code, the
definition of such term contained in Article or Division 9 shall govern; and provided, further, that in the event that, by reason of mandatory provisions of Law, any or all of the attachment, perfection, or priority of, or remedies with
respect to, Agent’s Lien on any Collateral is governed by the Uniform Commercial Code in effect in a jurisdiction other than the State of Maryland the term “Code” shall mean the Uniform Commercial Code as enacted and in effect
from time to time in such other jurisdiction solely for purposes of the provisions thereof relating to such attachment, perfection, priority, or remedies and for purposes of definitions relating to such provisions. 

“Collateral” means all property, now existing or hereafter acquired, mortgaged or pledged to, or purported to be subjected to
a Lien in favor of, Agent, for the benefit of Agent and Lenders, pursuant to this Agreement and the other Financing Documents, including, without limitation, all of the property described in Exhibit A hereto. 

“Collateral Account” means any Deposit Account, Securities Account or Commodity Account. 

“Commitment Commencement Date” has the meaning given it in the Credit Facility Schedule. 

“Commitment Termination Date” has the meaning given it in the Credit Facility Schedule. 

“Commodity Account” means any “commodity account”, as defined in the Code, with such additions to such term
as may hereafter be made. 
 “Communication” has the meaning given it in Article 11. 

“Compliance Certificate” means a certificate, duly executed by an authorized officer of Borrower, appropriately
completed and substantially in the form of Exhibit B. 

  
 40 

 “Contingent Obligation” means, for any Person, any direct or indirect
liability, contingent or not, of that Person for (a) any indebtedness, lease, dividend, letter of credit or other obligation of another such as an obligation directly or indirectly guaranteed, endorsed,
co-made, discounted or sold with recourse by that Person, or for which that Person is directly or indirectly liable; (b) any obligations for undrawn letters of credit for the account of that Person; and
(c) all obligations from any interest rate, currency or commodity swap agreement, interest rate cap or collar agreement, or other agreement or arrangement designated to protect a Person against fluctuation in interest rates, currency exchange
rates or commodity prices; but “Contingent Obligation” does not include endorsements in the Ordinary Course of Business. The amount of a Contingent Obligation is the stated or determined amount of the primary obligation for which the
Contingent Obligation is made or, if not determinable, the maximum reasonably anticipated liability for it determined by the Person in good faith; but the amount may not exceed the maximum of the obligations under any guarantee or other support
arrangement. 
 “Control Agreement” means any control agreement entered into among the Borrower, Agent, depository
institution at which Borrower maintains a Deposit Account, the securities intermediary at which Borrower maintains a Security Account or the commodity intermediary at which Borrower maintains a Securities Account or a Commodity Account, as the case
may be, pursuant to which Agent obtains control (within the meaning of the Code) for the benefit of the Lenders over such Deposit Account, Securities Account or Commodity Account, as applicable. 

“Credit Extension” means an advance or disbursement of proceeds to or for the account of Borrower in respect of a
Credit Facility under this Agreement. 
 “Credit Extension Form” means that certain form attached hereto as
Exhibit C. 
 “Credit Facility” means a credit facility specified on the Credit Facility Schedule.

 “Credit Party” means any Borrower, any Guarantor under a guarantee of the Obligations or any part thereof, and
any other Person (other than Agent, a Lender or a participant of a Lender), whether now existing or hereafter acquired or formed, that becomes obligated as a borrower, guarantor, surety, indemnitor, pledgor, assignor or other obligor under any
Financing Document, and any Person whose equity interests or portion thereof have been pledged or hypothecated to Agent under any Financing Document; and “Credit Parties” means all such Persons, collectively. 

“Default” means any fact, event or circumstance which with notice or passage of time or both, could constitute an Event of
Default. 
 “Default Rate” has the meaning given it in Section 2.6(b). 

“Deposit Account” means any “deposit account” as defined in the Code with such additions to such term as may
hereafter be made. 
 “Designated Funding Account” is Borrower’s Deposit Account, account number 771554789,
maintained with JP Morgan Chase Bank, N.A.and over which Agent has been granted control for the ratable benefit of all Lenders. 

“Dollars,” “dollars” and “$” each means lawful money of the United States. 

“Domestic Subsidiary” means each Subsidiary of the Borrower that is organized under the laws of the United States or any
state or district thereof. 
 “Draw Period” means, for each Credit Facility, the period commencing on the Commitment
Commencement Date and ending on the Commitment Termination Date. 
 “Eligible Assignee” means (a) a Lender,
(b) an Affiliate of a Lender, (c) an Approved Fund, and (d) any other Person (other than a natural person) approved by Agent; provided, however, that notwithstanding the foregoing, “Eligible Assignee” shall not
include (i) any Credit Party or any Subsidiary of a Credit Party or (ii) any competitor of Borrower so long as no Event of Default has occurred and is continuing. Notwithstanding the foregoing, in connection with assignments by a Lender
due to a forced divestiture at the request of any regulatory agency, the restrictions set forth herein shall not apply and Eligible Assignee shall mean any Person or party becoming an assignee incident to such forced divestiture. 

  
 41 

 “Environmental Law” means any law (statutory or common), ordinance,
treaty, rule, regulation, order, policy, other legal requirement or determination of an arbitrator or of a Governmental Authority and/or Required Permits imposing liability or standards of conduct for or relating to the regulation and protection of
human health, safety, the workplace, the environment and natural resources, and including public notification requirements and environmental transfer of ownership, notification or approval statutes. 

“Equipment” means all “equipment”, as defined in the Code, with such additions to such term as may hereafter be
made, and includes without limitation all machinery, fixtures, goods, vehicles (including motor vehicles and trailers), and any interest in any of the foregoing. 

“ERISA” means the Employee Retirement Income Security Act of 1974, and all regulations promulgated thereunder. 

“ERISA Affiliate” has the meaning given it in Section 5.6. 

“Event of Default” has the meaning given it in Section 10.1. 

“Excluded Domestic Holding Company” means a Domestic Subsidiary that has no material assets other than the voting stock or
other equity interests of one or more Foreign Subsidiaries or Excluded Domestic Subsidiaries. 
 “Excluded Domestic
Subsidiary” means any Domestic Subsidiary that is (a) a direct or indirect Subsidiary of a Foreign Subsidiary, or (b) an Excluded Domestic Holding Company. 

“Excluded Tax” means (v) any Taxes imposed on or measured by income, any franchise Taxes, and any branch profits
Taxes, imposed by the United States or by the jurisdiction under which a Recipient is organized or conducts business or as a result of a present or former connection between such Recipient and the jurisdiction imposing such Tax (other than a
connection arising as the result of entering into any of the Financing Documents or engaging in any transaction pursuant thereto) (w) any U.S. federal withholding Taxes that are imposed on amounts payable to or for the account of a Recipient
pursuant to a law in effect (A) on the date on which such Recipient becomes a party hereto or (B) on the date on which such Recipient designates a new lending office, except in either case, to the extent that amounts with respect to such
Taxes were payable either (I) to such Recipient’s assignor immediately before such Recipient became a party hereto or (II) to such Recipient immediately before it designated a new lending office, (x) any Taxes that are attributable to
such Recipient’s failure or inability to comply with Section 2.6(h)(iii), (y) any Taxes that are imposed pursuant to FATCA and (z) any Taxes that are imposed pursuant to Section 3406 of the Internal Revenue Code of
1986, as amended. 
 “Exigent Circumstance” has the meaning given it in Section 13.14. 

“Existing Equipment Leases” means collectively, the three equipment leases shown on the Schedule Permitted Liens
portion of the Disclosure Schedules, including two relating to Sharp Multifunction Printers, each with DeLage Landen Financial Services, Inc., as secured party/lessor, and one relating to a Filter Dryer with GL Filtration Limited as secured
party/lessor. 
 “Existing Licenses” shall mean (i) that certain License Restructuring Agreement between the
Borrower, UOP LLC, a Delaware limited liability company (“UOP”), and HemoCleanse, Inc., an Indiana corporation (“HemoCleanse”), dated December 19, 2011; and (ii) that certain License Agreement between the Borrower and
UOP, dated December 19, 2011, as such licenses may be amended, modified, extended, supplemented and restated from time to time. 

“Existing Sublicense” means the sublicense set forth on the Intangible Assets Schedule as of the Closing Date. 

“FATCA” means Sections 1471 through 1474 of the Internal Revenue Code of 1986, as amended, as of the date of this
Agreement (and any amended or successor version that is substantially comparable and not materially more onerous to comply with), any current or future regulations or official interpretations thereof and any agreements entered into pursuant to
Section 1471(b) of the Internal Revenue Code of 1986, as amended. 

  
 42 

 “Federal Funds Rate” means, for any day, the rate per annum equal to the
weighted average of the rates on overnight Federal funds transactions with members of the Federal Reserve System arranged by Federal funds brokers on such day, as published by the Federal Reserve Bank of New York on the Business Day next succeeding
such day, provided that if no such rate is so published on such next succeeding Business Day, the Federal Funds Rate for such day shall be the average rate quoted to Agent on such day on such transactions as determined by Agent in a
commercially reasonable manner. 
 “Fee Letter” means the fee letter agreement among Borrower and Agent and Borrower and
each Lender. 
 “Financing Documents” means, collectively, this Agreement, the Perfection Certificate, the Fee
Letter(s), each note and guarantee executed by one or more Credit Parties in connection with the indebtedness governed by this Agreement, and each other present or future agreement executed by one or more Credit Parties with, or for the benefit of,
the Lenders and/or Agent in connection with this Agreement, all as amended, restated, or otherwise modified from time to time. 

“First-Tier Foreign Subsidiary” means a Foreign Subsidiary held directly by a Credit Party (other than any Credit
Party that is a Foreign Subsidiary or an Excluded Domestic Subsidiary). 
 “Foreign Subsidiary” means each
Subsidiary of the Borrower that is not a Domestic Subsidiary. 
 “Funding Date” means any date on which a Credit
Extension is made to or on account of Borrower which shall be a Business Day. 
 “GAAP” means generally accepted accounting
principles set forth in the opinions and pronouncements of the Accounting Principles Board of the American Institute of Certified Public Accountants and statements and pronouncements of the Financial Accounting Standards Board or in such other
statements by such other Person as may be approved by a significant segment of the accounting profession in the United States, which are applicable to the circumstances as of the date of determination. 

“General Intangibles” means all “general intangibles”, as defined in the Code, with such additions to such
term as may hereafter be made, and includes without limitation, all copyright rights, copyright applications, copyright registrations and like protections in each work of authorship and derivative work, whether published or unpublished, any patents,
trademarks, service marks and, to the extent permitted under applicable Law, any applications therefor, whether registered or not, any trade secret rights, including any rights to unpatented inventions, payment intangibles, royalties, contract
rights, goodwill, franchise agreements, purchase orders, customer lists, route lists, telephone numbers, domain names, claims, income and other tax refunds, security and other deposits, options to purchase or sell real or personal property, rights
in all litigation presently or hereafter pending (whether in contract, tort or otherwise), insurance policies (including, without limitation, key man, property damage, and business interruption insurance), payments of insurance and rights to payment
of any kind. 
 “Governmental Authority” means any nation or government, any state or other political subdivision
thereof, any agency, authority, instrumentality, regulatory body, court, central bank or other entity exercising executive, legislative, judicial, taxing, regulatory or administrative functions of or pertaining to government, any securities exchange
and any self-regulatory organization. 
 “Guarantor” means any present or future guarantor of the Obligations, excluding,
for the avoidance of doubt, any Foreign Subsidiary and any Excluded Domestic Subsidiary. 
 “Hazardous Materials”
means petroleum and petroleum products and compounds containing them, including gasoline, diesel fuel and oil; explosives, flammable materials; radioactive materials; polychlorinated biphenyls and compounds containing them; lead and lead-based
paint; asbestos or asbestos-containing materials; underground or above-ground storage tanks, whether empty or containing any substance; any substance the presence of which is prohibited by any Laws; toxic mold, any substance that requires special
handling; and any other material or substance now or in the future defined as a “hazardous substance,” “hazardous material,” “hazardous waste,” “toxic substance,” “toxic pollutant,”
“contaminant,” “pollutant” or other words of similar import within the meaning of any Environmental Law, including: (a) any “hazardous substance” defined as such in (or for purposes of) CERCLA, or any so-called
“superfund” or “superlien” Law, including the judicial interpretation thereof; (b) any “pollutant or contaminant” as defined in 42 U.S.C.A. § 9601(33); 

  
 43 

 
(c) any material now defined as “hazardous waste” pursuant to 40 C.F.R. Part 260; (d) any petroleum or petroleum by-products, including crude oil or any fraction thereof;
(e) natural gas, natural gas liquids, liquefied natural gas, or synthetic gas usable for fuel; (f) any “hazardous chemical” as defined pursuant to 29 C.F.R. Part 1910; (g) any toxic or harmful substances, wastes, materials,
pollutants or contaminants (including, without limitation, asbestos, polychlorinated biphenyls (“PCB’s”), flammable explosives, radioactive materials, infectious substances, materials containing lead-based paint or raw materials which
include hazardous constituents); and (h) any other toxic substance or contaminant that is subject to any Environmental Laws or other past or present requirement of any Governmental Authority. 

“Hazardous Materials Contamination” means contamination (whether now existing or hereafter occurring) of the improvements,
buildings, facilities, personalty, soil, groundwater, air or other elements on or of the relevant property by Hazardous Materials, or any derivatives thereof, or on or of any other property as a result of Hazardous Materials, or any derivatives
thereof, generated on, emanating from or disposed of in connection with the relevant property. 
 “Indebtedness”
means (a) indebtedness for borrowed money (including the Obligations) or the deferred price of property or services, such as reimbursement and other obligations for surety bonds and letters of credit, (b) obligations evidenced by notes,
bonds, debentures or similar instruments, (c) capital lease obligations, (d) non-contingent obligations of such Person to reimburse any bank or other Person in respect of amounts paid under a letter of credit, banker’s acceptance or
similar instrument, (e) equity securities of such Person subject to repurchase or redemption other than at the sole option of such Person, (f) obligations secured by a Lien on any asset of such Person, whether or not such obligation is
otherwise an obligation of such Person, (g) “earnouts”, purchase price adjustments, profit sharing arrangements, deferred purchase money amounts and similar payment obligations of such Person arising out of purchase and sale
contracts, (h) all Indebtedness of others guaranteed by such Person, (i) off-balance sheet liabilities and/or pension plan or multiemployer plan liabilities of such Person, (j) obligations arising under non-compete agreements,
(k) obligations arising under bonus, deferred compensation, incentive compensation or similar arrangements, other than those arising in the Ordinary Course of Business, and (l) Contingent Obligations. 

“Indemnified Liabilities” means those liabilities described in Section 13.2(a) and (b). 

“Indemnified Tax” means any Tax imposed on or with respect to any payment made by or on account of any Obligation of Borrower
hereunder, other than an Excluded Tax. 
 “Indemnitee” has the meaning given it in Section 13.2. 

“Insolvency Proceeding” means any proceeding by or against any Person under the United States Bankruptcy Code, or any
other bankruptcy or insolvency Law, including assignments for the benefit of creditors, compositions, extensions generally with its creditors, or proceedings seeking reorganization, arrangement, or other relief. 

“Intellectual Property” includes without limitation, all copyright rights, copyright applications, copyright registrations
and like protections in each work of authorship and derivative work, whether published or unpublished, any patents, patent applications and like protections, including improvements, divisions, continuations, renewals, reissues, extensions, and
continuations-in-part of the same, trademarks, trade names, service marks, mask works, rights of use of any name, domain names, or any other similar rights, any applications therefor, whether registered or not, know-how, operating manuals, trade
secret rights, clinical and non-clinical data, rights to unpatented inventions, and any claims for damage by way of any past, present, or future infringement of any of the foregoing. 

“Interest Rate” means seven and one half of one percent (7.5%) per annum. 

“Internal Revenue Code” has the meaning given it in Section 5.6. 

“Inventory” means all “inventory”, as defined in the Code, with such additions to such term as may hereafter
be made, and includes without limitation all merchandise, raw materials, parts, supplies, packing and shipping materials, work in process and finished products, including without limitation such inventory as is temporarily out of Borrower’s
custody or possession or in transit and including any returned goods and any documents of title representing any of the above. 

  
 44 

 “Investment” means, with respect to any Person, directly or indirectly,
(a) to purchase or acquire any stock or stock equivalents, or any obligations or other securities of, or any interest in, any Person, including the establishment or creation of a Subsidiary, (b) to make or commit to make any acquisition
(including through one or more licensing transactions) of all or substantially all of the assets of another Person, or of any business, Product, business line or product line, division or other unit operation of any Person or (c) make or
purchase any advance, loan, extension of credit or capital contribution to, or any other investment in, any Person. 

“Joinder Requirements” has the meaning set forth in Section 6.8. 

“Law” or “Laws” means any and all federal, state, provincial, territorial, local and foreign
statutes, laws, judicial decisions, regulations, guidance, guidelines, ordinances, rules, judgments, orders, decrees, codes, plans, injunctions, permits, concessions, grants, franchises, governmental agreements and governmental restrictions, whether
now or hereafter in effect, which are applicable to any Credit Party in any particular circumstance. 
 “Lender” means any
one of the Lenders. 
 “Lenders” means the Persons identified on the Credit Facility Schedule as amended from time
to time to reflect assignments made in accordance with this Agreement. 
 “Lien” means a claim, mortgage, deed of trust,
lien, levy, charge, pledge, security interest or other encumbrance of any kind, whether voluntarily incurred or arising by operation of Law or otherwise against any property. 

“Margin Stock” means “margin stock” as such term is defined in Regulation T, U, or X of the Board of Governors of
the Federal Reserve System. 
 “Material Adverse Change” means (a) a material impairment in the perfection or priority
of the Agent’s Lien (or any Lender’s Lien therein to the extent provided for in the Financing Documents) in the Collateral; (b) a material impairment in the value of the Collateral; (c) a material adverse change in the business,
operations, or condition (financial or otherwise) or of any Credit Party, taken as a whole; or (d) a material impairment of repayment of any portion of the Obligations. 

“Material Agreement” means (a) the agreements listed in the Disclosure Schedule, (b) each agreement or
contract to which a Credit Party is a party relating to licensure of Intellectual Property or development of Products or Intellectual Property the termination of which could reasonably be expected to result in a Material Adverse Change, and
(c) any agreement or contract to which such Credit Party or its Subsidiaries is a party the termination of which could reasonably be expected to result in a Material Adverse Change. 

“Material Indebtedness” has the meaning given it in Section 10.1. 

“Material Intellectual Property” means Intellectual Property, the loss or impairment of which could reasonably be expected to
result in a Material Adverse Change. 
 “Material Required Permit” means, when and if it is approved by the FDA and
becomes effective, Borrower’s permit from the FDA allowing production of API materials (ZS-9). 
 “Maturity Date”
means January 1, 2019. 
 “Maximum Lawful Rate” has the meaning given it in Section 2.6(g). 

“MidCap” has the meaning given it in the preamble of this Agreement. 

“Obligations” means all of Borrower’s obligations to pay when due any debts, principal, interest, Protective
Advances, fees, indemnities and other amounts Borrower owes the Agent or Lenders now or later, under this Agreement or the other Financing Documents, including, without limitation, interest accruing after Insolvency Proceedings begin (whether or not
allowed) and debts, liabilities, or obligations of Borrower assigned to the Lenders and/or Agent, and the payment and performance of each other Credit Party’s covenants and obligations under the Financing Documents. “Obligations” does
not include obligations under any warrants issued to Agent or a Lender, if any. 

  
 45 

 “OFAC” means the U.S. Department of Treasury Office of Foreign Assets Control.

 “OFAC Lists” means, collectively, the Specially Designated Nationals and Blocked Persons List maintained by OFAC
pursuant to Executive Order No. 13224, 66 Fed. Reg. 49079 (Sept. 25, 2001) and/or any other list of terrorists or other restricted Persons maintained pursuant to any of the rules and regulations of OFAC or pursuant to any other applicable
Executive Orders. 
 “Operating Documents” means, for any Person, such Person’s formation documents, as certified with
the Secretary of State of such Person’s state of formation on a date that is no earlier than thirty (30) days prior to the Closing Date, and (a) if such Person is a corporation, its bylaws in current form, (b) if such Person is a
limited liability company, its limited liability company agreement (or similar agreement), and (c) if such Person is a partnership, its partnership agreement (or similar agreement), each of the foregoing with all current amendments or
modifications thereto. 
 “Ordinary Course of Business” means, in respect of any transaction involving any Credit Party,
the ordinary course of business of such Credit Party, as conducted by such Credit Party in accordance with past practices or then current business practices set forth in the most recent operating plan of Borrower provided to Agent, which shall in
any event be at arms-length. 
 “Organizational Documents” means (a) for any corporation, the certificate or articles
of incorporation, the bylaws, (b) for any partnership, the partnership agreement and, if applicable, the certificate of limited partnership related thereto, (c) for any limited liability company, the operating agreement and articles or
certificate of formation or organization (d) any agreement between any Credit Party and its shareholders, members, partners or its equity owners, or among any of the foregoing, including, without limitation, any certificate of designation or
other instrument relating to the rights of shareholders, stockholders, members, partners or other equity owners of such Person, any shareholder rights agreement, investor rights agreement, registration rights agreement, or similar agreements; or
(e) all applicable resolutions of the shareholders, stockholders, members, partners or other equity owners of such Person and/or board of directors, managers, board of managers, or similar governing body (or any committee thereof) of such
Person. 
 “Payment Date” means the first calendar day of each calendar month. 

“Perfection Certificate” means the Perfection Certificate delivered to Agent as of the Closing Date, together with any
amendments thereto required under this Agreement. 
 “Permitted Contingent Obligations” means (a) Contingent
Obligations resulting from endorsements for collection or deposit in the Ordinary Course of Business; (b) Contingent Obligations incurred in the Ordinary Course of Business with respect to surety and appeal bonds, performance bonds and other
similar obligations not to exceed Twenty-Five Thousand Dollars ($25,000) in the aggregate at any time outstanding; (c) Contingent Obligations arising under indemnity agreements with title insurers; (d) Contingent Obligations arising with
respect to customary indemnification obligations in favor of purchasers in connection with dispositions of personal property assets permitted under Article 7; (e) so long as there exists no Event of Default both immediately before and
immediately after giving effect to any such transaction, Contingent Obligations existing or arising under any swap contract, provided, however, that such obligations are (or were) entered into by Borrower or an Affiliate in the
Ordinary Course of Business for the purpose of directly mitigating risks associated with liabilities, commitments, investments, assets, or property held or reasonably anticipated by such Person and not for purposes of speculation; and (f) other
Contingent Obligations not permitted by clauses (a) through (e) above, not to exceed $25,000 in the aggregate at any time outstanding. 

“Permitted Indebtedness” means: (a) Indebtedness to the Lenders and Agent under this Agreement and the other Financing
Documents; (b) Indebtedness existing on the Closing Date and described on the Disclosure Schedule; (c) Indebtedness secured by Permitted Liens; (d) Subordinated Debt; (e) unsecured Indebtedness to trade creditors incurred
in the Ordinary Course of Business; (f) Permitted Contingent Obligations; (g) extensions, refinancings, modifications, amendments and restatements of any items of Permitted Indebtedness (a), (b), (c), and (f) above, provided,
however, that the principal amount thereof is not increased or the terms thereof are not modified to impose more burdensome terms upon the obligors 

  
 46 

 
thereunder; (h) bona fide equity financings or bridge financings with Borrower’s investors, provided that, any such bridge financings must satisfy the requirements of Subordinated Debt;
(i) other unsecured Indebtedness otherwise not permitted by Section 7.4 in an aggregate principal amount not to exceed Two Hundred Fifty Thousand Dollars ($250,000) at any time outstanding; (j) Indebtedness consisting of
intercompany loans and advances made by any Credit Party to any other Credit Party, provided that (1) the obligations of the Credit Parties under such intercompany loan shall be subordinated at all times to the Obligations of the Credit Parties
hereunder or under the other Financing Documents in a manner satisfactory to Agent and (2) to the extent that such Indebtedness is evidenced by a promissory note or other written instrument, Borrower shall pledge and deliver to Agent, for the
benefit of itself and the Lenders, the original promissory note or instrument, as applicable, along with an endorsement in blank in form and substance satisfactory to Agent; (k) obligations arising under non-compete agreements; and
(l) obligations arising under bonus, deferred compensation, incentive compensation or similar arrangements. 
 “Permitted
Investments” means: (a) Investments existing on the Closing Date and described on the Disclosure Schedule; (b) Investments consisting of cash equivalents; (c) any Investments in cash and Cash Equivalents permitted by
Borrower’s investment policy, as amended from time to time, provided that such investment policy (and any such amendment thereto) has been approved in writing by Agent (provided, that, under no circumstances shall Borrower be permitted to
invest in or hold Margin Stock); (d) Investments consisting of the endorsement of negotiable instruments for deposit or collection or similar transactions in the ordinary course of any Credit Party; (e) Investments consisting of deposit
accounts or securities accounts in which the Agent has a first priority perfected security interest except as otherwise provided by Section 6.6; (f) Investments in Subsidiaries (other than the Specified UK Pharma Subsidiary or any
Excluded Domestic Subsidiary or Foreign Subsidiary), solely to the extent permitted pursuant to Section 6.8; (g) Investments consisting of (i) travel advances and employee relocation loans and other employee loans and advances
in the Ordinary Course of Business, and (ii) loans to employees, officers or directors relating to the purchase of equity securities of Borrower or its Subsidiaries pursuant to employee stock purchase plans or agreements approved by
Borrower’s board of directors; (h) Investments (including debt obligations) received in connection with the bankruptcy or reorganization of customers or suppliers and in settlement of delinquent obligations of, and other disputes with,
customers or suppliers arising in the Ordinary Course of Business; (i) Investments consisting of intercompany Indebtedness in accordance with and to the extent permitted by clause (h) of the definition of “Permitted
Indebtedness”; (j) Investments in the Specified UK Pharma Subsidiary in an aggregate amount for any fiscal year not to exceed One Hundred Thousand Dollars ($100,000); (k) Investments in any Excluded Domestic Subsidiary or Foreign
Subsidiary (other than the Specified UK Pharma Subsidiary) in an aggregate amount not to exceed One Hundred Thousand Dollars ($100,000) in the aggregate during the term of this Agreement; (l) any Investment under clause (b) of the
definition of Investment, the purpose of which is to acquire the Equipment of such Person, business, division or other unit operation of such Person as to Equipment not to exceed $100,000 in the aggregate during the term of this Agreement; and
(m) other Investments not otherwise permitted by Section 7.7 not to exceed Two Hundred Fifty Thousand Dollars ($250,000) in the aggregate outstanding at any time (other than Investments in any Excluded Domestic Subsidiary or Foreign
Subsidiary, including the Specified UK Pharma Subsidiary). 
 “Permitted Liens” means: (a) Liens existing on the
Closing Date and shown on the Disclosure Schedule or arising under this Agreement and the other Financing Documents; (b) (i) purchase money Liens (A) on Equipment acquired or held by a Credit Party incurred for financing the
acquisition of the Equipment, or (B) existing on Equipment when acquired, if the Lien is confined to the property and improvements and the proceeds of the Equipment and (ii) Liens on Equipment subject to Equipment leases with third
party Equipment lenders or lessors or with manufacturers or suppliers of Equipment, to the extent that the aggregate amount secured by such Liens described in clauses (b)(i) and (b)(ii) does not exceed Three Million Dollars ($3,000,000) in the
aggregate amount outstanding at any time; (c) Liens for Taxes, either not delinquent or being contested in good faith and for which adequate reserves are maintained on the Books of the Credit Party against whose asset such Lien exists, provided
that (i) no notice of any such Lien has been filed or recorded under the Internal Revenue Code of 1986, as amended, and the treasury regulations adopted thereunder, (ii) the aggregate amount of such Taxes secured by such Liens does not at
any time exceed for all Credit Parties Two Hundred Fifty Thousand Dollars ($250,000), and (iii) notwithstanding the foregoing, Permitted Liens shall in any case include Liens for Taxes secured by such Liens as do not at any time exceed for all
Credit Parties Twenty Thousand Dollars ($20,000); (d) statutory Liens securing claims or demands of materialmen, mechanics, carriers, warehousemen, landlords and other Persons imposed without action of such parties, provided that they
have no priority over any of Agent’s Lien and the aggregate amount of such Liens for all Credit Parties does not any time exceed One Hundred Thousand Dollars ($100,000); (e) leases or subleases of real property granted in the Ordinary
Course of Business, and leases, subleases, non-exclusive licenses or sublicenses of property (other than real property or Intellectual Property) granted in the Ordinary Course of Business, if the leases, subleases, licenses and sublicenses do
not prohibit granting Agent a security interest; (f) banker’s liens, rights of set-off and Liens in favor of 

  
 47 

 
financial institutions incurred made in the Ordinary Course of Business arising in connection with a Credit Party’s Collateral Accounts provided that such Collateral Accounts are subject to
a Control Agreement to the extent required hereunder; (g) Liens to secure payment of workers’ compensation, employment insurance, old-age pensions, social security and other like obligations incurred in the Ordinary Course of Business
(other than Liens imposed by ERISA); (h) Liens arising from judgments, decrees or attachments in circumstances not constituting an Event of Default; (i) easements, reservations, rights-of-way, restrictions, minor defects or irregularities
in title and similar charges or encumbrances affecting real property not constituting a Material Adverse Change; (j) Liens incurred in the extension, renewal or refinancing of the indebtedness secured by Liens described in (a) and
(b) above, but any extension, renewal or replacement Lien must be limited to the property encumbered by the existing Lien and the principal amount of the Indebtedness may not increase; (k) Permitted Licenses; (l) deposits made
to secure the performance of bids, trade contracts, leases, statutory obligations, surety and appeal bonds, performance bonds and other obligations of a like nature, in each case in the Ordinary Course of Business which secure obligations in the
aggregate amount not to exceed One Hundred Thousand Dollars ($100,000) at any time; and (m) other Liens with respect to Permitted Indebtedness that do not at any time exceed Four Hundred Thousand Dollars ($400,000) at any time. 

“Permitted Purchase Money Financing” means a purchase money financing or an equipment lease financing (whether involving a
capital lease or an operating lease) with a third party lender, lessor, manufacturer or supplier of such Equipment to the extent (i) such purchase money financing or equipment lease financing that involves capital lease obligations is permitted
pursuant to clause (c) of the definition of Permitted Indebtedness; and (ii) the collateral for which, or the leased equipment relating to which, is solely the Equipment being acquired by such purchase money financing or equipment lease
financing and which lien or lease relating thereto is a Permitted Lien or otherwise permitted by Agent, in each case together with any refinancings thereof meeting the same requirements. 

“Person” means any individual, sole proprietorship, partnership, limited liability company, joint venture, company, trust,
unincorporated organization, association, corporation, institution, public benefit corporation, firm, joint stock company, estate, entity or government agency. 

“Preferred Investors” means the owners of preferred stock of the Borrower as of the Closing Date. 

“Pro Rata Share” means, as determined by Agent, with respect to each Credit Facility and Lender holding an Applicable
Commitment or Credit Extensions in respect of such Credit Facility, a percentage (expressed as a decimal, rounded to the ninth decimal place) determined by dividing (a) in the case of fully-funded Credit Facilities, the amount of Credit
Extensions held by such Lender in such Credit Facility by the aggregate amount of all outstanding Credit Extensions for such Credit Facility, and (b) in the case of Credit Facilities that are not fully-funded, the amount of Credit
Extensions and unfunded Applicable Commitments held by such Lender in such Credit Facility by the aggregate amount of all outstanding Credit Extensions and unfunded Applicable Commitments for such Credit Facility. 

“Protective Advances” means all audit fees and expenses, costs, and expenses (including reasonable attorneys’ fees and
expenses) of Agent and Lenders for preparing, amending, negotiating, administering, defending and enforcing the Financing Documents (including, without limitation, those incurred in connection with appeals or Insolvency Proceedings) or otherwise
incurred by Agent or the Lenders in connection with the Financing Documents. 
 “Recipient” means (a) the Agent and
(b) any Lender, as applicable. 
 “Register” has the meaning given it in Section 13.1(d). 

“Registered Organization” means any “registered organization” as defined in the Code, with such additions to such
term as may hereafter be made. 
 “Required Lenders” means, unless all of the Lenders and Agent agree otherwise in writing,
Lenders having (a) more than sixty percent (60%) of the Applicable Commitments of all Lenders, or (b) if such Applicable Commitments have expired or been terminated, more than sixty percent (60%) of the aggregate outstanding
principal amount of the Credit Extensions. 

  
 48 

 “Required Permit” means all licenses, certificates, accreditations, product
clearances or approvals, provider numbers or provider authorizations, supplier numbers, provider numbers, marketing authorizations, other authorizations, registrations, permits, consents and approvals of a Credit Party (a) issued or required
under Laws applicable to the business of Borrower or any of its Subsidiaries or necessary in the manufacturing, importing, exporting, possession, ownership, warehousing, marketing, promoting, sale, labeling, furnishing, distribution or delivery of
goods or services under Laws applicable to the business of Borrower or any of its Subsidiaries, or (b) issued by any Person from which Borrower or any of its Subsidiaries have received an accreditation. Without limiting the generality of the
foregoing, “Required Permits” includes any Drug Application (including without limitation, at any point in time, all licenses, approvals and permits issued by the FDA or any other applicable Governmental Authority necessary for the
testing, manufacture, marketing or sale of any Product by any applicable Borrower(s) as such activities are being conducted by such Borrower with respect to such Product at such time) and any drug listings and drug establishment registrations under
21 U.S.C. Section 510, registrations issued by DEA under 21 U.S.C. Section 823 (if applicable to any Product), and those issued by State governments for the conduct of Borrower’s or any Subsidiary’s business. 

“Reserve Percentage” means, on any day, for any Lender, the maximum percentage prescribed by the Board of Governors of the
Federal Reserve System (or any successor Governmental Authority) for determining the reserve requirements (including any basic, supplemental, marginal, or emergency reserves) that are in effect on such date with respect to eurocurrency funding
(currently referred to as “eurocurrency liabilities”) of that Lender, but so long as such Lender is not required or directed under applicable regulations to maintain such reserves, the Reserve Percentage shall be zero. 

“Responsible Officer” means any of the President and Chief Executive Officer or Chief Financial Officer of Borrower. 

“Secretary’s Certificate” means, with respect to any Person, a certificate, in form and substance satisfactory to Agent,
executed by such Person’s secretary on behalf of such Person certifying that (a) such Person has the authority to execute, deliver, and perform its obligations under each of the Financing Documents to which it is a party, (b) that
attached as Exhibit A to such certificate is a true, correct, and complete copy of the Borrower Resolutions then in full force and effect authorizing and ratifying the execution, delivery, and performance by such Person of the Financing Documents to
which it is a party, (c) the name(s) of the Person(s) authorized to execute the Financing Documents on behalf of such Person, together with a sample of the true signature(s) of such Person(s), and (d) that Agent and the Lenders may
conclusively rely on such certificate unless and until such Person shall have delivered to Agent a further certificate canceling or amending such prior certificate. 

“Secured Promissory Note” has the meaning given it in Section 2.7. 

“Securities Account” means any “securities account”, as defined in the Code, with such additions to such term as
may hereafter be made. 
 “Specified UK Pharma Subsidiary” means that certain wholly-owned Subsidiary of Borrower that may
be formed in the United Kingdom or Ireland after the Closing Date as disclosed to Agent prior to the Closing Date. 
 “Stated
Rate” has the meaning given it in Section 2.6(g). 
 “Subject Equipment” has the meaning ascribed to it in
Exhibit A of this Agreement. 
 “Subordinated Debt” means indebtedness incurred by Borrower which shall be
(a) in an amount satisfactory to Agent, (b) made pursuant to documents in form and substance satisfactory to Agent (the “Subordinated Debt Documents”), and (c) subordinated to all of Borrower’s now or hereafter
indebtedness to the Agent and Lenders pursuant to a Subordination Agreement. 
 “Subordination Agreement” means a
subordination, intercreditor, or other similar agreement in form and substance, and on terms, approved by Agent in writing. 

  
 49 

 “Subsidiary” means, with respect to any Person, any Person of which more than
fifty percent (50.0%) of the voting stock or other equity interests (in the case of Persons other than corporations) is owned or controlled, directly or indirectly, by such Person. 

“Taxes” means present or future income, excise, stamp, court, documentary, intangible, recording, filing, payroll,
employment, property, franchise or similar taxes, fees, duties, levies, assessments, withholdings or other charges of any nature whatsoever (including interest and penalties thereon) imposed by any taxing authority. 

“Transfer” has the meaning given it in Section 7.1. 

[SIGNATURES APPEAR ON FOLLOWING PAGE(S)] 

  
 50 

 IN WITNESS WHEREOF, intending that this instrument constitute an instrument executed and
delivered under seal, the parties hereto have caused this Agreement to be executed as of the Closing Date. 
 BORROWER: 

 

							
	ZS PHARMA, INC.	 		  	
				
	By:	 	 /s/ Todd A. Creech
	 	(SEAL)	  	
	Name:	 	Todd A. Creech	 		  	
	Title:	 	Chief Financial Officer	 		  	

 CREDIT AND SECURITY AGREEMENT – Signature Page 

 AGENT: 
  

									
	MIDCAP FINANCIAL SBIC, LP,	 		  	
	as Agent for Lenders	 		  	
				
	By:	 	Midcap Financial SBIC GP, LLC	 		  	
					
		 	By:	 	 /s/ Josh Groman
	 	(SEAL)	  	
		 	Name:	 	Josh Groman	 		  	
		 	Title:	 	Its Authorized Signatory	 		  	

 LENDERS: 
  

									
	MIDCAP FINANCIAL SBIC, LP,	 		  	
				
	By:	 	Midcap Financial SBIC GP, LLC	 		  	
					
		 	By:	 	 /s/ Josh Groman
	 	(SEAL)	  	
		 	Name:	 	Josh Groman	 		  	
		 	Title:	 	Its Authorized Signatory	 		  	

  

									
	MIDCAP FINANCIAL, LLC	 		  	
					
		 	By:	 	 /s/ Josh Groman
	 	(SEAL)	  	
		 	Name:	 	Josh Groman	 		  	
		 	Title:	 	Managing Director	 		  	

 CREDIT AND SECURITY AGREEMENT – Signature Page 

 EXHIBITS AND SCHEDULES 

 

			
	 EXHIBITS
	  	 
		
	Exhibit A	  	Collateral
	Exhibit B	  	Form of Compliance Certificate
	Exhibit C	  	Credit Extension Form

 SCHEDULES 
 Credit
Facility Schedule 
 Amortization Schedule (for each Credit Facility) 

Post-Closing Obligations Schedule 
 Closing Deliveries Schedule

 Disclosure Schedule 
 Intangible Assets Schedule 

Products Schedule 
 Required Permits Schedule 

  
 1 

 EXHIBIT A 

COLLATERAL 
 The
Collateral consists of all assets of Borrower, including all of Borrower’s right, title and interest in and to the following personal property: 

(a) all goods, Accounts (including health-care insurance receivables), Equipment, Inventory, contract rights or rights to payment of money,
leases, license agreements, franchise agreements, General Intangibles, commercial tort claims described on Schedule A hereto, documents, instruments (including any promissory notes), chattel paper (whether tangible or electronic), cash, deposit
accounts, investment accounts, commodity accounts and other Collateral Accounts, all certificates of deposit, fixtures, letters of credit rights (whether or not the letter of credit is evidenced by a writing), securities, and all other investment
property, supporting obligations, and financial assets, whether now owned or hereafter acquired, wherever located; and 
 (b) all
Borrower’s Books relating to the foregoing, and any and all claims, rights and interests in any of the above and all substitutions for, additions, attachments, accessories, accessions and improvements to and replacements, products, proceeds and
insurance proceeds of any or all of the foregoing. 
 Notwithstanding the foregoing, except as provided below, the Collateral shall not
include (i) the Equipment financed pursuant to the Existing Equipment Leases or the related leasehold interest, (ii) any Equipment acquired by a Borrower after the Closing Date pursuant to Permitted Purchase Money Financing to the extent
that (A) 100% of the cost of such acquisition is financed by a third party lender, lessor, manufacturer or supplier of such Equipment and (B) the collateral for which, or the leased equipment relating to which, is solely the Equipment
being acquired, (iii) any Equipment the lien for which has been released by Agent or will not be taken by Agent pursuant to the last sentence of Section 4.1 hereof (such Equipment pursuant to clauses (i), (ii), and (iii), the
“Subject Equipment”), in each case pursuant to clause (i), (ii) or (iii), until the date on which the Indebtedness secured by such lien has been paid in full by Borrower at which time such Subject Equipment shall automatically
and without any further action by Borrower, any Credit Party, Agent or any Lender constitute Collateral or until the date that the obligations under the lease have been paid in full by Borrower, and Borrower or any Credit Party acquires the Subject
Equipment, at which time such Subject Equipment shall automatically and without any further action by Borrower, any Credit Party, Agent or any Lender constitute Collateral, and (iv) any Intellectual Property of any Credit Party, whether now
owned or hereafter acquired, except to the extent that it is necessary under applicable law to have a Lien and security interest in any such Intellectual Property in order to have a perfected Lien and security interest in and to IP Proceeds (defined
below), and for the avoidance of any doubt, the Collateral shall include, and Agent shall have a Lien and security interest in, (i) all IP Proceeds, and (ii) all payments with respect to IP Proceeds that are received after the commencement
of a bankruptcy or insolvency proceeding. The term “IP Proceeds” means, collectively, all cash, Accounts, license and royalty fees, claims, products, awards, judgments, insurance claims, and other revenues, proceeds or income,
arising out of, derived from or relating to any Intellectual Property of any Credit Party, and any claims for damage by way of any past, present or future infringement of any Intellectual Property of any Credit Party (including, without limitation,
all cash, royalty fees, other proceeds, Accounts and General Intangibles that consist of rights of payment to or on behalf of a Credit Party and the proceeds from the sale, licensing or other disposition of all or any part of, or rights in, any
Intellectual Property by or on behalf of a Credit Party). 
 Pursuant to the terms of a certain negative pledge arrangement with Agent and
Lenders, Borrower has agreed not to encumber (except for Permitted Licenses) any of its Intellectual Property without Agent’s and Lenders’ prior written consent. 

  
 1 

 EXHIBIT B 

COMPLIANCE CERTIFICATE 
  

			
	TO:	  	MidCap Financial SBIC, LP, as Agent
	FROM:	  	ZS Pharma, Inc.
	DATE:	  	            , 201        

 The undersigned authorized officer of ZS Pharma, Inc., a Delaware corporation (“Borrower”),
certifies that under the terms and conditions of the Credit and Security Agreement between Borrower, Agent and the Lenders (as amended, restated, supplemented, replaced or otherwise modified from time to time, the “Agreement”): 

(1) Borrower is in complete compliance with all required covenants for the month ending
            , 201    , except as noted below; 
 (2) there
are no Events of Default, except as noted in any notice delivered pursuant to Section 6.7 of the Agreement; 
 (3) all
representations and warranties in the Agreement are true and correct in all material respects on this date except as noted below; provided, however, that such materiality qualifier shall not be applicable to any
representations and warranties that already are qualified or modified by materiality in the text thereof; and provided, further, that those representations and warranties expressly referring to a specific date shall be true, accurate and
complete in all material respects as of such date; 
 (4) Each of Borrower and the other Credit Parties has timely filed all Tax returns and
reports required to be filed thereby with any Governmental Authorities, and has timely paid all Taxes and the other amounts and contributions owed under Section 6.4 hereof, except as otherwise permitted pursuant to the terms of the
Agreement; and 
 (5) no Liens have been levied or claims made against Borrower or any of its Subsidiaries relating to unpaid employee
payroll or benefits of which Borrower has not previously provided written notification to Agent. 
 Attached are the required documents
supporting the certifications set forth in this Compliance Certificate. The undersigned certifies, in his/her capacity as an officer of the Borrower, that these are prepared in accordance with GAAP consistently applied from one period to the next
except as explained in an accompanying letter or footnotes. The undersigned acknowledges, in his/her capacity as an officer of Borrower, that no borrowings may be requested at any time or date of determination that Borrower is not in compliance with
any of the terms of the Agreement, and that compliance is determined not just at the date this certificate is delivered. Capitalized terms used but not otherwise defined herein shall have the meanings given them in the Agreement. 

Please indicate compliance status by circling Yes/No under “Complies” column. 

 

					
	 Reporting Covenant
	  	 Required
	  	Complies
	Monthly Financial Statements	  	Monthly within 45 days	  	Yes         No
			
	Audited Financial Statements	  	Annually within 120 days after FYE	  	Yes         No
			
	Board Approved Operating Budget	  	Annually within 60 days after FYE	  	Yes         No
			
	Compliance Certificate	  	Monthly within 45 days	  	Yes         No

  
 1 

 The following are the exceptions with respect to the certification above: (If no exceptions
exist, state “No exceptions to note.”) 
  
  

 
  
  

 
  

											
	ZS PHARMA, INC.	  		  	AGENT USE ONLY	  	
					
		 		  		  	Received by:                                 
                	  	
	By:	 	  
	  		  	AUTHORIZED SIGNER	  	
	Name:	 	  
	  		  	Date:                                   
                          	  	
	Title:	 	  
	  		  		 		  	
		 		  		  	Verified:                                  
                     	  	
		 		  		  	AUTHORIZED SIGNER	  	
		 		  		  	Date:                                   
                          	  	
					
		 		  		  	Compliance Status:         Yes     No	  	

  
 2 

 EXHIBIT C CREDIT EXTENSION FORM 

DEADLINE IS NOON E.S.T. 

Date:             , 201     

LOAN ADVANCE: 

Complete Outgoing Wire Request section below if all or a portion of the funds from this loan advance are for an
outgoing wire. 
  

			
	From Account
#                                         
            	  	To Account #                                  
               
	                                (Loan Account #)	  	                            (Deposit Account #)
		
	Amount of Advance
$                                         
  	  	

 All Borrower’s representations and warranties in the Credit and Security Agreement are true,
correct and complete in all material respects on the date of the request for an advance; provided, however, that such materiality qualifier shall not be applicable to any representations and warranties that already are qualified or modified
by materiality in the text thereof; and provided, further, that those representations and warranties expressly referring to a specific date shall be true, accurate and complete in all material respects as of such date: 

 

			
	Authorized Signature:                         	  	Phone
Number:                                        
     
	Print
Name/Title:                                   	  	

 OUTGOING WIRE REQUEST: 

Complete only if all or a portion of funds from the loan advance above is to be wired. 

 

			
	Beneficiary Name:                               
                                         
                                         
                                         
               
		 	Amount of Wire:
$                                         
                  
	
	Beneficiary
Lender:                                        
                                         
    
		 	Account
Number:                                        
                     
	City and
State:                                        
             	 	
		
	Beneficiary Lender Transit (ABA) #:                 	 	        Beneficiary Lender Code (Swift, Sort, Chip, etc.):           
	(For International Wire Only)	 	
	Intermediary
Lender:                                        
   	 	        Transit (ABA)
#:                                        
             

  

	
	For Further Credit
to:                                        
                                         
                                         
                                       
	 Special
Instruction:                                       
                                         
                                         
                                         
   

 By signing below, I (we) acknowledge and agree that my (our) funds transfer request shall be
processed in accordance with and subject to the terms and conditions set forth in the agreements(s) covering funds transfer service(s), which agreements(s) were previously received and executed by me. 

 

			
	Authorized
Signature:                                       
  	  	2nd Signature (if
required):                                       
          
	Print
Name/Title:                                       
         	  	Print
Name/Title:                                       
                        
	Telephone
#:                                        
               	  	Telephone
#:                                         
                              

  
 1 

 CREDIT FACILITY SCHEDULE 

The following Credit Facilities are specified on this Credit Facility Schedule: 

Credit Facility #1: 
  

			
	Credit Facility and Type:	 	Term, Tranche 1

 Lenders for and their respective Applicable Commitments to this Credit Facility: 

 

					
	 Lender
	  	Applicable Commitment	 
	 MidCap Financial SBIC, LP
	  	$	7,500,000	  
	 MidCap Financial, LLC
	  	$	2,500,000	  

 The following defined terms apply to this Credit Facility: 

Applicable Prepayment Fee: means the following amount, calculated as of the date (the “Accrual Date”) that the Applicable Prepayment
Fee becomes payable in the case of prepayments required under the Financing Documents or the date any voluntary prepayment is made: (a) for an Accrual Date on or after the Closing Date through and including the date which is twelve
(12) months after the Closing Date, three percent (3.0%) multiplied by the amount of the outstanding principal of the Credit Extensions prepaid or required to be prepaid (whichever is greater); (b) for an Accrual Date after the date
which is twelve (12) months after the Closing Date through and including the date which is twenty-four (24) months after the Closing Date, two percent (2.0%) multiplied by the amount of the outstanding principal of the Credit
Extensions prepaid or required to be prepaid (whichever is greater); (c) for an Accrual Date after the date which is twenty-four (24) months after the Closing Date through and including the date immediately preceding the Maturity Date, one
percent (1.0%) multiplied by the amount of the outstanding principal of the Credit Extensions prepaid or required to be prepaid (whichever is greater). 

Closed Period: not applicable. 
 Commitment
Commencement Date: the Closing Date 
 Commitment Termination Date: the earliest to occur of (a) the close of the Business Day following the
Closing Date, (b) an Event of Default, (c) the existence of any Default, or (d) the Maturity Date. 
 Minimum Credit Extension Amount:
$10,000,000 
 Permitted Purpose: not applicable. 

 Credit Facility #2: 
  

			
	Credit Facility and Type:	 	Term, Tranche 2

 Lenders for and their respective Applicable Commitments to this Credit Facility: 

 

					
	 Lender
	  	Applicable Commitment	 
	 MidCap Financial SBIC, LP
	  	$	7,500,000	  
	 MidCap Financial, LLC
	  	$	2,500,000	  

 The following defined terms apply to this Credit Facility: 

Applicable Funding Condition: means (1) Agent has received evidence of positive data based on pre-specified endpoints from Borrower’s ZS004
trial, (2) Agent has received a completed Credit Extension Form, in accordance with Section 2.3(a), and (3) Agent has received the fee set forth in the Fee Letter in respect of the funding of Tranche 2. 

Applicable Prepayment Fee: means the following amount, calculated as of the date (the “Accrual Date”) that the Applicable Prepayment
Fee becomes payable in the case of prepayments required under the Financing Documents or the date any voluntary prepayment is made: (a) for an Accrual Date on or after the Closing Date through and including the date which is twelve
(12) months after the Closing Date, three percent (3.0%) multiplied by the amount of the outstanding principal of the Credit Extensions prepaid or required to be prepaid (whichever is greater); (b) for an Accrual Date after the date
which is twelve (12) months after the Closing Date through and including the date which is twenty-four (24) months after the Closing Date, two percent (2.0%) multiplied by the amount of the outstanding principal of the Credit
Extensions prepaid or required to be prepaid (whichever is greater); (c) for an Accrual Date after the date which is twenty-four (24) months after the Closing Date through and including the date immediately preceding the Maturity Date, one
percent (1.0%) multiplied by the amount of the outstanding principal of the Credit Extensions prepaid or required to be prepaid (whichever is greater). 

Closed Period: not applicable. 
 Commitment
Commencement Date: the later to occur of (a) Closing Date, or (b) satisfaction of the Applicable Funding Conditions for this Credit Facility 

Commitment Termination Date: the earliest to occur of (a) October 31, 2014, (b) an Event of Default, (c) the existence of any
Default, or (d) the Maturity Date. 
 Minimum Credit Extension Amount: $10,000,000 

Permitted Purpose: not applicable. 

 AMORTIZATION SCHEDULE (FOR EACH CREDIT FACILITY) 

Commencing on January 1, 2016, and continuing on the first day of each calendar month thereafter, an amount per month equal to the total amount of Credit
Extensions made under all Credit Facilities divided by thirty-six (36) months. 

 POST CLOSING OBLIGATIONS SCHEDULE 

Borrower shall satisfy and complete each of the following obligations, or provide Agent each of the items listed below, as applicable, on or
before the date indicated below, all to the satisfaction of Agent in its sole and absolute discretion: 
  

	1.	on or before the date that is 30 days following the Closing Date, duly executed Control Agreements with respect to each of Borrower’s Collateral Accounts; 

 

	2.	on or before the date that is 30 days following the Closing Date, a duly executed Access Agreement with respect to Borrower’s leased property located at 508 Wrangler Drive, Suite 100, Coppell, Texas 75019; and

  

	3.	on or before the date that is 5 Business Days after the Specified UK Pharma Subsidiary is formed and registered in the applicable jurisdiction, a duly executed stock pledge agreement in form and substance satisfactory
to Agent pursuant to which Borrower shall pledge not more than 65% of the voting securities of the Specified UK Pharma Subsidiary (and the rights related thereto). 

Borrower’s failure to complete and satisfy any of the above obligations on or before the date indicated above, or Borrower’s failure
to deliver any of the above listed items on or before the date indicated above, shall constitute an immediate and automatic Event of Default; provided, however, Agent may extend the deadline with respect to, or waive, in each case by a written
document only, any Post-Closing Obligation, in Agent’s sole discretion. 

 CLOSING DELIVERIES SCHEDULE 

 

	1.	duly executed original signatures to the Financing Documents to which Borrower is a party; 

  

	2.	duly executed original Secured Promissory Notes in favor of each Lender with a face amount equal to such Lender’s Applicable Commitment under each Credit Facility; 

 

	3.	the Operating Documents of Borrower and good standing certificates of Borrower certified by the Secretary of State of the state(s) of organization of Borrower as of a date no earlier than thirty (30) days prior to
the Closing Date; 

  

	4.	good standing certificates dated as of a date no earlier than thirty (30) days prior to the Closing Date to the effect that Borrower is qualified to transact business in all states in which the nature of
Borrower’s business so requires; 

  

	5.	a copy of the duly executed Borrowing Resolutions for Borrower; 

  

	6.	evidence that (i) the Liens securing Indebtedness owed by Borrower to the Texas Emerging Fund have been terminated and (ii) the documents and/or filings evidencing the perfection of such Liens, including
without limitation any financing statements and/or control agreements (if any), have been terminated; 

  

	7.	certified copies, dated as of a recent date, of financing statement searches, as Agent shall request, accompanied by written evidence (including any UCC termination statements) that the Liens indicated in any such
financing statements either constitute Permitted Liens or have been or, in connection with the initial Credit Extension, will be terminated or released; 

  

	8.	the Perfection Certificate executed by Borrower; 

  

	9.	a legal opinion of Borrower’s counsel dated as of the Closing Date together with the duly executed original signatures thereto; 

 

	10.	evidence satisfactory to Agent that the insurance policies required by Article 6 are in full force and effect, together with appropriate evidence showing loss payable and/or additional insured clauses or
endorsements in favor of Agent, for the ratable benefit of the Lenders; 

  

	11.	payment of the fees and expenses of Agent and Lenders then accrued, including pursuant to the Fee Letter; 

  

	12.	a duly executed original Secretary’s Certificate dated as of the Closing Date which includes copies of the completed Borrowing Resolutions for Borrower; 

 

	13.	timely receipt by the Agent of an executed disbursement letter; and 

  

	14.	a certificate executed by a Responsible Officer of Borrower, in form and substance satisfactory to Agent, which shall, among other things, certify as to certain conditions to the funding of the Credit Extensions on the
Closing Date. 

 DISCLOSURE SCHEDULE 

This Disclosure Schedule (the “Schedule”) is furnished by ZS Pharma, Inc., a Delaware corporation (the
“Borrower”), dated as of July 14, 2014, pursuant to and as part of that Credit and Security Agreement (the “Agreement”), dated as of the date hereof by and among MidCap Financial SBIC, LP, a Delaware limited
partnership (“MidCap”), the Lenders listed on the Credit Facility Schedule attached thereto and otherwise party thereto from time to time (each a “Lender”, and collectively the “Lenders”), and the
Borrower, and comprises the “Disclosure Schedule” as described therein. Unless otherwise provided herein, the capitalized and other terms used in the Schedule have the meaning ascribed to them under the Agreement. 

The Schedule is qualified in its entirety by reference to the specific provisions of the Agreement, and is not intended to constitute, and
shall not be construed as constituting, representations or warranties of the Company except as and to the extent specifically provided in the Agreement. Nothing in the Agreement or herein constitutes an admission that any information disclosed, set
forth or incorporated by reference herein or in the Agreement is required by the terms of the Agreement to be so disclosed, set forth or incorporated. Neither the specification of any dollar amount in the representations and warranties contained in
the Agreement nor the inclusion of any specific item in the Schedule is intended to imply that the amounts, higher or lower amounts, the items included or any other items, are or are not material (except as and to the extent specifically provided in
the Agreement), and each party hereto shall not use the fact of the setting of such amounts or the fact of the inclusion of any such item in the Schedule in any dispute or controversy between the parties as to whether any obligation, item, matter or
dollar amount (x) is or is not material or may or may not constitute an event or condition that could be considered to have had, or that would reasonably be expected to result, individually or in the aggregate, in a Material Adverse Change
(except as and to the extent specifically provided in the Agreement) or (y) is or is not in the ordinary course of business and/or consistent with past practice (except as and to the extent specifically provided in the Agreement). 

Matters disclosed for the purpose of one section or subsection of the Schedule shall constitute disclosure of such matters for the purposes of
other sections or subsections hereof to the extent that it is reasonably apparent on the face of such disclosure that such disclosure is applicable to such other sections or subsections. The duplication or cross-references of any disclosures made
herein shall not, in any instance or in the aggregate, effect a waiver of the foregoing statement. Headings have been provided for the sections of the Schedule for convenience of reference only and shall to no extent have the effect of amending or
changing any express description of the sections set forth in the Agreement. 

 Scheduled Permitted Liens 

 

							
	 Debtor
	  	 Secured Party
	  	 Collateral
	  	 State and

Jurisdiction

	 ZS Pharma, Inc.
	  	GL Filtration Limited	  	Filter Dryer	  	Delaware
				
	 ZS Pharma, Inc.
	  	De Lage Landen Financial Services, Inc.	  	Sharp MX-5141N Multifunction Printer	  	Delaware
				
	 ZS Pharma, Inc.
	  	De Lage Landen Financial Services, Inc.	  	Sharp MX-3640N Multifunction Printer	  	Delaware

 Scheduled Permitted Indebtedness 

None. 

 Scheduled Permitted Investments 

None. 

 Scheduled Material Agreements 

 

	1.	License Agreement, between the Company and UOP LLC, dated December 19, 2011. 

  

	2.	License Restructuring Agreement, between the Company, HemoCleanse, Inc. and UOP LLC, dated December 19, 2011. 

  

	3.	Sublicense Agreement, between HemoCleanse, Inc. and the Company, dated December 19, 2011. 

  

	4.	Park West Commerce Center Lease, by and between the Company and PW Commerce Center LP, dated February 11, 2013. 

  

	5.	Consent by Landlord, executed by Clear Creek Business Park LLC, dated October 18, 2013. 

  

	6.	Sublease, by and between the Company and InB: Hauser Pharmaceutical Services, Inc., dated October 18, 2013. 

  

	7.	Letter Agreement, by and between the Company and InB: Hauser Pharmaceutical Services, Inc., dated October 18, 2013. 

 Scheduled Litigation 

None. 

 Scheduled ownership interest in any Chattel Paper, letter of credit rights, commercial tort claims,
Instruments, documents or investment property 
 None. 

 INTANGIBLE ASSETS SCHEDULE 

 

									
	 Microporous Zirconium Silicate for the Treatment of
Hyperkalemia

	 Pat/Appl. #
	  	 Ref. #
	  	 Filing Date
	  	 Projected

Issue Date
	  	 Projected

Expiration Date

	61/441,893	  	76955.000004	  	11 Feb 11	  	NA	  	expired
	PCT/US12/24727	  	76955.000005	  	10 Feb 12	  	NA	  	10 Feb 2032
	 •     Australia (AU 2012214224)

•     Canada (CA 2827056)

•     Chile (CL 2337/2013)

•     China (CN TBD)

•     Colombia (CO 13-204047)

•     EPO (EP 12744254.9)
	  	 •     Israel (IL 227907)

•     Indonesia (IN 6681/CHENP/2013)

•     Japan (TBD)

•     Korea (KR 10-2013-7023967)

•     Mexico (MX/A/2013/009271)

•     Philippines (PH 1-2013-501762)

	 US 13/371,080
 (US2012/0213847)
	  	76955.000004	  	10 Feb 12	  	10 Feb 15	  	10 Feb 2032
	 US 14/036,489
 (US2014/0044785)
	  	76955.000031	  	25 Sep 13	  	25 Sep 2014	  	10 Feb 2032
	US 14/096,692	  	76955.000043	  	4 Dec 13	  	4 Dec 2016	  	10 Feb 2032
	US 14/096,712	  	76955.000047	  	4 Dec 13	  	4 Dec 2016	  	10 Feb 2032
	US 14/096,728	  	76955.000048	  	4 Dec 13	  	4 Dec 2016	  	10 Feb 2032
	US 14/226,279	  	76955.000053	  	TBD	  		  	
	
	 Microporous Zirconium Silicate and its Method of
Production

	 Pat/Appl. #
	  	 Ref. #
	  	 Filing Date
	  	 Projected

Issue Date
	  	 Projected

Expiration Date

	 61/658,117
	  	76955.000006	  	11 Jun 12	  	NA	  	expired
	 PCT/US13/45219
	  	76955.000013	  	11 Jun 13	  	NA	  	NA
	 13/829,415

(US2013/0334122)
	  	76955.000011	  	14 Mar 13	  	14 Mar 16	  	14 Mar 2033
	
	 Microporous Zirconium Silicate for the Treatment of
Hyperkalemia in Hypercalcemic
 Patients and Improved Calcium-Containing Compositions for the Treatment of
Hyperkalemia

	 Pat/Appl. #
	  	 Ref. #
	  	 Filing Date
	  	 Projected Issue Date
	  	 Projected

Expiration Date

	 61/670,415
	  	76595.000007	  	15 Mar 13	  	NA	  	expired
	 61/800,291
	  	76955.000010	  	11 Jul 13	  	NA	  	expired
	 13/939,656

(US2014/0105971)
	  	76595.000015	  	11 Jul 13	  	11 Jul 16	  	11 Jul 2033
	 PCT/US13/50071
	  	76595.000014	  	11 Jul 13	  	11 Jul 16	  	11 Jul 2033

									
	 Microporous Zirconium Silicate for the Treatment of
Hyperkalemia

	 PAT/APPL. #
	  	 REF. #
	  	 FILING DATE
	  	 PUB. DATE
	  	 PROJECTED

EXPIRATION DATE

	61/800,182	  	76955.000009	  	15 Mar 13	  	NA	  	expired
	61/716,956	  	76955.000008	  	22 Oct 12	  	NA	  	expired
	 14/060,279
 (US2014/0113002)
	  	76955.000037	  	22 Oct 13	  	22 Oct 16	  	22 Oct 2033
	PCT/US13/66207	  	76955.000033	  	22 Oct 13	  	22 Oct 16	  	22 Oct 2033
	61/901,886	  	76955.000045	  	8 Nov 13	  	NA	  	NA
	61/914,354	  	76955.000044	  	10 Dec 13	  	NA	  	NA
	61/930,328	  	76955.000049	  	22 Jan 14	  	NA	  	NA
	61/930,336	  	76955.000051	  	22 Jan 14	  	NA	  	NA
	
	 Non-PCT Applications: 

Argentina (AR TBD filed 10/22/2013)
 Venezuela (VE TBD filed
10/22/2013)
 Taiwan (TW TBD filed 10/22/2013)
 Pakistan (PK TBD
filed 10/22/2013)

	
	 Microporous Zirconium Silicate for the Reduction of
Aldosterone and Treatment of Chronic Kidney and/or Chronic Heart Disease

	 Pat/Appl. #
	  	 Ref. #
	  	 Filing Date
	  	 Projected

Issue Date
	  	 Projected

Expiration Date

	61/808,897	  	76955.000012	  	5 Apr 13	  	NA	  	NA
	61/914,362	  	76955.000041	  	10 Dec 13	  		  	NA
	14/244,446	  	76955.000057	  	5 Apr 14	  	5 Apr 2017	  	5 Apr 2034
	PCT/US14/32815	  	76955.000058	  	5 Apr 14	  	5 Apr 2017	  	5 Apr 2034
	61/930,331	  	76955.000050	  	22 Jan 14	  	NA	  	NA
	
	 Non-PCT Applications:
 Argentina (AR
TBD filed 4/5/2014)
 Venezuela (VE TBD filed 4/5/2014)
 Taiwan
(TW TBD filed 4/5/2014)
 Pakistan (PK TBD filed 4/5/2014)

	
	 Microporous Zirconium Silicate for the Treatment of
Hyperkalemia Without Co-Administration of Lithium

	 Pat/Appl. #
	  	 Ref. #
	  	 Filing Date
	  	 Projected

Issue Date
	  	 Projected

Expiration Date

	61/914,377	  	76955.000042	  	10 Dec 2013	  	NA	  	NA

 INTANGIBLE ASSETS SCHEDULE 

LICENSE AND SIMILAR AGREEMENTS 
  

							
	 License Agreement #1

		
	Name and Date of License Agreement:	  	License Agreement, between the Company and UOP LLC, dated December 19, 2011
		
	Borrower that is Licensee:	  	ZS Pharma, Inc.
		
	Name and address of Licensor:	  	 UOP LLC
 UOP Legal Department

25 East Algonquin Road
 Des Plaines, Illinois
60017-5017

		
	Expiration Date of License	  	Agreement continues until the expiration or termination of the UOP Patent Rights.
		
	Exclusive License [Y/N]?	  	Yes
			
	Restrictions on:	  	Right to Grant a Lien [Y/N]?	  	None stated.
			
		  	Right to Assign [Y/N]?	  	Yes. The agreement is not assignable without prior written consent of the other party; however, it may be assigned to a successor in interest of all or substantially all of the business and assets of such
party.
			
		  	Right to Sublicense [Y/N]?	  	Yes. Borrower must give written notice to UOP. Sublicensee does not have the right to further sublicense.
		
	Does Default or Termination Affect Agent’s Ability to sell [Y/N]?	  	Yes. If UOP determines that Borrowers ability to honor its indemnification or insurance obligations is materially impaired due to the number of claims anticipated or Borrowers financial condition. There is a 90 day cure
period for default in paying the royalty fees.

							
	Describe Licensed Intellectual Property For This License
				
	 Identifier of IP
	  	 Type of IP
	  	 Registration or Application Number
	  	 Filing Date / Expiration Date

	 Process for removing pollutants from aqueous streams
	  	Patent	  	US 6,814,871	  	Jul 01, 2013 / Oct 26, 2021
				
	 Process and composition for removing toxins from bodily fluids
	  	 Patent
	  	 US 6,579,460
	  	 Mar 01, 2013 / Oct 26, 2021

				
	 Process for removing toxins from
bodily fluids using zirconium or titanium microporous compositions
	  	 Patent
	  	 US 6,332,985
	  	 Jun 19, 2000 / Mar 29, 2019

				
	 Process for removing toxins from blood using zirconium metallate or titanium metallate compositions
	  	 Patent
	  	 US 6,099,737
	  	 Mar 29, 1999 (CIP of Mar 29, 1999) / Mar 29, 2019

				
	 Zircomium silicate and zirconium germanate molecular sieves and process using the same
	  	 Patent
	  	 US 5,891,417
	  	 Dec 15, 1997 (CIP of Apr 08, 1997) / Apr 08, 2017

				
	 Zirconium silicate molecular sieves and process using the same
	  	 Patent
	  	 US 5,888,472
	  	 Apr 08, 1997 / Apr 08, 2017

				
		  	Patent	  	US 13/211,012	  	Aug 16, 2011 / Aug 16, 2031
				
		  	Patent	  	PCT/US2011/050984	  	Aug 16, 2011 / Aug 16, 2031

  

							
	License Agreement #2
		
	Name and Date of License Agreement:	  	License Restructuring Agreement, between the Company, HemoCleanse, Inc. and UOP LLC, dated December 19, 2011
		
	Borrower that is Licensee:	  	ZS Pharma, Inc.
		
	Name and address of Licensor:	  	 UOP LLC
 25 East Algonquin Road

Des Plaines, Illinois 60017-5017

		
	Expiration Date of License	  	Agreement continues until termination of both the License Agreement (License #1) and Sublicense Agreement (License #3)
		
	Exclusive License [Y/N]?	  	n/a
			
	Restrictions on:	  	Right to Grant a Lien [Y/N]?	  	None stated.
			
		  	Right to Assign [Y/N]?	  	Yes. The agreement is not assignable without prior written consent of the other parties; however, it may be assigned to a successor in interest of all or substantially all of the business and assets of such
party.
			
		  	Right to Sublicense [Y/N]?	  	None stated.
		
	Does Default or Termination Affect Agent’s Ability to sell [Y/N]?	  	n/a - See License #1 and Sublicense #3.

							
	Describe Licensed Intellectual Property For This License
				
	 Identifier of IP
	  	 Type of IP
	  	 Registration or Application Number
	  	 Filing Date / Expiration Date

	n/a	  	n/a	  	n/a	  	n/a

  

					
			
	License Agreement #3	  		  	
		
	Name and Date of License Agreement:	  	Sublicense Agreement, between HemoCleanse, Inc. and the Company, dated December 19, 2011
		
	Licensee:	  	HemoCleanse
		
	Borrower who is Licensor:	  	ZS Pharma, Inc.
		
	Expiration Date of License	  	Continues until expiration or invalidation of all of the UOP Patent Rights
		
	Exclusive License [Y/N]?	  	Yes
			
	Restrictions on:	  	Right to Grant a Lien [Y/N]?	  	None stated.
			
		  	Right to Assign [Y/N]?	  	Yes. The agreement is not assignable without prior written consent of the other party; however, it may be assigned to a successor in interest of all or substantially all of the business and assets of such party.
			
		  	Right to Sublicense [Y/N]?	  	Yes. None stated, but limited by the License Agreement #1.
		
	Does Default or Termination Affect Agent’s Ability to sell [Y/N]?	  	Potentially. Sublicense terminates upon termination of the UOP License #1 (above).

  

							
	Describe Licensed Intellectual Property For This License
				
	 Identifier of IP
	  	 Type of IP
	  	 Registration or Application Number
	  	 Filing Date / Expiration Date

	(See License Agreement #1 - Sublicense applies to the same intellectual property related to removing toxins from bodily fluids outside the body of humans and animals.)

 INTANGIBLE ASSETS SCHEDULE 

TRADEMARKS 
  

							
	 Serial No.
	  	 Application Date
	  	 Mark
	  	 Registrant

	86240215	  	04/02/2014	  	Lokelma	  	ZS Pharma, Inc.
				
	86240210	  	04/02/2014	  	Balpota	  	ZS Pharma, Inc.
				
	86240203	  	04/02/2014	  	Kiskeda	  	ZS Pharma, Inc.
				
	86240195	  	04/02/2014	  	ZS Pharma	  	ZS Pharma, Inc.
				
	86214882	  	03/07/2014	  	ZS Pharma (logo)	  	ZS Pharma, Inc.
				
	in process	  	in process	  	Ekryxla	  	ZS Pharma, Inc.
				
	in process	  	in process	  	Kryxla	  	ZS Pharma, Inc.

 PRODUCTS SCHEDULE 

None. 

 REQUIRED PERMITS SCHEDULE 

 

	1.	Certificate of Registration for Industrial Radiation Machines, Registration Number R37548, issued by the Texas Department of State Health Services, dated June 21, 2013. 

 

	2.	Certificate confirming Borrower to be a Conditionally Exempt Small Quantity Generator, EPA ID Number COR98377056, issued by the Hazardous Materials & Waste Management Division of the Colorado Department of
Public Health and Environment, dated December 16, 2013. 

  

	3.	Certificate of Occupancy, Permit Number CB-13-1491, issued by the City of Coppell, dated July 18, 2013. 

  

	4.	FM200 Test Certificate, issued by the City of Coppell, dated July 15, 2013. 

  

	5.	When and if it is approved and becomes effective, Borrower’s permit from the FDA allowing production of API materials (ZS-9).

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00233-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00233-of-00352.parquet"}]]